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Carbohydrates are the most abundant biomolecules found in living organisms. In 
addition to their roles such as fuel storage and structural components, carbohydrates 
encode molecular recognition information. Carbohydrates presented on the cell surface 
interact with cell surface receptors. These carbohydrate-receptor interactions are involved 
in a variety of biological processes including intercellular adhesion, microbial 
attachment, and signal transduction. Research in the DeShong laboratory has been 
focused on the development of cellular probes and targeted delivery vehicles utilizing 
carbohydrate-cell surface receptor interactions. The work reported herein details (1) the 
synthesis of glycoconjugates to functionalize the surface of gold, silica, nanoparticles, 
and surfactant vesicles, and (2) the preparation and characterization of carbohydrate-
functionalized gold nanospheres and surfactant vesicles. 
A variety of N-linked glycoconjugates tethered to thiols, siloxanes, and 
hydrocarbons were synthesized via modified Staudinger methodology with a high 
stereoselectivity. The stereochemistry at the anomeric center (α vs. β) was readily 
controlled by choosing the appropriate reaction conditions. Typically, the α-
stereochemistry arose from the reaction of ester derivatives with isoxazolines generated 
in-situ via epimerization of β-phosphorimines at high temperature. The ability to control 
tether length has been demonstrated. 
Carbohydrate-functionalized gold nanospheres were prepared by two methods: (1) 
in-situ reduction of gold salt in the presence of thiolated glycoconjugates to provide ca. 2 
nm particles and (2) a stepwise method where thiolated glycoconjugates were self-
assembled on the surface of pre-formed, citrate-capped gold nanospheres to provide 
nanospheres with larger diameters (15 - 73 nm).  
Carbohydrate-functionalized surfactant vesicles were prepared by mixing a cationic 
surfactant cetyltrimethylammonium tosylate (CTAT) and an anionic surfactant sodium 
dodecylbenzenesulfonate (SDBS) in the presence of lipidated glycoconjugates. The 
resulting surfactant vesicles were stable, in mean diameter of ca. 140 nm, and showed 
significant amounts of glycoconjugate incorporation.  
The bioactivity of carbohydrates on the surface of gold nanospheres and surfactant 
vesicles was investigated through agglutination assays using carbohydrate-binding lectins 
concanavalin A and peanut agglutinin. These agglutination results indicated that both 
gold nanospheres and surfactant vesicles display multiple presentations of carbohydrates 
on their surfaces that can be used for binding of receptors. 
The suitability of the resulting glycosylated nanomaterials for use as cellular 
probes and targeted delivery vehicles is being investigated.  
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Chapter 1: Introduction 
Biological Importance of Carbohydrates 
Carbohydrates (i.e., saccharides) are the most abundant biomolecules found in 
living organisms. The roles of carbohydrates in living cells are as fuel storage elements 
(starch and glycogen) and structural components (cellulose, chitin, and peptidoglycans).1 
In addition, carbohydrates encode molecular recognition information. Carbohydrates 
presented on the cell surfaces are covalently attached either to proteins or lipids to form 
glycoconjuates (glycoproteins and glycolipids). Receptors (proteins) presented on other 
cell surfaces recognize specific carbohydrate moieties on the glycoconjugates. These 
carbohydrate-receptor interactions are involved in a wide range of biological processes 

















Figure 1. Schematic illustration of carbohydrate-receptor interactions on cell surfaces. 
 1
Carbohydrates have been of great significance for human health due to their central 
roles in pathogen infection, cancer metastasis, and mediation of immune response. 
Furthermore, aberrant glycosylation has been detected in diseases such as autoimmune 
diseases and cancer.2,3 For example, Vibrio cholerae (cholera) toxin, Clostridium tetani 
(tetanus) toxin, influenza virus, polyoma virus, Helicobacter pylori bacterium, and 
malaria parasite target terminal sialic acid residues of glycoconjugates presented on 










R = various α-glycosidic linked carbohydrate chains  
Figure 2. Structure of N-acetylneuraminic acid which is the most common form of sialic 
acid found in mammalian glycoconjugates.  
 
The human immunodeficiency virus (HIV-1) utilizes carbohydrate-receptor 
interactions to facilitate infection of T cells.6 During transmission, HIV encounters 
dendritic cells located in the mucosae (including the oral, vaginal, and intestinal mucosa), 
and the viral envelope glycoprotein gp120 targets a receptor known as dendritic cell-
specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) expressed on 
the surface of dedritic cells. The interaction of the DC-SIGN receptor with mannose-rich 
oligosaccharides on the viral surface gp120 is required for the binding of HIV to dendritic 
cells. Thus, dendritic cells carry captured HIV to lymph nodes, where HIV migrates to 
the CD4 receptor on T cell surfaces through the cell-cell junctions known as infectious 














Figure 3. Schematic illustration of dendritic cell-mediated HIV infection.  
 
In the human defense system, five distinct classes of immunoglobulins (IgA, IgD, 
IgE, IgG, and IgM) have been identified, and these are highly glycosylated with 
considerable diversity in the number, type, and location (Figure 4).8 The oligosaccharides 
attached to immunoglobulins (Igs) play crucial roles both on the structure and biological 
functions of Igs.8-10 For example, IgA and IgD are the only Igs that have oligosaccharides 
in the hinge regions (Figure 4). Since the hinge regions in IgA and IgD are more 
extended than those in the other Igs, they are susceptible to proteolytic cleavage. The 
oligosaccharides located on the hinge regions in IgA and IgD protect the hinge regions 
from proteases secreted by pathogens.8 Oligosaccharides on Igs directly or indirectly 
participate in binding events with a variety of receptors to initiate effector systems which 
are on the pathways to eliminate targeted antigens. Directly, oligosaccharides provide 
recognition epitopes to the receptors. Indirectly, oligosaccharides maintain a specific 
conformation of crystalizable fragment (Fc) for optimal binding with Fc receptors.8 The 
distribution of oligosaccharides in a given state of Igs is well controlled and reproducible. 
However, alternations in glycosylation of Igs cause diseases such as rheumatoid arthritis 
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(RA), IgA nephropathy, and congenital disorders of glycosylation (CDGs).8-10 
 
 
Figure 4. Diagrammatic representation of immunoglobulins (Igs) showing light chains 
(purple), heavy chains (blue), interchain disulfide bridges (black), and carbohydrates 
(green). Each number corresponds to the sites of glycosylation in Igs. Redrawn from ref. 
8. 
 
Leukocyte extravasation is another process in which carbohydrates play a key role. 
Leukocyte extravasation is the migration of leukocytes from the circulatory system 
toward the site of tissue damage or infection in order to initiate inflammatory response. 
During the multistep extravasation process (Figure 5), leukocytes circulating in the 
bloodstream interact in a sequential fashion with cell adhesion molecules expressed on 
the vascular endothelium, resulting in weak adhesion and rolling, firm attachment, and 
transendothelial migration of leukocytes into the target tissue (Figure 5).11,12 In order to 
have an acute inflammatory response, the recruitment of leukocytes to the sites of injury 
is essential. The first stage, involved in the specific recruitment and rolling of leukocytes, 
is mediated by the multiple interactions between carbohydrates (sialyl Lewis a or sialyl 
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and rolling 











































Sialyl Lewis a (sLea)  
Figure 5. Schematic illustration of leukocyte extravasation from the blood stream into 
the target tissues. The weak adhesion and rolling steps of leucocytes with different 
receptors are specified, and the structures of carbohydrates responsible for the adhesion 
are shown. 
 
Altered glycosylation is a universal feature of cancer cells.3 Changes in 
glycosylation include under- and overexpression of naturally-occurring carbohydrates. 
For example, carbohydrates expressed on cancer cells are often increased in size and 
branching. The increased branching produces additional sites for terminal sialic acid 
residues, which leads to an increase in sialylation.13 Examples of carbohydrate epitopes 



























































































































































Figure 6. Cancer-associated oligosaccharide epitopes.  
 
In addition, cancer cells utilize altered carbohydrates to regulate many different 
stages of cancer progression, including proliferation, invasion, angiogenesis and 
metastasis.14 For instant, metastasis responsible for the death of most cancer patients is a 
multi-step process where cancer cells intravasate from their primary site to the blood 
stream (dissociation and invasion), disseminate through the bloodstream, extravasate to 
the targeted organs, and form metastases. These processes are similar to those of 
leukocyte-endothelial interaction in inflammation (Figure 5).11 During the intravasation, 
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sialylated oligosaccharides (e.g., sTn in Figure 6) overexpressed on cancer cells promote 
dissociation of cancer cells. Once the cancer cells enter the bloodstream, they form an 
aggregation with host cells such as platelets and leukocytes to facilitate dissemination and 
migrate to the metastatic organ by binding to the endothelium.14 The formation of an 
aggregate and binding to the endothelium are mediated by the interactions between 
altered carbohydrates (i.e., sLea and sLex in Figure 6) on the cancer cells and selectins 
expressed on activated platelets (P-selectin), leukocytes (L-selectin) and endothelial cells 
(E-selectin).14  
 
The examples described above represent a fraction of the biological systems that 
demonstrate the importance of carbohydrates. It is clear that carbohydrates are associated 
with many aspects of human health and diseases, which means that they are also critical 
in developing a new generation of therapeutics and diagnostics. Understanding the 
structure and function of carbohydrates in cellular events (carbohydrate-receptor 
interaction), monitoring and controlling glycosylation processes (altered glycosylation), 









Glycotechnology: Carbohydrate Meets Modern Technologies 
Carbohydrates have intrigued biologists for decades because of their tremendous 
importance in complex cellular events. Therefore, glycobiology dealing with the structure 
and function of carbohydrates has become one of the most widely studied areas in 
biochemistry and cell biology. Rapid advances in glycobiology, however, have been 
hindered by the lack of research tools and the complexity of oligosaccharides. Due to 
their nature of linkage diversity, oligosaccharides have an inherent structural 
complexity.2,3 For example, each monosaccharide can have linkage up to five positions 
with either α or β stereochemistry. This means that there are more than 15 million 
possible combinations to form tetrasaccharides from the eight common 
monosacchrides.15 The identification of the oligosaccharide sequence on a specific 
glycoconjugate is further complicated because several of the eight common 
monosaccharides have identical masses. Technically, it is very difficult to isolate 
sufficient quantities of chemically defined oligosaccharides and glycoconjugates from 
natural sources because of their heterogeneity and low concentration. Simple and 
effective synthetic approaches are, therefore, essential to solve many problems in 
glycobiology.  
Two general synthetic strategies are used for the preparation of oligosacchrides: 
enzymatic synthesis and chemical synthesis (Figure 7).16 In enzymatic synthesis (Figure 
7a), the formation of glycosidic bonds is catalyzed by enzymes, typically, 
glycosyltransferases or glycosidases. Although their availability, cost, and ability to 
assemble novel saccharides are major limitations, a great advantage utilizing enzymes is 
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that absolute regio- and stereochemistry can be controlled, which is the central challenge 
in carbohydrate chemistry.  
In chemical synthesis (Figure 7b), a nucleophilic acceptor reacts with an 
electrophilic intermediate created by the activation of glycosyl donor, resulting in the 
formation of either α- or β-anomer. In order to obtain the desired configuration of a 
glycosidic linkage, it is necessary to control regio- and stereochemistry in chemical 
synthesis. Current chemical methods to achieve regiochemical and stereochemical control 
in glycosidic bond formation require tremendous manipulation of protecting groups, time 























































































Figure 7. Two general approaches for the preparation of oligosaccharides. 
 
Recent advances in chemical synthesis of oligosaccharides and the development of 
solid phase enzymatic synthesis have provided access to obtaining pure, chemically 
 9
defined oligosaccharides.15,17 Solid phase enzymatic synthesis has been achieved by the 
immobilization of ether the acceptor carbohydrate or the enzyme to the solid support 
(Figure 8). When the acceptor carbohydrates are bound to the solid supports (Figure 8a), 
the required enzymes and their corresponding nucleotide sugars react consecutively to 
produce complex oligosaccharides.18 Alternatively, the growing carbohydrates attached 
to a water-soluble polymer react consecutively with nucleotide sugars and enzymes 
immobilized on solid supports (Figure 8b).19 In each step, the carbohydrates produced are 
readily purified by gel filtration due to the size of polymer.   































Transferase 1 Transferase 2 Transferase 3
(b) Immobilized enzymes
Nucleotide sugar Nucleotide sugar
 
Figure 8. Schematic illustration of solid phase enzymatic synthesis of oligosaccharides. 
 
The strategy of programmable solution phase, one-pot synthesis (Figure 9a) is 
based on the relative reactivity of different protected carbohydrate ‘building blocks’.20 A 
 10
computer program known as ‘OptiMer’ contains the database regarding relative reactivity 
values of hundreds of building blocks. OptiMer uses this database to analyze a target 
oligosaccharide, selects the best combinations of build blocks, and determines the order 
in which they should be added during oligosaccharide assembly. This approach has been 
used with success in the synthesis of a large number of oligosaccharides, including 




































(b) Automated solid phase synthesis
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Figure 9. Recent advances in chemical synthesis of oligosaccharides. 
 
The automation of solid phase oligosaccharide synthesis (Figure 9b) has been 
achieved by the modification of existing automated peptide technology.24 Like a general 
procedure of solid phase synthesis of oligosaccharides, the first carbohydrate building 
block is bound to the solid support by coupling reaction. Selective deprotection reveals a 
new acceptor hydroxyl group, and the cycle of coupling and selective deprotection is 
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repeated as many times as needed. Finally, cleavage and global deprotection produce the 
desire oligosaccharide. This process has been fully automated and has been utilized for 
the preparation of oligosaccharides of interest.25 Linear heptamannoside (seven mannose 
linked in a linear fashion), for example, was prepared by this automated synthesizer in 20 
hours with 42 % overall yield. As a comparison, manual synthesis of linear 
heptamannoside on solid support took 14 days with 9 % overall yield.24 
The interaction between a carbohydrate and the individual binding site in a protein 
is typically weak. However, binding strength and specificity are often increased through 
polyvalent interactions characterized by simultaneous binding of multiple carbohydrates 
presented on the cell surfaces to oligomeric carbohydrate-binding proteins.26 Therefore, 
carbohydrate immobilized onto a solid surface, which presents multiple copies of 
carbohydrate, could be particularly suitable for studying carbohydrate-protein 
interactions. 
At present some of the fascinating tools for studying carbohydrate-protein 
interactions are illustrated in Figure 10.17,27-29 Carbohydrate-based vaccines consisting of 
a carbohydrate antigen and an immunogenic protein (Figure 10a) have been developed 
against bacteria, parasites, viruses, and human cancers.17 The cell surface of pathogens 
and human cancers often display distinct carbohydrates. Those carbohydrate markers are 
either isolated30 or synthesized31 and then attached to the proteins by a number of viable 
linking chemistries32 to generate immune responses.  
Analogous to DNA and protein arrays, carbohydrate microarrays (Figure 10b) have 
been used for the high-throughput evaluation of carbohydrate binding to a variety of 
macromolecules, as well as entire cells.17,27,28,33 Mono- and multivalent interactions 
 12
between self-assembled monolayer of carbohydrates (Figure 10b) and proteins have been 




















































Figure 10. Glycotechnology: tools for glycobiology. 
 
Carbohydrate functionalized nanoparticles (Figure 10c) have lately gained a great 
attraction as cellular probes and drug delivery vehicles.27,29,36 Gold nanoparticles and 
quantum dots functionalized with carbohydrates have unique properties which include 
size-related electronic, magnetic, and optical responses. The dense presentation of the 
carbohydrates on the globular surface can mimic the situation encountered on cell 
surfaces that allows for multivalent interactions of relatively weak binding carbohydrates. 
These materials have been utilized as tools for the study of carbohydrate-carbohydrate 
interactions, carbohydrate-protein interactions, as biolabels, in toxin detection, and in 
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biomedicine.27,29 The preparation and applications of gold nanoparticles functionalized 
with carbohydrates will be discussed in Chapter 3.  
Liposomes have been employed as pharmaceutical carriers due to their huge inside 
cavity in which pharmaceuticals can be entrapped and released.37,38 A major drawback of 
liposomal formulations, however, is the inherent instability, expense and difficulty of 
preparation associated with liposomes. In Chapter 4, the preparation and characterization 
of surfactant-based vesicles as alternatives to conventional liposomes is reported. It is 
hoped that these carbohydrate-functionalized vesicles will have applications in both basic 
and applied glycobiology. 
 
Research Goals 
Research in the DeShong group has been focused on the development of cellular 
probes and targeted delivery vehicles utilizing carbohydrate-cell surface receptor 
interactions. Toward this goal, three distinct sub-goals were included: first, simple and 
effective methodologies for the synthesis of a variety of N-linked glycoconjugates to 
functionalize solid surfaces were to be achieved, and the results of these studies are 
discussed in Chapter 2. Once the glycoconjugates were prepared, the second phase was to 
prepare carbohydrate-functionalized gold nanospheres and surfactant vesicles. Finally, 
the bioactivity of carbohydrates on the surface of gold nanospheres and surfactant 
vesicles was to be investigated. The results of studies with gold nanoparticles and 
surfactant vesicles are discussed in Chapter 3 and Chapter 4, respectively. 
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Chapter 2: Stereoselective Synthesis of N-Linked Glycoconjugates for 
the Functionalization of Solid Surfaces  
 
INDRODUCTION 
As the dense presentation of carbohydrates on the cell surfaces allows for 
multivalent interactions of relatively weak binding carbohydrates, correctly immobilized 
carbohydrates on the solid surface can provide both excellent selectivity and quantitative 
performance toward the binding of proteins that mimic natural systems. Therefore, 
effective synthetic methods and efficient functionalization techniques that control the 
density and orientation of carbohydrates on a solid surface are prerequisites to understand 
the structure and the function of carbohydrates in biological systems. 
 
Structural Features of Glycoconjugates Found on the Cell Surface 
Oligosaccharides are synthesized by glycosyltransferases and trimmed by 
glycosylases in step-wise fashion primarily in the endoplasmic reticulum and Golgi 
apparatus.3 Most of the oligosaccharides presented on the cell surface are attached either 






























Figure 11. Structural features of glycoconjugates found on the cell surface. (a) N-linked 
glycoprotein, (b) O-linked glycoprotein, and (c) O-linked glycolipid. 
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Glycoproteins in which the carbohydrate is attached to proteins are classified into 
two principle groups according to the linkage between the carbohydrate and the amino 
acid residue: N-linked glycoproteins and O-linked glycoproteins. In most N-linked 
glycoproteins, an initial N-acetylglucosamine (GlcNAc) is attached to the nitrogen of an 
asparagine (Asn) residue on the protein and the linkage is typically β-configuration 
(Figure 11a).2 In most O-linked glycoproteains, an initial N-acetylgalactosamine 
(GalNAc) is attached to the oxygen of a serine or a threonine residue on the protein and 
the linkage is typically α-configuration (Figure 11b).2 Glycolipids in which the 
carbohydrate is linked to the oxygen of head groups of lipids are usually used to describe 
the glycosphingolipids (GSL). There are two main subgroups of glycosphingolipids, 
which can be differentiated by whether the first carbohydrate attached to ceramide is 
galactose or glucose with β-configuration (Figure 11c).3  
These structural features of glycoconjugates have been utilized for the construction 
of specific linkages (N-linkages or O-linkages) to immobilize carbohydrates on the solid 
surface. 
 
Strategies for the Functionalization of Solid Surfaces with Carbohydrates 
To date, a variety of strategies for the immobilization of carbohydrates on the 
surface have been developed.39-41 The general scheme is outlined in Figure 12. The 
required carbohydrates (simple carbohydrates, oligosaccharides, and polysaccharides) are 
obtained from chemical, enzymatic synthesis or a natural source after being detached 
from glycoconjugates. Sequential chemical manipulations enable the obtained 
carbohydrates to be immobilized on the surface. By the construction of tethers containing 
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functional groups, carbohydrates are immobilized on the surface by either direct 
attachments (Figure 12a and 12b) with adsorptive groups or indirect attachments with 






































Carbohydrate building block Glycoconjugate
X = O or N
R = Adsorptive or
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Figure 12. Strategies for the functionalization of solid surfaces with carbohydrates. (a) 
adsorption to the surface, (b) self-assembled on gold, (c) noncovalent coupling using a 
ligand-receptor interactions, and (d) attached surface by covalent coupling. 
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As representative methods to build up the specific tethers, the Fischer-Helferich, 
Koenigs-Knorr, and trichloroacetimidate method have been used for O-glycosylation. For 
N-glycosylation, a reductive amination with various amine derivatives has been utilized. 
As proper solid surfaces, glass slides are the most extensively used, but gold and 
nitrocellulose membrane are also utilized. 
 
Methods for the Construction of Specific Linkages 
Via O-glycosidation 
The Fischer-Helferich method, reported a century ago, is still the simplest 








































Scheme 1. Methods for the construction of O-linkage. 
 
It consists of an acid-catalyzed activation of anomeric oxygen, followed by 
addition of an alcohol to provide a mixture of α- and β-anomeric glycosides 2. Generally, 
longer reaction time results in the anomerization to the thermodynamically more stable 
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α-adduct due to the anomeric effect. However, as a result of its reversibility, this method 
has hardly gained any significance. 
In the Koenigs-Knorr method introduced also a century ago, an anomeric hydroxyl 
group is exchanged by bromide or chloride, which provides a good leaving group 
(Scheme 1b).42,43 It involves the activation of a glycosyl bromide or chloride 3 by 
halophilic promoter, typically heavy metal salts, and sequential addition of an alcohol 
derivative to produce O-linked glycosides 4 in an irreversible manner. The resulting 
anomeric stereochemistry including most glycosidation reactions is controlled by the 
























































When the C2 oxygen is protected with an alkyl or benzyl group (path A), the α-
anomer 7 is preferentially formed because of the anomeric effect. When the C2 oxygen is 
protected with participating groups such as an acetyl or benzoyl (path B), the 
stereochemical outcome is opposite to that of the C2 protecting groups and the β-anomer 
8 is formed.44
 19
This method is a very valuable technique for the synthesis of glycoconjugates and 
has been extensively developed. However, several disadvantages of this method are that 
the glycosyl halides 3 exhibit low thermal stability and are sensitive to hydrolysis. 
Therefore, it is often generated only in situ. Also this method requires at least an 
equimolar amount of the heavy metal salt as promoter. This is problematic for large-scale 
preparation due to safety concerns and disposal of waste materials. 
The trichloroacetimidate method developed by Schmidt is a very powerful method 
to control the stereochemistry at anomeric center (Scheme 1c and 3).42 The glycosyl 
trichloroacetimidates 5 can be selectively prepared by the addition of the anomeric 
hydroxyl group to trichloroacetonitrile in the presence of a base such as NaH or K2CO3 
under kinetically (β-anomer in Scheme 3) or thermodynamically (α-anomer in Scheme 3) 
controlled conditions.45 The imidates 5 produced are stable, isolable, and require only 
catalytic amounts of Lewis acids such as  TMSOTf or BF3·OEt2 to activate. Unless a C2-
participating group is present, the glycosidation usually proceeds with inversion of 



































β-glycoside α-glycoside  
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Via N-Glycosidation 
The preparation of N-linked glycoconjugates has been achieved by amination 
(Scheme 4), whereby the reducing end of the carbohydrates is reacted with an amino 
group. When amine derivatives are utilized (Scheme 4a), imines 9 are produced. Since 
the formation of imines 9 is reversible, it is required to reduce the imines 9 with reducing 
agents to form a physiologically stable amine bond 10. However, the ring opening of the 
reducing end residue 10 occasionally affects the biological function of carbohydrates.46,47 












































































As an alternative to amine groups, when hydrazides are employed (Scheme 4b), the 
β-N-linked glycosylhydrazides 12 are predominantly produced in the absence of reducing 
agents.48,49 The glycosylhydrazide linkage is very stable under neutral to basic conditions. 
However, the linkage is easily hydrolyzed under acidic condition.50
Highly nucleophilic aminooxy groups can be condensed with the reducing end 
aldehydes of carbohydrates to form acyclic oximes 13 with minor amounts of cyclic 
forms 14 (Scheme 4c).46,51,52 The resulting oxime linkages are stable under a wide range 
of pH. 
A much improved approach involves the introduction of primary amines at the 
reducing terminus of carbohydrates by the Kochetkov method.53,54 The terminal hydroxyl 
group is converted to an amino group upon treatment with aqueous ammonium 
bicarbonate (Scheme 4d). The predominantly produced β-linked glycosylamines 16 have 
been used as intermediates for further elaboration that leads to selectively defined 
glycoconjugates.55,56
 
Methods for the Immobilization of Carbohydrates 
Two general strategies have been used for immobilizing simple and complex 
carbohydrates. The first strategy is based on the direct attachment in which chemically 
modified or free carbohydrates are immobilized on the surface. The surface can be 
derivatized or underivatized. The second strategy is based on the indirect attachment in 
which chemically conjugated carbohydrate are immobilized on the derivatized surface by 
ligand-receptor interactions or to form covalent linkages. 
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Direct Immobilization of Carbohydrates  
I. Nonspecific Immobilization of Chemically Unmodified Carbohydrates  
Chemically unmodified carbohydrates are nonspecifically and directly adsorbed on 
solid surfaces. As an example of this method, Wang and co-workers demonstrated that a 
variety of unmodified microbial polysaccharides can be immobilized on nitrocellulose-
coated glass slides through nonspecific adsorption (Figure 13).57 The immobilization 
efficiency of carbohydrates was significantly influenced by their molecular weight. The 
large polysaccharides of 3.3 - 2000 kDa were efficiently adsorbed on the surface, but 



























Figure 13. Nonspecific adsorption of chemically unmodified carbohydrates on 
nitrocelluose-coated glass slides. 
 
This is the most straightforward method for the immobilization of carbohydrates 
because it needs neither a modified surface nor chemical-linking techniques. However, 
the use of this method is limited by the fact that carbohydrates simply adsorb to the 
surface in nonspecific manner and display various orientations, many of which are 





II. Site-Specific Immobilization of Chemically Conjugated Carbohydrates  
The chemical conjugation of carbohydrates with tethers allows site-specific 
immobilization on a solid surface. For example, carbohydrates linked to lipids were 
shown to adsorb on nitrocellulose-coated glass slides by mainly hydrophobic interactions 
(Figure 14).58 The oligosaccharides 18 were obtained by chemical or enzymatic cleavage 
from biological sources 17, and then conjugated with amino lipid 19 by reductive 


























































Figure 14. Site-specific adsorption of lipid-conjugated carbohydrates on nitrocellulose-
coated glass slides. 
 
The immobilization efficiency of the neoglycolipids 20 on nitrocellulose was found 
to be independent of the size of carbohydrates. However, the generation of neoglycolipids 
20 by reductive amination resulted in the open-chain form of the reducing terminal 
residue, which may affect the biological activities of oligosaccharides if it is part of the 
recognition motif. Therefore, they recently prepared neoglycolipids by oxime ligation as 
an alternative to reductive amination. From the NMR studies, they provided evidence that 
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a significant proportion of the oxime-linked core monosaccharide is in the ring-closed 
form, and this form selectively interacts with a carbohydrate-binding protein.46
Wang and co-workers studied the retention ability of lipid-linked galactoses on the 
hydrophobic polystyrene surface, depending on the nature of lipids.59 They prepared a 
variety of galactoses linked to lipids ranging from aliphatic to aromatic hydrocarbons in 
different lengths. When the lipid component was a saturated hydrocarbon between 13 and 
15 carbons in length, the galactose showed complete retention after extensive aqueous 
washing, which suggested that the chain length of lipids is a critical factor in determining 
the stability of glycolipids on the hydrophobic surface. 
Monosaccharides linked to a single fluorous tail (C8F17) were recently shown to 
adsorb avidly to glass slides coated with fluoroalkylsilane60,61 because of the affinity 
arising from the nature of fluorine-fluorine interactions.62 Fluorous-tagged 
monosaccharides were even shown to resist washing with detergent-containing buffer. 
It was known that alkanethiolates form self-assembled monolayers (SAMs) on gold 
with well-defined structures and the properties of the monolayer depend on the functional 
groups that are exposed at the surface.63
Self-assembled monolayers (SAMs) derived from biological molecules on gold 
have been shown to be useful multivalent systems for studying cell adhesion.64 In order 
to fabricate SAMs of carbohydrates on gold, carbohydrates are linked to tethers 
containing thiol groups by chemical manipulation.65-67 For example, Penades and co-
workers prepared SAMs presenting the disaccharide maltose (Figure 15).67 The 
perbenzoylated maltose 21 was conjugated with the corresponding linker 22 under 
trichloroacetimidate conditions in the presence of a participating neighboring group at the 
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C2-position to generate β-O-linked maltose conjugate 23. Deprotection of benzoyl 
groups in basic media gave disulfide-tethered glycoconjugate 24, which was self-
assembled on gold surfaces. The structural features of the SAMs were characterized by 





















































Figure 15.  Site-specific immobilization of thiol-terminated maltoses on gold-coated 
glass slides. 
 
III. Site-specific Immobilization of Chemically Unmodified Carbohydrates on 
Derivatized Surface 
Chemically unmodified carbohydrates have been attached to hydrazide-,47,68 
aminooxy-,47,69 or diazirine70-functionalized surfaces. Advantages of this method are that 
free carbohydrates are attached to the surface irrespective of their size. Also, it is not 
necessary to introduce a multiple chemical synthesis and individual purification steps to 
prepare carbohydrate conjugates. Although a couple of chemical steps are needed to 
fabricate the active surfaces, purification steps are simple just like solid-phase synthesis.  
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Zhi and co-workers site-specifically attached heparin oligosaccharides 27 to SAMs 
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Figure 16. Site-specific immobilization of unmodified oligosaccharides on hydrazide-
derivatized SAMs on gold. 
 
First, mercaptohexadecanoic acid 25 was self-assembled on gold-coated glass 
slides. Then, the acid groups on the surface were reacted with adipic anhydride 26 to 
afford the corresponding hydrazide surfaces. Reducing end heparin oligosaccharides 27 
were efficiently coupled to the hydrazide surfaces to initially form the acyclic hydrazone 
28, followed by conversion to the β-cyclic adduct 29.  
Diazirines have been widely used to investigate the structure and function of 
nucleic acids, proteins, and various macromolecular complexes.71,72 The advantages 
utilizing diazirines as a photoaffinity labeling reagent are that they possess excellent 
chemical stability and rapid photolysis at wavelengths (350-360 nm) beyond the 
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absorbance region of most biomolecules, which circumvents the problem of irradiation 
damage of biomolecules. Upon photolysis, they generate highly reactive carbenes, which 
readily crosslink to various functional groups including the inert aliphatic C-H bonds.72             
The feasibility of unmodified carbohydrate immobilization using diazirines was 
demonstrated by Sigrist and co-workers (Figure 17).70 Photolabile aryltrifluoromethyl 
diazirine-functionalized glass slides 30 were irradiated at the wavelength of 365 nm for 4 
min in the presence of polysaccharides 31. The generated active carbene species 32 
rapidly reacted with free polysaccharides 31 to form covalent bonds. The whole 
photoimmobilization process is very fast and occurs in a single step. However, a 
drawback of this approach is that free glycans were nonspecifically immobilized on the 











































Figure 17. Photo-induced immobilization of free oligosaccharides on diazirine-




Indirect Immobilization of Carbohydrates  
This strategy requires both a modified surface and chemical-linking techniques. 
Carbohydrates linked to specific functional groups selectively react with a 
complementary-activated surface to form a non-covalent attachment (Figure 12c) or 
covalent attachment (Figure 12d). Non-covalent attachment depends on the binding of 
biotinylated carbohydrates to streptavidin-functionalized surfaces. This method has been 
successfully employed for the presentation of carbohydrates on a surface.73,74
A great effort has been placed on the covalent attachment. Although preparation of 
functionalized carbohydrates requires multiple chemical sequences and is time-
consuming, simple carbohydrates and oligosaccharides are efficiently immobilized on the 
surface in a site-specific manner, resulting in the enhancement of protein binding. 
Shin and co-workers reported the method to immobilize carbohydrates on a solid 
surface by covalent attachment of maleimide-terminated carbohydrates to thiol-
derivatized glass slides (Figure 18).75,76 They prepared a variety of mono- and 
disaccharides in the form of glycosylamines (33, 34, and 35) with controlling 
stereochemistry at the anomeric center. The condensation of the corresponding 
carbohydrates with allyl alcohol under Fischer-Helferich conditions or Koenigs-Knorr 
conditions provided α-O-linked 33 or β-O-linked glycoside 34, respectively. The 
resulting glycosides were reacted with cysteamine to give α-O-linked 33 or β-O-linked 
glycosylamines 34, respectively. The one-pot amination by Kochetkov method afforded 
β-N-linked glycosylamines 35. Finally, glycosylamines were coupled to the bifunctional 
cross-linker to produce maleimide-terminated glycoconjugates (36, 37, and 38), which 
were then covalently immobilized on the thiol-derivatized glass surfaces by hetero-
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Michael addition of thiol groups on the surfaces to the maleimide moieties of the 
glycoconjugates. The binding study with proteins demonstrated that both the anomeric 
configuration (α- or β-) and the nature of the anomeric linkage (O-linked or N-linked) of 































































































Figure 18. Immobilization of maleimide-linked carbohydrates on thiol-derivatized glass 
slides. 
 
Alternatively, thiol-linked carbohydrates were immobilized on maleimide-
functionalized SAMs on gold.77,78
Houseman and Mrksich described the approach that relies on the Diels-Alder 
reaction-mediated immobilization of cyclopentadiene-linked carbohydrates to the self-
assembled monolayers presenting benzoquinone groups (Figure 19).79 Monosaccharides 
42 linked to cyclopentadiene were stereoselectively prepared by the condensation of the 
corresponding peracetylated glycosyl bromides 39 with aminopentanol under Koenigs-
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Knorr conditions, followed by deprotection to give glycosyl amines 40. Conjugation of 
glycosyl amines 40 with linker 41 provided cyclopentadiene-conjugated carbohydrates 
42. The monolayers were prepared by the immersion of gold-coated glass slides into a 
mixture of two alkanethiols, one of which has a hydroquinone group exposed. By 
adjusting the relative concentration of the two alkanethiols, they controlled the density of 
carbohydrates on the surface. Hydroquinone-containing SAMs were oxidized to 
corresponding benzoquinone derivatives to which cyclopentadiene-conjugated 


























































































Figure 19. Immobilization of cyclopentadiene-conjugated carbohydrates on SAMs of 
benzoquinone via a Diels-Alder reaction. 
 
The advantages of this method are that the density of immobilized carbohydrates 
can be controlled by adjusting the relative concentration of the two alkanethiols. Also, the 
 31
surfaces presenting penta(ethylene glycol) moieties are inert into the nonspecific 
adsorption of proteins. 
The Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition, termed “click chemistry” 
has been employed to immobilize carbohydrates on solid surfaces such as microtiter 
plates,80 glass slides,81 and gold.82 The formation of triazole by the reaction of azide and 
alkyne is irreversible and usually quantitative. In addition, the reaction is extremely mild 
and indifferent to solvent and pH.  
Wang and co-workers explored a Huisgen 1,3-dipolar cycloaddition reaction as a 
general strategy for the immobilization of carbohydrates on gold surface (Figure 20).82 
Mono-, di- and trisacchrides 44 linked to an azide were stereoselectively prepared by the 
condensation of corresponding peracetylated trichloroacetimidates 43 with 
azidotriethylene glycols, followed by the deprotection. Alkyne disulfide 45 synthesized 
was self-assembled on gold surface, and then azido carbohydrates 44 were covalently 
attached by the Cu(I)-catalyzed regiospecific 1,3-dipolar cycloaddition reaction. 
O 1.
O CCl3


















































Figure 20. Immobilization of azide-terminated carbohydrates on SAMs of alkyne using a 
Huisgen 1,3-dipolar cycloaddition. 
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With so many alternatives for the immobilization of carbohydrates, it is difficult to 
conclude that one method is superior to all others. However, the methods for site-specific 
immobilization of carbohydrates would be better than nonspecific attachment, since 
carbohydrate immobilized on the surface are presented in homogeneous and oriented 
fashion so that all carbohydrates have equal activity toward carbohydrate binding 
proteins. Furthermore, the preservation of the correct ring form of the terminal 
carbohydrate residue and the stereochemical control of anomeric center are obviously 
important for the binding of proteins. Accordingly, a general synthetic approach that can 
control the stereochemistry of the anomeric center is required. The trichloroacetimidate 
method introduced by Schmidt two decades ago has been extensively developed and is a 
powerful method to control the stereochemistry at the anomeric center with preserving 
the cyclic form. However, this method is mainly limited to the O-linkage. In spite of 
significant progress over the few decades, controlling the stereochemistry of N-linkages 
still presents a significant challenge, especially for the amide linkages. 
Damkaci and DeShong83,84 have developed a methodology for the stereoselective 
synthesis of N-linked glycosyl amides 49 and 51 (Scheme 5) by the modification of 
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In this process, the stereochemistry of amide linkages is easily controlled by the 
reaction conditions. For example, β-stereochemistry arises from the reaction of β-
glycosyl azide 46 with trimethyl phosphine to generate β-phosphorimine 47, followed by 
the coupling with thiopyridyl ester 48. On the other hand, α-stereochemistry results from 
the formation of isoxazoline intermediate 50 (Scheme 6). At high temperature, the β-
phosphorimine 52 initially produced by the reaction of β-glycosyl azide 46 with 
triphenylphosphine is equilibrated to the α-phosphorimine 53, which then cyclized to 

































This coupling reaction is very useful because by choosing the appropriate reaction 
conditions a variety of N-linked glycoconjugate containing different tethers can be 
prepared in a stereoselective manner. 
The goal of this study was to synthesize N-linked glycoconjugates that are tethered 
to thiols 54 for the functionalization of gold surfaces, to siloxanes 55 for the 
functionalization of silica surfaces, and to alkyl chains 56 for the functionalization of 
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surfactant vesicles by hydrophobic insertion into the outer bilayer of the vesicle, utilizing 
this methodology (Scheme 7). For these studies, the preparation of a range of building 







































RESULTS AND DISCUSSION 
A range of building blocks were prepared by the reaction of glycosyl peracetates 
with trimethylsilyl azide in the presence of tin tetrachloride. The results are summarized 
in Table 1.  


























































































































a Reactions were performed at room temperature for 24 h. b For detailed acetylation procedures for the 
substrates, see experimental section. The configuration of major anomer was as shown. c Isolated yields. 
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All the glycosyl azides were smoothly transformed from corresponding peracetates 
in moderate to excellent yields with β-configuration except for mannose azide 65 (Table 
1, entry 3). The stereoselectivities, including mannose azide 65, of this glycosylation 
reaction are explained by the 1,2 trans rule with neighboring group participation at C2 
oxygen, as discussed early.42
Having synthesized a variety of building blocks, the feasibility of the coupling 
reaction to construct N-linked glycoconjugates in stereoselective manner was 
investigated.  
 
Synthesis of Glycoconjugates Anchored to Thiols  
For the direct and site-specific immobilization of carbohydrates on gold surface, 
naturally occurring thioctic acid 69 (lipoic acid) was selected as a coupling partner for a 
number of reasons: the presence of two sulfur atoms in thioctic acid provides a strong 
attachment to gold surfaces, and thioctic acid-anchored biomolecules prevent nonspecific 
protein binding.86,87
In order to construct β-linkage, trimethylphosphine was added into the solution 
containing glycosyl azides at room temperature to β-phosphorimines according to a 
typical Staudinger reaction.85 Before anomerization occurs, the in situ formed β-
phosphorimines were coupled with D/L-thioctic aicd 69 to produce exclusively β-N-


























































































a All reactions were performed in dichloromethane at room temperature. D/L-thioctic acid 69 was added 
into in situ formed phosphorimine. b Isolated yields. c The reaction was performed in 1,2-dichloroethane at 
95 oC to generate isoxazoline, which then coupled with thiopyridyl ester 83. See experimental section for 
full reaction details. 
 
All mono- and disaccharide azides which have β-confiugation were transformed 
into the β-linked glycoconjugates under these reaction conditions. However, mannose 
azide 65 has the α-configuration, which may not produce β-mannose conjugate 72. 
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Therefore, a different reaction condition requires producing β-linkage of mannose 
conjugate. It was known that α-mannose azide 65 treated with triphenylphosphine at high 
temperature initially forms the α-phosphorimine 75, which is then epimerized to the β-
phosphorimine 76. As soon as the β-phosphorimine 76 is produced, condensation occurs 




























By utilizing a reaction condition producing α-stereochemistry, α-mannose azide 65 
was converted into the isoxazoline intermediate 77, and the resulting isoxazoline 77 was 
coupled with thiopyridyl ester 83 to facilitate the formation of β-linked mannose 
conjugate 72. 
The final task remaining was to deprotect the acetyl groups. Under basic condition, 
the desired products were readily prepared in good yields, and the results are summarized 

































































   a Isolated yields except for entry 2. The yield of galactose disulfide 79 was based on the crude               
product. 1H NMR showed that the crude product 79 was essentially pure. 
 
Following the successful preparation of the β-N-linked glycoconjugates in a 
stereoselective manner, attention turned toward the construction of α-N-linkage utilizing 
isoxazoline formation.  
It was shown that among the coupling reactions between isoxazoline and a variety 
of acid derivatives, thiopyridyl esters 48 in the presence of copper (II) chloride resulted in 
the production of α-adduct in excellent yield and stereoselectivity. Presumably, the 
coordination of copper to the pyridyl moiety increases the electrophilicity of the coupling 
partner.83 Therefore, the thiopyridyl ester 83 was synthesized according to the modified 
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procedure of Mukaiyama.88 The reaction of thioctic acid 69 with dipyridyl disulfide 82 in 
the presence of triphenylphosphine at room temperature produced the thiopyridyl ester 83 













69 82 83  
 
With the desired coupling partner 83 in hand, β-glucose azide 63 was employed. 
Under the coupling conditions, the isoxazoline generated in-situ by the reaction of β-
glucose azide 63 with triphenyl phosphine at 95 oC was coupled with thiopyridyl ester 83 
to give exclusively the α-addcut 84 in moderate yields, which were sequentially 
deprotected to produce α-N-linked glucose conjugate 85.  
Under the same reaction conditions, β-lactose azide 67 was successfully converted 
into the α-N-linked lactose conjugate 87. Table 4 summarizes the results of coupling 













































































a The coupling reactions were performed in 1,2-dichloroethane in the presence of 4Å molecular sieves. The 
thiopyridyl ester and the additive, respectively, were added at room temperature and run for 24 h. For the 
deprotection step, all reactions were performed in methanol at room temperature for 24 h. b Isolated yields. 
c Crude yields. 1H NMR showed that the crude products were essentially pure. 
 
It was our intention to show that the methodology developed by Damkaci and 
DeShong83,84 can be used for the stereoselective synthesis of N-linked glycoconjugates 
anchored to thiol groups. The results of coupling reactions with thioctic acid or its 
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derivative demonstrated the feasibility. However, for the effective binding of proteins, 
carbohydrate moieties have to be extended enough from the surface. The tether length of 
thioctic acid utilized in coupling reactions is already set. Therefore, a simple and 
effective method for controlling the tether length is required. For this purpose, an 
alternative approach was employed. For the construction of β-linkage (Scheme 10), 
acetylated β-glucose azide 63 was allowed to react with trimethyl phosphine to generate 
β-phosphorimine, which was coupled with acid chloride 88 prepared by the literature89 to 
provide acetylated β-glucose amide 89. Displacement of the bromide with thioacetate, 
followed by removal of the acetate protecting groups with sodium methoxide in methanol 
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α-Glucose disulfide 94 was also synthesized by the similar manner in 42 % overall 















































These results demonstrate that the tether length of N-linked glycoconjugates can be 
controlled by simply introducing acid halides 88 that have a different length during the 
coupling reactions.  
Having the method that can control the stereochemistry and tether length of the 
glycoconjugates anchored to thiol groups, attention turned towards the immobilization of 
glycoconjugates on gold surfaces to investigate whether they are presented in oriented 
and homogeneous fashion with reproducibility. A variety of thiolated glycoconjugates 
were immobilized on gold surfaces and characterized their structural features on gold 
surfaces by atomic force microscopy, reflection Fourier transform infrared spectroscopy, 
and X-ray photoelectron spectroscopy with collaboration of Dr. Tarlov group in NIST.  
Potentially, there are a number of conformations when glycoconjugates are 
immobilized on the gold surface (Figure 11), many of which may be unsuitable for the 













































Figure 21. Possible conformations of thiol-anchored glycoconjugates adsorbed on gold 
surface. 
 
The experimental data indicated that α- or β-linked glycoconjugates attach to gold 
in an upright interacting fashion via the thiol linker, and both glycoconjugates form 
monolayers with high packing densities comparable to those typically observed for 
alkanethiol monolayers on gold. Also the surface density is sensitive to the 
stereochemistry of the glycoconjugates. For details, see Appendix. 
 
Synthesis of Glycoconjugates Anchored to Siloxanes 
For the direct immobilization of carbohydrates on a glass surface including silica 
particles, it is required to introduce siloxane moieties to the terminal of glycoconjugates.  
The hydrosilylation catalyzed by various transition metals (Pd, Pt, Rh, Ru, Co, and 
Ir) has been used for the formation of C-Si bond from unsaturated carbon bonds.90-93 
Mioskowski and co-workers have reported an excellent catalytic activity of platinum 
oxide (PtO2) for the hydrosilylation reactions with a wide range of functional alkenes.94  
In order to investigate the possibility of hydrosilylation reaction, β-glucose azide 
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63 was initially selected and coupled to 4-pentenoic acid 95 under β-linkage formation 
condition to give β-glucose pentenamide 96. Using a modified hydrosilylation condition, 
β-glucose pentenamide 96 was treated with triethoxysilane in the presence of platinum 
oxide, which resulted in the formation of a mixture of desired adduct 97 and saturated 
adduct 98. Analogous reactions with β-lactose azide 67 provided triethoxysilyl-β-lactose 
conjugate 100 and its saturated adduct 101. Table 5 summaries the results of coupling 
reaction and hydrosilylation reaction.  


















































































a The coupling reactions were performed in dichloromethane at room temperature for 24 h. The 
hydrosilylation reactions were performed in a sealed tube at 95 oC for 2 h. The hydrogenation reaction were 
performed in methanol for 2 h. b Isolated yield. c The mole ratio of two compounds was determined by GC 
and 1H NMR. d Yield of the desired adduct. The yield was calculated on the basis of GC and 1H NMR 
spectroscopy. 
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The presence of saturated adducts (98 and 101, respectively) in the mixture was 
confirmed by the hydrogenation of their corresponding glycosyl pentenamides (96 and 
99, respectively). The formation of the saturated adduct presumably arises from the 
hydrogenation of glycosyl pentenamides on the surface of colloidal platinum particles 
generated during the reaction.95
 
Synthesis of Glycoconjugates Modified with Alkyl Chains  
Our group has been interested in the surfactant-based vesicles as a drug carrier 
because of their stability and ease of preparation. Targeted delivery of toxic drugs, such 
as chemotherapeutic agents, is critical for enhancing the therapeutic index of the drug and 
reducing the toxic side effects to normal cells. To achieve targeted delivery of drugs, it is 
prerequisite to functionalize the surface of surfactant vesicles with targeting agents. 
Utilizing carbohydrate-receptor interactions, it was thought that the surface of surfactant 
vesicles could be functionalized with lipidated carbohydrates by insertion into the 
hydrophobic interior of vesicle bilayer.  
Initially, β-glucose azide 63 was coupled with octanoic acid 102 as an alkyl chain 
under the reaction condition generating β-linkage. The resulting acetylated β-glucose-
octanamide 103 was deprotected under basic condition to give the desired product 107. 
More complex di- and trisaccharide conjugates were also obtained under the same 































































































a Typical reaction conditions were used for the coupling reaction and deprotection reaction. See the 
experimental section for details. b,c Isolated yields. 
 
The study of surface functionalization of surfactant vesicles with lipidated 
carbohydrates is discussed in Chapter 4. 
 
CONCLUSIONS AND OUTLOOK 
A variety of N-linked glycoconjugates tethered to thiol groups, siloxane group, and 
alkyl chain have been synthesized by the modified Staudinger reaction in a high 
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stereoselective manner. The possibility to control tether length has been successfully 
demonstrated. The generality of the coupling reaction has also been demonstrated by 
introducing the complex trisaccharide, maltotriose. During the chemical manipulation, 
the carbohydrate moieties remained intact. Therefore, this coupling methodology has the 
potential to allow for the synthesis of complex glycoconjugates with a range of linkers.  
The glycoconjugates synthesized are being utilized for the development of 
biosensors. In the Dagenais group (Department of Electrical and Computer Engineering 
at UMCP), they utilize siloxane-anchored glycoconjugates to functionalize optical fibers. 
The Tarlov group in NIST utilizes thiol-anchored glycoconjugates to functionalize gold 
electrodes. The resulting optical and electrochemical sensors show excellent performance 
toward binding of lectins. These initial results hold promise for the biomedical 
applications with further development. 
 
EXPERIMENTAL SECTION 
General Experimental. All reagents and solvents were purchased from commercial 
suppliers and used without further purification unless otherwise noted. 
Thin-layer chromatography (TLC) was performed on 0.25 mm Merck silica-coated 
glass plates treated with a UV-active binder, with compounds being identified in one or 
more of the following manners: UV (254 nm) or vanillin/sulfuric acid charring. 
Melting points were taken in Kimax soft glass capillary tubes using a Thomas-
Hoover Uni-Melt capillary melting point apparatus equipped with a calibrated 
thermometer and are corrected. 
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Infrared spectra were recorded on a Nicolet 5DXC FT-IR spectrophotometer. Band 
positions are given in reciprocal centimeters (cm-1) and relative intensities are listed as br 
(broad), s (strong), m (medium) or w (weak). 
1H and 13C NMR spectra were recorded on a Bruker DRX-400 MHz spectrometer. 
Chemical shifts are reported in parts per million (ppm) relative to CDCl3 (δ 7.24). 
Coupling constants (J values) are given in hertz (Hz). Spin multiplicities are indicated by 
the following symbols: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br 
(broad). 
Low resolution (LRMS) and high resolution (HRMS) mass spectra were obtained 
on a VG-7070E magnetic sector instrument. 
Tetrahydrofuran (THF) was distilled from sodium/benzophenone. Methylene 
chloride (CH2Cl2), dimethyl formamide (DMF) and 1,2-dichloroethane were distilled 
from calcium hydride. Triphenylphosphine (Ph3P) was recrystallized from hexane. 
Glassware used in the reactions dried overnight in an oven at 120 ºC. All reactions 
were performed under an atmosphere of nitrogen unless otherwise noted.  
All compounds were determined to be > 95 % pure by 1H NMR spectroscopy 
unless otherwise noted. 
 
Synthesis of Starting Materials 
General procedure for the synthesis of glycosyl peracetate (Table 1). To a refluxing 
suspension of anhydrous NaOAc (4.0 equiv) in acetic anhydride (20 equiv) was added 
carbohydrate (1.0 equiv). The reaction mixture was refluxed for 3 h and cooled to 100 °C, 
then immediately transferred into ice-water mixture and stirred vigorously until a gum 
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formed. After decanting the aqueous layer, the gum was dissolved in CH2Cl2, washed 
with sat. aq. NaHCO3, H2O, dried over MgSO4, filtered, and concentrated in vacuo. The 
crude product was purified by column chromatography on silica unless otherwise noted 
to give glycosyl peracetate. 
 
Mannose peracetate (59) (Table 1, entry 3).  D-(+)-Mannose (5.00 g, 
27.8 mmol), NaOAc (9.10 g, 111 mmol) and acetic anhydride (52.0 
mL, 555 mmol). Without further purification, 10.0 g (93%) of mannose peracetate (59) as 
a mixture of anomers (α/β, 70/30, determined by 1H NMR) was obtained. The crude 
mixture was used directly in the next step without further purification: Rf = 0.46 
(hexane/EtOAc, 1/1); IR (CCl4, cm-1) 2959 (w), 1759 (s), 1369 (m), 1214 (s), 974 (m). 







Maltose peracetate (60) (Table 1, entry 4). D-(+)-
Maltose monohydrate (9.00 g, 25.0 mmol), NaOAc (8.20 
g, 100 mmol) and acetic anhydride (47.0 mL, 500 mmol). 
Purification by column chromatography (hexane/EtOAc, 1/2) afforded 16.7 g (98%) of β-
maltose peracetate (60) containing a significant amount of α-anomer (α/β, 28/72, 
determined by 1H NMR) as a white foam: Rf = 0.61 (hexane/EtOAc, 1/2). The spectral 














Lactose peracetate (61) (Table 1, entry 5). α-D-
Lactose monohydrate (9.00 g, 25.0 mmol), NaOAc 
(8.20 g, 100 mmol) and acetic anhydride (47.0 mL, 500 mmol). Purification by column 
chromatography (hexane/EtOAc, 1/1), followed by two successive recrystallizations 
(CH2Cl2/ether/hexane) afforded 14.7 g (87%) of β-lactose peracetate  (61) containing a 
trace amount of α-anomer (α/β, 7/93, determined by 1H NMR) as a white solid: Rf = 0.21 
(hexane/EtOAc, 1/1). The melting point and spectral data (IR, 1H, and 13C NMR) were 







Maltotriose peracetate (62) (Table 1, entry 6). 
Maltotriose hydrate (1.00 g, 1.98 mmol), 
NaOAc (0.810 g, 9.90 mmol) and acetic 
anhydride (4.70 mL, 49.5 mmol). Purification 
by column chromatography (hexane/EtOAc, 1/3) afforded 1.83 g (96%) of β-maltotriose 
peracetate (62) containing a significant amount of α-anomer (α/β, 29/71, determined by 
1H NMR) as a white foam: Rf = 0.34 (hexane/EtOAc, 1/2); IR (CCl4, cm-1) 2959 (w), 
1760 (s), 1368 (m), 1232 (s), 1037 (s); 1H NMR (β-anomer, 400MHz, CDCl3) δ 1.97 (s, 
3H), 1.97 (s, 3H), 1.97 (s, 3H), 1.98 (s, 3H), 1.99 (s, 3H), 2.00 (s, 3H), 2.03 (s, 3H), 2.07 
(s, 3H), 2.07 (s, 3H), 2.12 (s, 3H), 2.14 (s, 3H), 3.83-4.09 (m, 6H), 4.13 (dd, J = 12.4, 2.4, 
1H), 4.22 (dd, J = 12.4, 3.4, 1H), 4.27 (dd, J = 12.4, 4.2, 1H), 4.40-4.46 (m, 2H), 4.71 
(dd, J = 10.4, 4.0, 1H), 4.82 (dd, J = 10.4, 4.4, 1H), 4.93 (dd, J = 9.2, 8.1, 1H), 5.04 (t, J 
= 10.4, 1H), 5.24 (d, J = 4.0, 1H), 5.27-5.41 (m, 3H), 5.38 (d, J = 4.4, 1H), 5.71 (d, J = 
















20.8, 20.8, 20.8, 20.8, 20.9, 61.3, 62.2, 62.6, 67.8, 68.5, 69.0, 69.3, 70.0, 70.4, 70.9, 71.6, 
72.4, 72.9, 73.4, 75.1, 91.2, 95.6, 95.9, 168.8, 169.4, 169.6, 169.8, 169.8, 170.0, 170.3, 
170.5, 170.5, 170.6, 170.6; HRMS (ESI) cacld. for C40H54O27Na [M + Na]+ 989.2750, 
found 989.2765. 
 
Synthesis of Glycosyl Azides 
General Procedure for the Synthesis of Glycosyl Azide (Table 1). To a solution of 
glycosyl peracetate (1.0 equiv) in anhydrous CH2Cl2 was added trimethylsilyl azide (1.3 
equiv), followed by 1.0 M solution of SnCl4 (0.5 equiv). The resulting solution was 
stirred at room temperature for 24 h under a nitrogen atmosphere. The reaction mixture 
was diluted with CH2Cl2, washed with sat. aq. NaHCO3, H2O, dried over MgSO4, 
filtered, and concentrated in vacuo. The crude product was purified by column 
chromatography on silica unless otherwise noted to give β-glycosyl azide. The α-anomer 
was rarely observed. 
 
Peracetylated β-glucosyl azide (63) (Table 1, entry 1). β-D-Glucose 
pentaacetate (57) (10.0 g, 25.6 mmol), trimethylsilyl azide (4.40 mL, 
33.3 mmol), and SnCl4 (12.8 mL, 12.8 mmol). Purification by recrystallization 
(hexane/CH2Cl2) afforded 9.10 g (95%) of β-glucosyl azide 63 as a white solid: Rf = 0.14 
(hexane/ether, 1/1); m.p. 126-127 °C (lit. m.p. 126-127 °C)97;  IR (CCl4, cm-1) 2961 (w), 
2119 (s), 1757 (s), 1543 (s), 1223 (s); 1H NMR (400MHz, CDCl3) δ 2.01 (s, 3H), 2.04 (s, 
3H), 2.08 (s, 3H), 2.11 (s, 3H), 3.80 (ddd, J = 9.0, 4.8, 2.4, 1H), 4.18 (dd, J = 12.4, 2.4, 







9.0, 1H), 5.22 (t, J = 9.0, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5, 20.5, 20.5, 20.7, 
61.6, 67.8, 70.6, 72.5, 73.6, 87.9, 169.2, 169.3, 170.1, 170.6. 
 
Peracetylated β-galactosyl azide (64) (Table 1, entry 2). β-D-
Galactose pentaacetate (58) (3.00 g, 7.69 mmol), trimethylsilyl azide 
(1.30 mL, 9.99 mmol), and SnCl4 (3.85 mL, 3.85 mmol). Purification by recrystallization 
(hexane/CH2Cl2) afforded 2.40 g (83%) of β-galactosyl azide 64 as white crystals: Rf = 
0.32 (hexane/ether, 1/2). The melting point and spectral data (IR, 1H, and 13C NMR) were 







 Peracetylated β-mannosyl azide (65) (Table 1, entry 3). Mannose 
pentaacetate (59) (2.86 g, 7.33 mmol), trimethylsilyl azide (1.16 mL, 
8.79 mmol), and SnCl4 (3.67 mL, 3.67 mmol). Purification by column chromatography 
(hexane/EtOAc, 1/1) afforded 2.65 g (97%) of β-mannosyl azide 65 as a light yellow 
gum: Rf = 0.58 (hexane/EtOAc, 1/1). The spectral data (IR, 1H, and 13C NMR) were 







 Peracetylated β-maltosyl azide (66) (Table 1, entry 4). 
Maltose peracetate (60) (1.67 g, 2.46 mmol), trimethylsilyl 
azide (0.430 mL, 3.20 mmol), and SnCl4 (1.23 mL, 1.23 
mmol). Purification by column chromatography (hexane/EtOAc, 1/1) afforded 1.50 g 












spectral data (IR, 1H, and 13C NMR) were identical to those previously reported by 
Damkaci.84
 
 Peracetylated β-lactosyl azide (67) (Table 1, entry 5). 
Lactose peracetate (61) (2.65 g, 3.91 mmol), 
trimethylsilyl azide (0.670 mL, 5.08 mmol), and SnCl4 (1.96 mL, 1.96 mmol). 
Purification by column chromatography (hexane/EtOAc, 1/1) afforded 2.30 g (89%) of 
acetylated β-lactosyl azide 67 as a white foam: Rf = 0.34 (hexane/ EtOAc, 1/1) The 








 Peracetylated β-maltotriose azide (68) (Table 
1, entry 6). Maltotriose peracetate (62) (1.54 g, 
1.59 mmol), trimethylsilyl azide (0.250 mL, 
1.91 mmol), and SnCl4 (0.800 mL, 0.800 mmol). 
Without further purification, 1.40 g (93%) of β-maltotriosyl azide 68 as a colorless gum 
was obtained: Rf = 0.49 (hexane/ EtOAc, 1/2); 1H NMR (400MHz, CDCl3) δ 1.97 (s, 
3H), 1.98 (s, 3H), 1.98 (s, 3H), 1.99 (s, 3H), 2.01 (s, 3H), 2.03 (s, 3H), 2.03 (s, 3H), 2.08 
(s, 3H), 2.14 (s, 3H), 2.16 (s, 3H), 3.89 (ddd, J = 9.0, 4.0, 2.8, 1H), 3.89-3.99 (m, 4H), 
4.03 (dd, J = 12.4, 2.4, 1H), 4.15 (dd, J = 12.4, 3.2, 1H), 4.22 (dd, J = 12.4, 3.6, 1H), 4.30 
(dd, J = 12.0, 4.0, 1H), 4.44 (dd, J = 12.4, 2.0, 1H), 4.48 (dd, J = 12.0, 2.8, 1H), 4.69 (d, J 
= 9.0, 1H), 4.72 (dd, J = 9.6, 4.0, 1H), 4.76 (t, J = 9.0, 1H), 4.83 (dd, J = 10.4, 4.0, 1H), 
















(d, J = 4.0, 1H); HRMS (ESI) cacld. for C38H51O25N3Na [M + Na]+ 972.2709, found 
972.2706. The spectral data (IR and 13C NMR) were identical to those previously 
reported by Damkaci.84
 
Synthesis of Acetylated Glycoconjugates 



















To a solution of acetylated β-glycosyl azide (1.0 equiv) in anhydrous CH2Cl2 was added 
diisopropylethylamine (2.0 equiv), followed by 1.0 M solution of PMe3 (given equiv, 
typically 1.1 equiv). The reaction mixture was stirred at room temperature for 30 min and 
then a coupling partner (2.0 equiv) was added dropwise. After being stirred 24 h, the 
reaction mixture was diluted with CH2Cl2 and washed with brine, dried over MgSO4, 
filtered, and concentrated in vacuo. The crude product was purified by column 
chromatography unless otherwise noted to give acetylated β-glycoconjugate. 
 

















Acetylated β-glycosyl azide (1.0 equiv) and Ph3P (1.1 equiv) were dissolved in 
anhydrous 1,2-dichloroethane in the presence of 4Å molecular sieves. The resulting 
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suspension was heated at 95 °C for 24 h without stirring to form isoxazoline intermediate 
and then cooled to room temperature. A coupling partner (1.3 equiv) and additive (1.3 
equiv) were added. The reaction mixture was stirred at given temperature for 24 h and 
diluted with CH2Cl2. The molecular sieves were filtered, washed with H2O and brine. The 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The crude 
product was purified by column chromatography unless otherwise noted to give 
acetylated α-glycoconjugate with a trace amount of β-anomer. 
 













To a solution of acetylated glycoconjugate (1.0 equiv) in MeOH was added 0.2 M 
solution of sodium methoxide (given equiv) and then stirred at room temperature for 24 h 
under a nitrogen atmosphere. The reaction mixture was neutralized with Amberlite IR-
120 resin or Dowex MAC-3 resin, filtered and concentrated in vacuo. The crude product 
was purified by a short column chromatography unless otherwise noted to give 
deacetylated glycoconjugate. 
 
Acetylated β-glucosyl thioctanamide 70 (Table 
2, entry 1).  Amide 70 was prepared following 
general procedure A using acetylated β-glucosyl azide 63 (2.00 g, 5.36 mmol), 
diisopropylethylamine (1.90 mL, 10.7 mmol), Me3P (6.43 mL, 6.43 mmol) and D/L-









chromatography (hexane/EtOAc, 2/3) afforded 1.76 g (61%) of β-glucosyl thioctanamide 
70 as a light yellow foam: Rf = 0.39 (hexane/EtOAc, 1/2); IR (CCl4, cm-1) 3432 (w), 
2929 (w), 1755 (s), 1707 (m), 1550 (s), 1231 (s), 1055 (s); 1H NMR (400MHz, CDCl3,) 
δ 1.39-1.49 (m, 2H), 1.59-1.72 (m, 4H), 1.90 (sextet, J = 6.4, 1H), 2.02 (s, 3H), 2.03 (s, 
3H), 2.05 (s, 3H), 2.08 (s, 3H), 2.16-2.23 (m, 2H), 2.45 (sextet, J = 6.4, 1H), 3.08-3.21 
(m, 2H), 3.53-3.58 (m, 1H), 3.82 (ddd, J = 9.5, 4.0, 2.0, 1H), 4.08 (dd, J = 13.0, 2.0, 1H), 
4.31 (dd, J = 13.0, 4.0, 1H), 4.91 (t, J = 9.5, 1H), 5.06 (t, J = 9.5, 1H), 5.25 (t, J = 9.5, 
1H), 5.31 (t, J= 9.5, 1H), 6.21 (d, J = 9.5, 1H); 13C NMR (100 MHz, CDCl3) δ 20.6, 20.6, 
20.7, 20.7, 24.7, 28.7, 28.7, 34.5, 36.2, 36.3, 38.4, 40.2, 40.2, 56.2, 61.6, 68.1, 70.6, 72.6, 
73.5, 78.1, 169.1, 169.4, 170.1, 170.6, 172.4. There are three more carbons (25) than 
expected (22), due to the fact that racemic thioctic acid 69 was utilized. So a mixture of 
diastereomers was obtained. 
 
Acetylated β-galactosyl thioctanamide 71 (Table 
2, entry 2). Amide 71 was prepared following 
general procedure A using acetylated β-galactosyl azide 64 (2.00 g, 5.36 mmol), 
diisopropylethylamine (1.90 mL, 10.7 mmol), Me3P (6.43 mL, 6.43 mmol) and D/L-
thioctic acid 69 (2.21 g, 10.7 mmol) as coupling partner. Purification by column 
chromatography (hexane/EtOAc, 1/1) afforded 1.50 g (52%) of acetylated β-galactosyl 
thioctanamide 71 as a light yellow foam: Rf = 0.28 (hexane/EtOAc, 1/1); IR (CCl4, cm-1) 
3433 (w), 2934 (w), 1752 (s), 1704 (m), 1369 (m), 1225 (s), 1056 (m), 907 (m); 1H NMR 
(400MHz, CDCl3,) δ 1.33-1.45 (m, 2H), 1.55-1.72 (m, 4H), 1.87 (sextet, J = 6.5, 1H), 










6.5, 1H), 3.05-3.18 (m, 2H), 3.50-3.54 (m, 1H), 3.98-4.03 (m, 1H), 4.06-4.12 (m, 2H), 
5.06 (t, J = 9.0, 1H), 5.10 (dd, J = 9.0, 3.0, 1H), 5.20 (t, J = 9.0, 1H), 5.40 (d, J = 3.0, 
1H), 6.22 (d, J = 9.0, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5, 20.6, 20.6, 20.8, 24.7, 
24.7, 28.6, 28.7, 34.5, 36.3, 36.3, 38.4, 40.2, 56.2, 61.0, 67.1, 68.3, 70.7, 72.2, 78.4, 
169.7, 170.0, 170.3, 171.3, 172.8; HRMS (DEI) cacld. for C22H33O10N1S2 [M ]+ 
535.1546, found 535.1555. There are three more carbons (25) than expected (22), due to 
the fact that racemic thioctic acid 69 was utilized. 
 
Acetylated β-mannosyl thioctanamide 72 
(Table 2, entry 3). Amide 72 was prepared 
following general procedure B using acetylated β-mannosyl azide 65 (0.490 g, 1.31 
mmol), PPh3 (0.38 mg, 1.44 mmol), thiopyridyl ester 83 (0.510 g, 1.71 mmol) as 
coupling partner, and CuCl2·2H2O (0.290, 1.71 mmol) as an additive. Purification by 
column chromatography (hexane/EtOAc, 1/2) afforded 0.340 g (48%) of acetylated β-
mannosyl thioctanamide 72 as a light yellow foam: Rf = 0.42 (hexane/EtOAc, 1/2); IR 
(CCl4, cm-1) 3448 (w), 2927 (m), 1759 (s), 1709 (m), 1368 (m), 1223 (s), 1057 (m); 1H 
NMR (400MHz, CDCl3,) δ 1.39-1.49 (m, 2H), 1.59-1.70 (m, 4H), 1.87 (sextet, J = 6.5, 
1H), 1.95 (s, 3H), 2.02 (s, 3H), 2.07 (s, 3H), 2.15-2.22 (m, 2H),  2.22 (s, 3H), 2.44 
(sextet, J = 6.5, 1H), 3.05-3.17 (m, 2H), 3.50-3.56 (m, 1H), 3.75 (ddd, J = 10.0, 5.2, 2.4, 
1H), 4.05 (dd, J = 12.4, 2.4, 1H), 4.29 (dd, J = 12.4, 5.2, 1H), 5.08 (dd, J = 10.0, 3.0, 1H), 
5.21 (t, J = 10.0, 1H), 5.34 (t, J = 3.0, 1H), 5.53 (d, J = 9.5, 1H), 6.08 (d, J = 9.5, 1H); 
13C NMR (100 MHz, CDCl3) δ 20.5, 20.7, 20.8, 20.9, 24.7, 24.7, 28.7, 28.7, 34.6, 36.1, 










172.0. There are four more carbons (26) than expected (22), due to the fact that racemic 
thiopyridyl ester 83 was utilized. 
 
Acetylated β ctanamide 
73 (Table 2, entry 4). Amide 73 was 
prepared following general procedure 
A using acetylated β-maltosyl azide 66 (0.25 g, 0.38 mmol), diisopropylethylamine 
(0.070 mL, 0.42 mmol), Me
-maltosyl thio
d
3P (0.49 mL, 0.49 mmol) and D/L-thioctic acid 69 (0.16 g, 
0.76 mmol) as coupling partner. Purification by column chromatography (hexane/EtOAc, 
2/3) afforded 0.15 g (48%) of β-maltosyl thioctanamide 73 as a light yellow foam: Rf = 
0.41 (hexane/EtOAc, 1/2): IR (CCl4, cm-1) 3432 (w), 2931 (w), 1757 (s), 1706 (m), 1360 
(m), 1225 (s), 1065 (m). The spectral data (1H and 13C NMR) were identical to those 
















thioctanamide 74 (Table 2, entry 5). 
Ami e 74 was prepared following 
general procedure A using acetylated β-lactosyl azide 67 (1.00 g, 1.51 mmol), 
diisopropylethylamine (0.530 mL, 3.02 mmol), Me3P (1.81 mL, 1.81 mmol) and D/L-
thioctic acid 69 (0.624 g, 3.02 mmol) as coupling partner. Purification by column 
chromatography (hexane/EtOAc, 1/2) afforded 0.670 g (54 %) of β-lactosyl 










3310 (w), 2930 (w), 1752 (s), 1706 (w), 1376 (m), 1219 (s). The spectral data (1H and 13C 
NMR) were identical to those previously reported by Damkaci.84
 
β-Glucosyl thioctanamide 78 (Table 3, entry 1).  
Amide 78 was prepared following general 
procedure C using acetylated β-glucosyl thioctanamide 70 (1.76 g, 3.29 mmol) and 
sodium methoxide (32.9 mL, 6.58 mmol). The reaction mixture was neutralized with 
Dowex MAC-3 resin. Purification by column chromatography (CH2Cl2/MeOH, 3/1) 
afforded 1.10 g (91%) of β-glucosyl thioctanamide 78 as an amorphous solid: Rf = 0.67 
(CH2Cl2/MeOH, 3/1); IR (KBr, cm-1) 3442 (br), 2917 (s), 1634 (s), 1549 (s), 1080 (s); 1H 
NMR (400MHz, D2O) δ 1.27-1.36 (m, 2H), 1.46-1.55 (m, 3H), 1.58-1.65 (m, 1H), 1.86 
(sextet, J = 6.8, 1H), 2.20 (t, J = 7.2, 2H), 2.36 (sextet, J = 6.8, 1H), 3.02-3.13 (m, 2H), 
3.21-3.30 (m, 2H), 3.36-3.43 (m, 2H), 3.55-3.61 (m, 2H), 3.74 (dd, J = 12.0, 2.4, 1H), 
4.82 (d, J = 9.2, 1H); 13C NMR (100 MHz, D2O) δ 24.6, 27.7, 33.6, 35.4, 37.9, 40.1, 
56.3, 60.4, 69.1, 71.6, 76.4, 77.4, 79.1, 178.2; HRMS (ESI) cacld. for C14H25NO6S2Na 









β-Galactosyl thioctanamide 79 (Table 3, entry 2).  
Amide 79 was prepared following general 
procedure C using acetylated β-galactosyl thioctanamide 71 (0.49 g, 0.93 mmol) and 
sodium methoxide (14 mL, 2.8 mmol). The reaction mixture was neutralized with Dowex 
MAC-3 resin. Without further purification, 0.30 g (88%) of β-galactosyl thioctanamide 










(400MHz, D2O) δ 1.29-1.35 (m, 2H), 1.48-1.56 (m, 3H), 1.58-1.63 (m, 1H), 1.85 (sextet, 
J = 6.8, 1H), 2.20 (t, J = 7.2, 2H), 2.35 (sextet, J = 6.8, 1H), 3.03-3.12 (m, 2H), 3.48 (t, J 
= 9.2, 1H), 3.54-3.65 (m, 5H), 3.83 (d, J = 3.2, 1H), 4.76 (d, J = 9.2, 1H); 13C NMR (100 
MHz, D2O) δ 24.6, 27.8, 33.6, 35.4, 37.9, 40.1, 56.3, 60.8, 68.5, 69.1, 73.3, 76.6, 79.5, 
178.3; HRMS (ESI) cacld. for C14H25NO6S2Na [M + Na]+ 390.1021, found 390.1015. 
 
β-Mannosyl thioctanamide 80 (Table 3, entry 3).  
Amide 80 was prepared following general 
procedure C using acetylated β-mannosyl thioctanamide 72 (0.30 g, 0.56 mmol) and 
sodium methoxide (11 mL, 2.2 mmol). The reaction mixture was neutralized with Dowex 
MAC-3 resin. Purification by column chromatography (CH2Cl2/MeOH, 3/1) afforded 
0.18 g (85%) of β-mannosyl thioctanamide 80 as an amorphous solid: Rf = 0.62 
(CH2Cl2/MeOH, 3/1); IR (drop casting on CaF2, cm-1) 3320 (br), 2916 (w), 1650 (m), 
1527 (w), 1073 (m); 1H NMR (400MHz, D2O) δ 1.29-1.35 (m, 2H), 1.46-1.56 (m, 3H), 
1.58-1.65 (m, 1H), 1.84-1.89 (m, 1H), 2.22 (t, J = 7.2, 2H), 2.32-2.40 (m, 1H), 3.04-3.13 
(m, 2H), 3.33 (ddd, J = 9.6, 6.0, 2.4, 1H), 3.47 (t, J = 9.6, 1H), 3.56-3.61 (m, 3H), 3.76 
(dd, J = 12.4, 2.4, 1H), 3.80 (br d, J = 3.2, 1H), 5.08 (br s, 1H); 13C NMR (100 MHz, 
D2O) δ 24.6, 24.6, 27.7, 27.7, 33.6, 33.6, 35.0, 35.1, 37.9, 40.1, 56.3, 60.7, 66.2, 70.0, 
73.2, 77.5, 77.6, 177.4. There are four more carbons (18) than expected (14), due to the 











β-Lactosyl thioctanamide 81 (Table 
3, entry 4).  Amide 81 was prepared 
following general procedure C using 
acetylated β-lactosyl thioctanamide 74 (1.48 g, 1.80 mmol) and sodium methoxide (31.5 
mL, 6.29 mmol). The reaction mixture was neutralized with Dowex MAC-3 resin. 
Purification by column chromatography (CH2Cl2/MeOH, 2/1) afforded 0.80 g (84%) of 
β-lactosyl thioctanamide 81 as an amorphous solid: Rf = 0.32 (CH2Cl2/MeOH, 3/1); IR 
(Neat, cm-1) 3299 (br), 2921 (w), 1649 (m), 1538 (m), 1386 (m), 1019 (s); 1H NMR 
(400MHz, D2O,) δ 1.29-1.37 (m, 2H), 1.44-1.56 (m, 3H), 1.56-1.65 (m, 1H), 1.87 (sextet, 
J = 6.4, 1H), 2.22 (t, J = 7.2, 2H), 2.37 (sextet, J = 6.4, 1H), 3.04-3.13 (m, 2H), 3.29-3.33 
(m, 1H), 3.42 (dd, J = 10.0, 7.6, 1H), 3.52-3.71 (m, 9H), 3.79-3.83 (m, 2H), 4.33 (d, J = 
7.6, 1H), 4.85 (d, J = 9.2, 1H); 13C NMR (100 MHz, D2O) δ 24.6, 27.7, 33.6, 35.4, 37.9, 
40.1, 56.3, 59.7, 60.9, 68.4, 70.8, 71.3, 72.4, 75.0, 75.2, 76.2, 77.6, 78.9, 102.7, 178.2; 










Thiopyridyl ester 83.  (±)-Thioctic acid (69) (2.00 g, 
9.69 mmol), Ph3P (3.05 g, 11.6 mmol) and 2,2’-dipyridyl 
disulfide 82 (2.56 g, 11.6 mmol) were dissolved in 30 mL of anhydrous THF. The 
solution was stirred at room temperature for 24 h and then concentrated in vacuo to give 
the crude product. Purification by column chromatography (hexane/EtOAc, 2/1) afforded 
2.87 g (99%) of (±)-thiopyridyl ester 83 as a yellow oil: Rf = 0.34 (hexane/EtOAc, 2/1); 
IR (CCl4, cm-1) 3057 (w), 2934 (s), 1711 (s), 1575 (s), 1425 (s), 1123 (m), 995 (m); 1H 






1H), 2.42 (sextet, J = 6.8, 1H), 2.69 (t, J = 7.4, 2H), 3.04-3.17 (m, 2H), 3.50-3.56 (m, 
1H), 7.25 (ddd, J = 8.0, 5.0, 1.0, 1H), 7.57-7.59 (m, 1H), 7.71 (td, J = 8.0, 2.0, 1H), 8.58 
(ddd, J = 5.0, 2.0, 1.0, 1H); 13C NMR (100 MHz, CDCl3) δ 25.0, 28.4, 34.5, 38.4, 40.1, 
43.8, 56.1, 123.5, 130.1, 137.2, 150.1, 151.2, 196.1. 
 
Acetylated α-glucosyl thioctanamide 84 (Table 4, 
entry 1). Amide 84 was prepared following general 
procedure B using acetylated β-glucosyl azide 63 
(0.83 g, 2.2 mmol), Ph3P (0.64 g, 2.5 mmol), thiopyridyl ester 83 (0.87 g, 2.9 mmol) as 
coupling partner and CuCl2·2H2O (0.50 g, 2.9 mmol) as additive. After the coupling 
partner and the additive were added, the resulting mixture was stirred at room 
temperature for 24 h. Purification by column chromatography (hexane/EtOAc, 1/1.5) 
afforded 0.75 g (63%) of acetylated α-glucosyl thioctanamide 84 as a light yellow foam: 
Rf = 0.39 (hexane/EtOAc, 1/2); IR (CCl4, cm-1) 3336 (br w), 2932 (m), 1755 (s), 1705 
(m), 1219 (s), 1027 (m); 1H NMR (400 MHz, CDCl3) δ 1.38-1.51 (m, 2H), 1.55-1.73 (m, 
4H), 1.80-1.92 (m, 1H), 1.99 (s, 3H), 2.00 (s, 6H), 2.04 (s, 3 H), 2.27 (br t, J = 7.3, 2H), 
2.43 (sextet, J = 6.6, 1H), 3.05-3.18 (m, 2H), 3.50-3.56 (m, 1H), 3.89-3.92 (m, 1H), 4.01 
(dd, J = 12.4, 2.2, 1H), 4.25 (dd, J = 12.4, 4.2, 1H), 5.03 (t, J = 10.0, 1H), 5.15 (dd, J = 
10.0, 5.0, 1H), 5.33 (t, J = 10.0, 1H), 5.84 (br t, J = 7.3, 1H), 6.56 (d, J = 7.3, 1H); 13C 
NMR (100 MHz, CDCl3) δ 20.5, 20.5, 20.6, 20.7, 25.0, 28.7, 34.5, 36.2, 36.2, 38.4, 40.2, 
56.3, 56.3, 61.7, 68.0, 68.3, 68.4, 70.1, 74.2, 169.0, 169.4, 170.3, 170.7, 173.3; HRMS 










more carbons (24) than expected (22), due to the fact that racemic thiopyridyl ester 83 
was utilized. 
 
Acetylated α-lactosyl thioctanamide 
86 (Table 4, entry 2). Amide 86 was 









B using acetylated β-lactosyl azide 67 (1.00 g, 1 3P (0.440 g, 1.66 mmol), 
thiopyridyl ester 83 (0.590 g, 1.97 mmol) as coupling partner and CuCl2·2H2O (0.340 g, 
1.97 mmol) as additive. After the coupling partner and the additive were added, the 
resulting mixture was stirred at room temperature for 24 h. Purification by column 
chromatography (hexane/EtOAc, 2/3) afforded 0.690 g (55%) of acetylated α-lactosyl 
thioctanamide 86 as a light yellow foam: Rf = 0.45 (hexane/ EtOAc, 1/2); IR (CCl4, cm-1) 
3260 (w), 2936 (w), 1759 (s), 1701 (w), 1376 (m), 1219 (s); 1H NMR (400MHz, CDCl3,) 
δ 1.38-1.53 (m, 2H), 1.58-1.73 (m, 4H), 1.83-1.92 (m, 1H), 1.93 (s, 3H), 2.01 (s, 3H), 
2.02 (s, 3H), 2.03 (s, 3H), 2.04 (s, 3H), 2.07 (s, 3H), 2.12 (s, 3H), 2.27 (br t, J = 7.5, 2H), 
2.43 (sextet, J = 6.5, 1H), 3.05-3.18 (m, 2H), 3.50-3.57 (m, 1H), 3.70-3.75 (m, 2H), 3.86 
(dd, J = 7.0, 0.8, 1H), 4.03-4.13 (m, 3H), 4.33 (br d, J = 11.3, 1H), 4.44 (d, J = 8.0, 1H), 
4.92 (dd, J = 10.0, 3.4, 1H), 5.03-5.09 (m, 2H), 5.28 (dd, J = 10.0, 8.0, 1H), 5.32 (dd, J = 
3.4, 0.8, 1H), 5.76 (dd, J = 7.5, 5.5, 1H), 6.46 (br d, J = 7.5, 1H); 13C NMR (100 MHz, 
CDCl3) δ 20.5, 20.6, 20.6, 20.6, 20.7, 20.8, 20.8, 25.0, 28.7, 34.5, 36.2, 38.4, 40.2, 56.3, 
60.8, 61.9, 66.6, 68.3, 69.0, 69.3, 69.8, 70.7, 70.8, 73.7, 75.8, 101.1, 169.2, 169.3, 169.9, 
170.0, 170.0, 170.4, 170.4, 173.3; HRMS (FAB) cacld. for C34H49O18NS2Cs [M + Cs]+ 
956.1445, found 956.1454. 
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α-Glucosyl thioctanamide 85 (Table 4, entry 3).  
Amide 85 was prepared following general procedure 
C using acetylated α-glucosyl thioctanamide 84 
(1.09 g, 2.04 mmol) and sodium methoxide (13.2 mL, 2.65 mmol). The reaction mixture 
was neutralized with Amberlite IR-120 resin. Without further purification, 0.740 g (99%) 
of α-glucosyl thioctanamide 85  as an amorphous solid was obtained. The 1H NMR of the 
crude product indicated high purity: Rf = 0.67 (CH2Cl2/MeOH, 3/1); IR (KBr, cm-1) 3378 
(br), 2926 (s), 1662 (s), 1533 (s), 1060 (s); 1H NMR (400MHz, D2O) δ 1.21-1.31 (m, 
2H), 1.43-1.63 (m, 4H), 1.79-1.87 (m, 1H), 2.17-2.27 (m, 2H), 2.29-2.37 (m, 1H), 3.01-
3.08 (m, 2H), 3.27-3.35 (m, 2H), 3.54-3.68 (m, 5H), 5.43 (d, J = 5.6, 1H); 13C NMR 
(100MHz, D2O) δ 24.9, 24.9, 27.7, 27.8, 33.7, 33.7, 35.1, 35.2, 38.0, 40.1, 40.1, 56.3, 
56.4, 60.3, 69.1, 69.2, 72.5, 72.9, 76.4, 178.6; HRMS (ESI) cacld. for C14H25NO6S2Na 
[M + Na]+ 390.1021, found 390.1013. There are six more carbons (20) than expected 










α-Lactosyl thioctanamide 87 (Table 4, 
entry 4).  Amide 87 was prepared 
following general procedure C using 
0.72 mmol) and sodium methoxide (4.7 
mL, 0.93 mmol). The reaction mixture was neutralized with Amberlite IR-120 resin. 
Without further purification, 0.340 g (90%) of α-lactosyl thioctanamide 87 as an 








acetylated α-lactosyl thioctanamide 86 (0.59 g, 
1H NMR of the crude product indicated high purity: 
Rf = 0.32 (CH2Cl2/MeOH, 3/1); IR (Neat, cm-1) 3317 (br), 2921 (w), 1654 (m), 1520 (m), 
 66
1386 (m), 1019 (s); 1H NMR (400MHz, D2O,) δ 1.24-1.32 (m, 2H), 1.44-1.56 (m, 3H), 
1.56-1.66 (m, 1H), 1.79-1.89 (m, 1H), 2.19-2.28 (m, 2H), 2.33 (m, 1H), 3.00-3.13 (m, 
2H), 3.41 (dd, J = 10.0, 7.8, 1H), 3.47-3.66 (m, 7H), 3.69-3.75 (m, 4H), 3.78 (d, J = 3.3, 
1H), 4.31 (d, J = 7.8, 1H), 5.43 (d, J = 4.1, 1H); 13C NMR (100 MHz, D2O) δ 24.9, 27.7, 
27.8, 33.7, 33.7, 35.2, 35.3, 38.1, 40.2, 40.2, 56.4, 56.5, 59.8, 61.0, 68.5, 69.0, 70.9, 71.3, 
71.7, 72.5, 75.3, 76.2, 78.0, 102.8, 178.7; HRMS (FAB) cacld. for C20H35O11NS2Cs [M + 
Cs]+ 662.0706, found 662.0704. There are five more carbons (25) than expected (20), due 
to the fact that a mixture of diastereomers 86 was utilized. 
 
5-Bromopentanoyl chloride (88).  Thionyl chloride (6.05 mL, 82.9 
e
 




mmol) was added to a flask containing 5-bromovaleric acid (5.00 g, 
action mixture was refluxed for 2.5 h and concentrated in vacuo. 
Purification by vacuum distillation at 112 - 114 °C, 26 mmHg (lit. b.p. 102 - 104 °C, 15 
mmHg)
Br
27.6 mmol). The r
89 afforded 4.80 g (87%) of acid chloride 88 as a colorless oil: IR (CCl4, cm-1) 
2963 (w), 1800 (s), 1255 (w), 970 (w); 1H NMR (400MHz, CDCl3) δ 1.84-1.93 (m, 4H), 
2.93 (t, J = 6.4, 2H), 3.39 (t, J = 6.4, 2H); 13C NMR (100 MHz, CDCl3) δ 23.6, 31.1, 
32.4, 46.0, 173.4. 
A
(Scheme 10).  Amide 89 was prepared following 
ylated β-glucosyl azide 63 (1.00 g, 2.68 mmol), 
diisopropylethylamine (0.930 mL, 5.36 mmol), Me
general procedure A using ace
3P (2.95 mL, 2.95 mmol) and acid 










chromatography (hexane/EtOAc, 1/1) afforded 0.630 g (46%) of β-glucose-5-
bromopentanamide 89 as a yellow gum: Rf = 0.37 (hexane/EtOAc, 2/3); IR (CCl4, cm-1) 
3433 (w), 2959 (w), 1755 (s), 1705 (m), 1227 (s), 1041 (s); 1H NMR (400MHz, CDCl3,) 
δ 1.71-1.75 (m, 2H), 1.80-1.87 (m, 2H), 2.00 (s, 3H), 2.01 (s, 3H), 2.03 (s, 3H), 2.06 (s, 
3H), 2.14-2.24 (m, 2H), 3.37 (t, J = 6.7, 2H), 3.79 (ddd, J = 9.6, 4.3, 2.1, 1H), 4.05 (dd, J 
= 12.5, 2.1, 1H), 4.29 (dd, J = 12.5, 4.3, 1H), 4.88 (t, J = 9.6, 1H), 5.04 (t, J = 9.6, 1H), 
5.23 (t, J = 9.6, 1H), 5.29 (t, J= 9.6, 1H), 6.22 (d, J = 9.6, 1H); 13C NMR (100 MHz, 
CDCl3) δ 20.6, 20.6, 20.7, 20.7, 23.6, 31.9, 32.8, 35.4, 61.5, 68.1, 70.6, 72.6, 73.5, 78.1, 
169.6, 169.8, 170.6, 171.1, 172.5; HRMS (FAB) cacld. for C19H29O9NBr79 [M + H]+ 
510.0975, found 510.0976. 
 




90 (Scheme 10).  To a solution of acetylated β-
0 g, 1.20 mmol) in 10 mL of anhydrous DMF was 
added potassium thioacetate (0.177 g, 1.55 mmol). The reaction mixture was stirred at 






2O (3 × 100 mL), the organic layer was dried over MgSO4 and concentrated in 
vacuo. Purification by column chromatography (hexane/EtOAc, 1/1) afforded 0.580 g 
(96%) of acetylated β-glucose-5-thioacetyl pentanamide 90 as a yellow gum: Rf = 0.30 
(hexane/EtOAc, 2/3); IR (CCl4, cm-1) 3371 (w), 2944 (w), 1756 (s), 1696 (s), 1227 (s), 
1040 (s); 1H NMR (400MHz, CDCl3,) δ 1.52-1.57 (m, 2H), 1.59-1.63 (m, 2H), 1.98 (s, 
3H), 2.00 (s, 3H), 2.02 (s, 3H), 2.05 (s, 3H), 2.15-2.20 (m, 2H), 2.30 (s, 3H), 2.82 (td, J = 




12.4, 4.4, 1H), 4.87 (t, J = 9.6, 1H), 5.03 (t, J = 9.6, 1H), 5.22 (t, J = 9.6, 1H), 5.27 (t, J= 
9.6, 1H), 6.28 (d, J = 9.6, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5, 20.5, 20.6, 20.7, 
24.0, 28.4, 28.9, 30.6, 35.8, 61.6, 68.1, 70.6, 72.7, 73.5, 78.1, 169.5, 169.8, 170.6, 171.0, 
172.8, 195.9; HRMS (DEI) cacld. for C21H31O11NS [M]+ 505.1618, found 505.1615. 
 
β-Glucose disulfide 91 (Scheme 10).  Disulfide 91 
o
O
was prepared following general procedure C using 
acetylated β-glucose-5-thioacetyl pentanamide 90 
xide (7.0 mL, 1.4 mmol). After being stirred for 24 
h under a nitrogen atmosphere, the reaction mixture was exposed to air for an additional 
24 h to complete the oxidation of the thiol group to the disulfide. The reaction mixture 
was neutralized with Amberlite IR-120 resin. Without further purification, 0.25 g (80%) 




(0.54 g, 1.1 mmol) and sodium meth
1H NMR of the crude 
product indicated high purity (> 95%): Rf = 0.34 (MeOH/CH2Cl2, 1/3); IR (neat, cm-1) 
3293 (br), 2921 (w), 1654 (m), 1544 (s), 1020 (s); 1H NMR (400MHz, D2O) δ 1.59 (br s, 
4H), 2.23 (br s, 2H), 2.63 (br s, 2H), 3.22-3.31 (m, 2H), 3.37-3.44 (m, 2H), 3.59 (dd, J = 
12.4, 5.2, 1H), 3.74 (dd, J = 12.4, 2.0, 1H), 4.82 (d, J = 9.2, 1H); 13C NMR (100 MHz, 
D2O) δ 23.7, 27.6, 35.1, 37.5, 60.4, 69.1, 71.6, 76.4, 77.4, 79.1, 177.9; HRMS (FAB) 










Acetylated α-glucose-5-bromopentanamide 92 
(Scheme 11). Amide 92 was prepared following general 
procedure B using β-glucosyl azide 63 (0.20 g, 0.54 
mmol), Ph3P (0.15 g, 0.59 mmol) and acid chloride 88 (0.21 g, 1.1 mmol) as coupling 
partner. After formation of the isoxazoline intermediate, the reaction mixture was stirred 
at 95 °C for 24 h. Purification by column chromatography (hexane/EtOAc, 1/1) afforded 
0.14 g (52%) of acetylated α-glucose-5-bromopentanamide 92 as a yellow gum: Rf = 
0.28 (hexane/EtOAc, 1/1); IR (CCl4, cm-1) 3445 (w), 2959 (w), 1755 (s), 1705 (m), 1223 
(s), 1033 (m); 1H NMR (400 MHz, CDCl3) δ 1.75-1.79 (m, 4H), 2.00 (s, 3H), 2.02 (s, 6 
H), 2.05 (s, 3H), 2.32 (br s, 2H), 3.50-3.55 (m, 2H), 3.86-3.90 (m, 1H), 4.03 (dd, J = 
12.4, 2.2, 1H), 4.25 (dd, J = 12.4, 4.4, 1H), 5.03 (t, J = 9.7, 1H), 5.16 (dd, J = 9.7, 5.4, 1 
H), 5.34 (t, J = 9.7, 1H), 5.85 (dd, J = 7.4, 5.4, 1H), 6.53 (d, J = 7.4, 1H); 13C NMR (100 
MHz, CDCl3) δ 20.5, 20.6, 20.6, 20.7, 22.7, 31.7, 35.5, 44.4, 61.7, 68.1, 68.3, 68.3, 70.2, 









Acetylated α-glucose-5-thioacetyl pentanamide 93 
(Scheme 11). To a solution of acetylated α-glucose-
5-bromopentanamide 92 (0.12 g, 0.24 mmol) in 3 
mL of DMF was added potassium thioacetate (0.035 g, 0.31 mmol). The reaction mixture 
was stirred at room temperature for 20 h and then diluted with 50 mL of EtOAc. After 
being washed with H2O (3 × 100 mL), the organic layer was dried over MgSO4, filtered, 
and concentrated in vacuo. Purification by column chromatography (hexane/EtOAc, 1/1) 









gum: Rf = 0.30 (hexane/EtOAc, 2/3); IR (CCl4, cm-1) 3386 (w), 2959 (w), 1755 (s), 1697 
(m), 1227 (s); 1H NMR (400 MHz, CDCl3) δ 1.59-1.64 (m, 2H), 1.66-1.72 (m, 2H), 2.00 
(s, 3H), 2.01 (s, 6H), 2.05 (s, 3 H), 2.30-2.35 (m, 5H), 2.85-2.88 (m, 2H), 3.85-3.88 (m, 
1H), 4.03 (dd, J = 12.4, 2.8, 1H), 4.25 (dd, J = 12.4, 4.4, 1H), 5.04 (t, J = 9.6, 1H), 5.16 
(dd, J = 9.6, 5.6, 1H), 5.37 (t, J = 9.6, 1H), 5.86 (dd, J = 7.6, 5.6, 1H), 6.75 (d, J = 7.6, 
1H); 13C NMR (100 MHz, CDCl3) δ 20.5, 20.6, 20.6, 20.7, 24.3, 28.0, 29.0, 30.6, 35.5, 
61.8, 68.0, 68.4, 68.4, 70.2, 74.2, 169.0, 169.4, 170.4, 170.7, 173.4, 197.4; HRMS (FAB) 
calcd. for C21H32O11NS [M + H ]+ 506.169, found 506.169. 
 
α-Glucose disulfide 94 (Scheme 11).  Disulfide 94 
was prepared following general procedure C using 
acetylated α-glucose-5-thioacetyl pentanamide 93 
(0.082 g, 0.16 mmol) and sodium methoxide (1.0 mL, 0.21 mmol). After being stirred for 
24 h under a nitrogen atmosphere, the reaction mixture was exposed to air for additional 
24 h to complete the oxidation of the thiol group to the disulfide. The reaction mixture 
was neutralized with Amberlite IR-120 resin. Without further purification, 0.046 g (96%) 
of α-glucose disulfide 94  as an amorphous solid was obtained. The 1H NMR of the crude 
product indicated high purity: Rf = 0.34 (MeOH/CH2Cl2, 1/3); IR (neat, cm-1) 3272 (br), 
2921 (w), 1654 (m), 1528 (s), 1020 (s); 1H NMR (400MHz, D2O) δ 1.56-1.58 (m, 4H), 
2.22-2.28 (m, 2H), 2.59-2.62 (m, 2H), 3.27-3.35 (m, 2H), 3.55-3.68 (m, 4H), 5.43 (d, J = 
5.6, 1H); 13C NMR (100 MHz, D2O) δ 23.9, 27.5, 34.9, 37.4, 60.3, 69.1, 69.2, 72.5, 72.9, 











Acetylated β-glucose-4-pentenamide 96 (Table 5). 
Amide 96 was prepared following general procedure A 
using acetylated β-glucosyl azide 63 (3.00 g, 8.04 mmol), diisopropylethylamine (2.80 
mL, 16.1 mmol), Me3P (9.64 mL, 9.64 mmol) and 4-pentenoic acid (95) (1.61 g, 16.1 
mmol) as coupling partner. Purification by column chromatography (hexane/EtOAc, 2/3) 
afforded 2.65 g (77%) of acetylated β-glucose-4-pentenamide 96 as a white foam: Rf = 
0.50 (hexane/EtOAc, 1/2); IR (CCl4, cm-1) 3432 (w), 3080 (w), 2955 (w), 1759 (s), 1709 
(s), 1509 (s), 1227 (s), 909 (m); 1H NMR (400MHz, CDCl3) δ 1.99 (s, 3H), 2.00 (s, 3H), 
2.02 (s, 3H), 2.05 (s, 3H), 2.18-2.36 (m, 4H), 3.79 (ddd, J = 9.5, 4.4, 2.2, 1H), 4.05 (dd, J 
= 12.4, 2.2, 1H), 4.28 (dd, J = 12.4, 4.4, 1H), 4.86 (t, J = 9.5, 1H), 4.98 (dd, J = 10.3, 1.6, 
1H), 5.02 (dd, J = 17.3, 1.6, 1H), 5.03 (t, J = 9.5, 1H), 5.23 (t, J = 9.5, 1H), 5.28 (t, J = 
9.5, 1H), 5.70-5.80 (m, 1H), 6.20 (d, J = 9.5, 1H); 13C NMR (100 MHz, CDCl3) δ 20.6, 
20.6, 20.7, 20.7, 28.8, 35.6, 61.6, 68.1, 70.5, 72.6, 73.5, 78.1, 115.8, 136.3, 169.5, 169.8, 









Acetylated β-lactose-4-pentenamide 99 
(Table 5). Amide 99 was prepared following 
general procedure A using acetylated β-
lactose azide 67 (2.00 g, 3.02 mmol), diisopropylethylamine (1.60 mL, 9.07 mmol), Me3P 
(3.63 mL, 3.63 mmol) and 4-pentenoic acid 95 (0.910 g, 9.07 mmol) as coupling partner. 









acetylated β-lactose-4-pentenamide 99 as a white foam: Rf = 0.33 (hexane/EtOAc, 1/2); 
IR (CCl4, cm-1) 3436 (w), 3083 (w), 2943 (w), 1755 (s), 1704 (m), 1227 (s), 1052 (s); 1H 
NMR (400MHz, CDCl3) δ 1.94 (s, 3H), 2.01 (s, 3H), 2.02 (s, 3H), 2.02 (s, 3H), 2.04 (s, 
3H), 2.09 (s, 3H), 2.13 (s, 3H), 2.18-2.36 (m, 4H), 3.67-3.76 (m, 2H), 3.82-3.85 (m, 1H), 
4.01-4.14 (m, 3H), 4.40 (dd, J = 12.4, 1.4, 1H), 4.42 (d, J = 8.0, 1H), 4.79 (t, J = 9.4, 1H), 
4.91 (dd, J = 10.4, 3.4, 1H), 4.96 (dd, J = 10.3, 1.5, 1H), 5.01 (dd, J = 18.8, 1.5, 1H), 5.06 
(dd, J = 10.4, 8.0, 1H), 5.18 (t, J = 9.4, 1H), 5.26 (dd, J = 9.4, 8.7, 1H), 5.32 (dd, J = 3.4, 
1.0, 1H), 5.69-5.78 (m, 1H), 6.11 (d, J = 9.4, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5, 
20.6, 20.6, 20.6, 20.7, 20.7, 20.9, 28.8, 35.6, 60.8, 61.9, 66.6, 68.9, 70.7, 70.9, 71.0, 72.3, 
74.4, 75.9, 77.9, 100.9, 115.8, 136.3, 168.9, 169.2, 170.1, 170.1, 170.3, 170.3, 171.2, 
172.3; HRMS (FAB) cacld. for C31H44O18N [M + H]+ 718.2558, found 718.2562. 
 
Acetylated β-glucose-5-
(triethoxysilyl)pentanamide 97 (Table 5). To a 
sealed tube were added acetylated β-glucose-4-pentenamide 96 (0.800 g, 0.687 mmol), 
triethoxysilane (1.53 g, 9.32 mmol), platinum oxide (PtO2, 21.0 mg, 93.0 μmol), and 2.8 
mL of THF. The tube was charged with nitrogen and sealed. The resulting mixture was 
stirred at 95 oC for 2 h. After cooling to room temperature, the crude product was filtered 
through activated charcoal with ethanol and concentrated. Purification by column 
chromatography (hexane/EtOAc, 1/1) afforded 0.77 g of a mixture of siloxane amide 97 
and saturated amide 98 (97/98, 85/15 mol ratio, determined by GC and 1H NMR 
spectroscopy). The yield of acetylated β-glucose-5-(triethoxysilyl)pentanamide 97 was 









(hexane/EtOAc, 1/1); IR (CCl4, cm-1) 3432 (w), 2973 (m), 1755 (s), 1707 (m), 1511 (m), 
1224 (s), 956 (w) 1H NMR (97, 400MHz, CDCl3) δ 0.57-0.62 (m, 2H), 1.19 (t, J = 7.0, 
9H), 1.35-1.42 (m, 2H), 1.57-1.63 (m, 2H), 1.99 (s, 3H), 2.00 (s, 3H), 2.02 (s, 3H), 2.05 
(s, 3H), 2.14-2.20 (m, 2H), 3.77 (q, J = 7.0, 6H), 3.78-3.82 (m, 1H), 4.04 (dd, J = 12.4, 
2.0, 1H), 4.28 (dd, J = 12.4, 4.4, 1H), 4.88 (t, J = 9.5, 1H), 5.04 (t, J = 9.5, 1H), 5.22 (t, J 
= 9.5, 1H), 5.28 (t, J = 9.5, 1H), 6.16 (d, J = 9.5, 1H); 13C NMR (97, 100 MHz, CDCl3) 
δ 10.2, 18.3 (x 3),  20.6, 20.6, 20.6, 20.7, 22.5, 28.4, 36.3, 58.3 (x 3), 61.6, 68.1, 70.5, 
72.6, 73.5, 78.1, 169.5, 169.8, 170.6, 171.1, 173.2; 29Si NMR (97, 79.5 MHz, CDCl3, 
externally referenced to TMS at 0 ppm) δ _45.6; HRMS (FAB) cacld. for 




(Table 5). To a sealed tube were 
added acetylated β-lactose-4-pentenamide 99 (0.310 g, 0.430 mmol), triethoxysilane 
(0.350 g, 2.16 mmol), platinum oxide (PtO2, 5.00 mg, 22.0 μmol), and 0.7 mL of THF.  
The tube was charged with nitrogen and sealed. The resulting mixture was stirred at 95 
oC for 2 h. After cooling to room temperature, the crude product was filtered through 
activated charcoal with ethanol and concentrated. Purification by column 
chromatography (hexane/EtOAc, 1/1) afforded 0.200 g of a mixture of siloxane amide 
100 and saturated amide 101 (100/101, 72/28 mol ratio, determined by 1H NMR 
spectroscopy). The yield of acetylated β-lactose-5-(triethoxysilyl)pentanamide 100 was 










(hexane/EtOAc, 2/3) ; IR (CCl4, cm-1) 3305 (w), 2974 (m), 1752 (s), 1703 (m), 1225 (s), 
956 (m); 1H NMR (100, 400MHz, CDCl3) δ 0.56-0.61 (m, 2H), 1.18 (t, J = 7.0, 9H), 
1.34-1.41 (m, 2H), 1.54-1.62 (m, 2H), 1.93 (s, 3H), 2.01 (s, 3H), 2.01 (s, 3H), 2.02 (s, 
3H), 2.05 (s, 3H), 2.09 (s, 3H), 2.14 (s, 3H), 2.08-2.18 (m, 2H), 3.77 (q, J = 7.0, 6H), 
3.67-3.85 (m, 3H), 4.01-4.14 (m, 3H), 4.37-4.40 (m, 1H), 4.41 (d, J = 8.0, 1H), 4.79 (t, J 
= 9.5, 1H), 4.90 (dd, J = 10.5, 3.4, 1H), 5.07 (dd, J = 10.5, 8.0, 1H), 5.17 (t, J = 9.5, 1H), 
5.27 (br t, J = 9.5, 1H), 5.32 (br d, J = 3.4, 1H), 6.07 (d, J = 9.5, 1H); 13C NMR (100, 100 
MHz, CDCl3) δ 10.2, 18.3 (x 3), 20.5, 20.6, 20.6, 20.6, 20.6, 20.7, 20.9, 22.5, 28.4, 36.3, 
58.3 (x 3), 60.8, 61.9, 66.6, 68.9, 70.7, 70.9, 71.0, 72.3, 74.4, 75.9, 77.9, 100.9, 168.9, 
169.3, 170.1, 170.1, 170.3, 170.3, 171.3, 173.0; 29Si NMR (100, 79.5 MHz, CDCl3, 
externally referenced to TMS at 0 ppm) δ _45.5; HRMS (FAB) cacld. for 
C37H59O21NSiCs [M + Cs]+ 1014.2403, found 1014.2426. 
 
Acetylated β-glucosyl pentanamide 98 (Table 5). 
Acetylated β-glucose-4-pentenamide 96 (130 mg, 0.303 
mmol) and palladium on carbon (5%, 64.0 mg, 30.3 μmol) were stirred in 5 mL of 
MeOH under 1 atm of hydrogen for 1 h. The reaction mixture was filtered and 
concentrated. Without further purification, 120 mg (98%) of acetylated β-glucosyl 
pentanamide 98 as a white foam was obtained: Rf = 0.29 (hexane/EtOAc, 1/1); IR (CCl4, 
cm-1) 3436 (w), 2961 (m), 1755 (s), 1707 (s), 1512 (s), 1224 (s), 1039 (s); 1H NMR 
(400MHz, CDCl3) δ 0.87 (t, J = 7.2, 3H), 1.25-1.31 (m, 2H), 1.51-1.56 (m, 2H), 1.99 (s, 
3H), 2.00 (s, 3H), 2.01 (s, 3H), 2.05 (s, 3H), 2.07-2.22 (m, 2H), 3.79 (ddd, J = 9.6, 4.4, 








5.03 (t, J = 9.6, 1H), 5.23 (t, J = 9.6, 1H), 5.28 (t, J = 9.6, 1H), 6.19 (d, J = 9.6, 1H); 13C 
NMR (100 MHz, CDCl3) δ 13.7, 20.6, 20.6, 20.6, 20.7, 22.2, 27.2, 36.4, 61.6, 68.1, 70.5, 
72.6, 73.5, 78.1, 169.6, 169.8, 170.6, 171.0, 173.4; HRMS (DEI) cacld. for C19H29O10N 
[M ]+ 431.1791, found 431.1776. 
 
Acetylated β-lactosyl pentanamide 101 
(Table 5). Acetylated β-lactose-4-
dium on carbon (5%, 12 mg, 5.9 μmol) were 
stirred in 5 mL of MeOH under 1 atm of hydrogen for 2 h. The reaction mixture was 
filtered and concentrated. Without further purification, 40 mg (94%) of acetylated β-








pentenamide 99 (42 mg, 59 μmol) and palla
f = 0.29 (hexane/EtOAc, 1/2); 
IR (CCl4, cm-1) 3438 (w),  2960 (w), 1753 (s), 1706 (m), 1225 (s), 1048 (s); 1H NMR 
(400MHz, CDCl3) δ 0.87 (t, J = 7.4, 3H), 1.22-1.35 (m, 2H), 1.49-1.59 (m, 2H), 1.94 (s, 
3H), 2.01 (s, 3H), 2.02 (s, 3H), 2.03 (s, 3H), 2.05 (s, 3H), 2.09 (s, 3H), 2.13 (s, 3H), 2.08-
2.20 (m, 2H), 3.69-3.77 (m, 2H), 3.82-3.86 (m, 1H), 4.02-4.15 (m, 3H), 4.40 (dd, J = 
12.4, 1.4, 1H), 4.44 (d, J = 8.0, 1H), 4.80 (t, J = 9.5, 1H), 4.91 (dd, J = 10.4, 3.4, 1H), 
5.08 (dd, J = 10.4, 8.0, 1H), 5.19 (t, J = 9.5, 1H), 5.27 (t, J = 9.5, 1H), 5.32 (br d, J = 3.4, 
1H), 6.07 (d, J = 9.5, 1H); 13C NMR (100 MHz, CDCl3) δ 13.6, 20.5, 20.6, 20.6, 20.6, 
20.6, 20.8, 20.9, 22.2, 27.2, 36.4, 60.8, 61.9, 66.6, 68.9, 70.7, 70.9, 71.0, 72.3, 74.4, 76.1, 
78.0, 100.9, 168.9, 169.2, 170.1, 170.1, 170.3, 170.4, 171.3, 173.2; HRMS (FAB) cacld. 




Acetylated β-glucosyl octanamide 103 (Table 6). 
3






Amide 103 was prepared following general 
63 (0.520 g, 1.39 mmol), diisopropylethylamine 




procedure A using β-glucosyl azide 
3 (1.67 mL, 1.67 mmol), and octanoic acid (102) (0.400 g, 
2.79 mmol). Purification by column chromatography (hexane/EtOAc, 2/1) afforded 0.376 
g (57%) of acetylated β-glucosyl octanamide 103 as a colorless gum: Rf = 0.48 (hexane/ 
EtOAc, 1/1); IR (CCl4, cm-1) 3434 (w), 2957 (m), 1759 (s), 1708 (m), 1507 (m), 1228 (s); 
1H NMR (400MHz, CDCl ) δ 0.85 (t, J = 7.2, 3H), 1.23 (br s, 8H), 1.54-1.57 (m, 2H), 
1.99 (s, 3H), 2.01 (s, 3H), 2.02 (s, 3H), 2.05 (s, 3H), 2.11-2.18 (m, 2H), 3.80 (ddd, J = 
9.6, 4.0, 2.0, 1H), 4.05 (dd, J = 12.4, 2.0, 1H), 4.29 (dd, J = 12.4, 4.0, 1H), 4.89 (t, J = 
9.6, 1H), 5.04 (t, J = 9.6, 1H), 5.23 (t, J = 9.6, 1H), 5.28 (t, J = 9.6, 1H), 6.15 (d, J = 9.6, 
1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 20.6, 20.6, 20.6, 20.7, 22.6, 25.1, 28.9, 29.0, 
31.6, 36.7, 61.6, 68.1, 70.6, 72.7, 73.5, 78.1, 169.6, 169.9, 170.6, 171.0, 173.4; HRMS 
(FAB) cacld. for C22H36O10N [M + H]+ 474.2339, found 474.2340. 
 
A
104 (Table 6). Amide 104 was 
prepared following general procedure 







A using β-maltosyl azide 66 (1.05 g, 1.58 mmo
3 (2.06 mL, 2.06 mmol), and octanoic acid (102) (0.460 g, 3.17 mmol). 
Purification by column chromatography (hexane/EtOAc, 1/2) afforded 0.730 g (61%) of 
acetylated β-maltosyl octanamide 104 as a white foam: Rf = 0.18 (hexane/ EtOAc, 1/1); 









NMR (400MHz, CDCl3) δ 0.84 (t, J=7.0, 3H), 1.23 (br s, 8H), 1.53-1.64 (m, 2H), 1.97 (s, 
3H), 1.98 (s, 3H), 2.00 (s, 3H), 2.00 (s, 3H), 2.04 (s, 3H), 2.07 (s, 3H), 2.11 (s, 3H), 2.09-
2.18 (m, 2H), 3.77 (ddd, J = 9.5, 4.0, 2.4, 1H), 3.89 (ddd, J = 10.0, 3.8, 2.2, 1H), 3.94 (t, 
J = 9.5, 1H), 4.01 (dd, J = 12.4, 2.2, 1H), 4.20 (dd, J = 12.4, 3.8, 1H), 4.21 (dd, J = 12.4, 
4.0, 1H), 4.39 (dd, J = 12.4, 2.4, 1H), 4.73 (t, J = 9.5, 1H), 4.83 (dd, J = 10.0, 4.0, 1H), 
5.03 (t, J = 10.0, 1H), 5.25 (t, J = 9.5, 1H), 5.30-5.38 (m, 3H), 6.02 (d, J = 9.5, 1H); 13C 
NMR (100 MHz, CDCl3) δ 14.0, 20.6, 20.6, 20.6, 20.6, 20.7, 20.8, 20.8, 22.5, 25.1, 28.9, 
29.0, 31.6, 36.6, 61.4, 62.8, 67.9, 68.5, 69.2, 70.0, 71.3, 72.6, 73.9, 74.9, 77.6, 95.5, 
169.5, 169.6, 169.8, 170.4, 170.5, 170.7, 171.1, 173.2; HRMS (ESI) cacld. for 
C34H52O18N [M + H]+ 762.3184, found 762.3192. 
 
Acetylated β-lactosyl octanamide 
A using β-lactosyl azide 67 (0.480 g, 0.726 mmol),
O
AcO OAcOAc
105 (Table 6). Amide 105 was 
prepared following general procedure 
 diisopropylethylamine (0.187 g, 1.45 
mmol), PMe3 (0.871 mL, 0.871 mmol), and octanoic acid (102) (0.210 g, 1.45 mmol). 
Purification by column chromatography (hexane/EtOAc, 1/2) afforded 0.300 g (54%) of 
acetylated β-lactosyl octanamide 105 as a white foam: Rf = 0.45 (hexane/ EtOAc, 1/2); 
IR (CCl4, cm-1) 3309 (w), 2957 (m), 1756 (s), 1707 (m), 1369 (s), 1221 (s), 1050 (s); 1H 
NMR (400MHz, CDCl3) δ 0.81 (t, J = 7.2, 3H), 1.20 (br s, 8H), 1.49-1.53 (m, 2H), 1.91 
(s, 3H), 1.98 (s, 3H), 1.99 (s, 3H), 2.00 (s, 3H), 2.01 (s, 3H), 2.06 (s, 3H), 2.10 (s, 3H), 
2.05-2.17 (m, 2H), 3.66-3.75 (m, 2H), 3.81-3.84 (m, 1H), 3.99-4.12 (m, 3H), 4.37 (dd, J 







5.05 (dd, J = 10.0, 8.0, 1H), 5.16 (t, J = 9.2, 1H), 5.24 (t, J = 9.2, 1H), 5.30 (d, J = 3.2, 
1H), 6.12 (d, J = 9.2, 1H); 13C NMR (100 MHz, CDCl3) δ 13.9, 20.4, 20.5, 20.6, 20.6, 
20.6, 20.7, 20.8, 22.5, 25.1, 28.8, 28.9, 31.5, 36.5, 60.8, 61.9, 66.5, 68.9, 70.6, 70.8, 70.9, 
72.2, 74.3, 75.9, 77.8, 100.8, 168.9, 169.2, 169.9, 170.1, 170.2, 170.3, 171.1, 173.2; 
HRMS (FAB) cacld. for C34H51O18NCs [M + Cs]+ 894.2160, found 894.2137. 
 
OA Acetylated β-maltotriosyl 
tanamide 106 (Table 6). 
 
is e







Amide 106 was prepared 
following general procedure 
opropyl thylamine (0.320 g, 
 (102) (0.350 g, 2.44 mmol). 
Purification by column chromatography (hexane/EtOAc, 1/2) afforded 0.640 g (50%) of 
acetylated β-maltotriosyl octanamide 106 as a white foam: R
A using β-maltotriosyl azide 68 (1.16 g, 1.22 mmol), di
f = 0.37 (hexane/ EtOAc, 
1/2); IR (CCl4, cm-1) 3412 (w), 2958 (m), 1758 (s), 1709 (m), 1368 (m), 1233 (s), 1040 
(s); 1H NMR (400MHz, CDCl3) δ 0.81-0.87 (m, 3), 1.24 (br s, 8H), 1.53-1.56 (m, 2H), 
1.97 (s, 3H), 1.98 (s, 3H), 1.98 (s, 3H), 1.98 (s, 3H), 2.00 (s, 3H), 2.01 (s, 3H), 2.04 (s, 
3H), 2.07 (s, 3H), 2.12 (s, 3H), 2.14 (s, 3H), 2.09-2.18 (m, 2H), 3.80 (ddd, J=9.4, 4.0, 2.6, 
1H), 3.87-3.99 (m, 4H), 4.02 (dd, J = 12.4, 2.2, 1H), 4.13 (dd, J = 12.2, 2.7, 1H), 4.22 
(dd, J = 12.4, 3.5, 1H), 4.28 (dd, J = 12.2, 4.0, 1H), 4.39 (dd, J = 12.2, 2.6, 1H), 4.44 (dd, 
J = 12.2, 1.5, 1H), 4.71 (dd, J = 10.3, 4.1, 1H), 4.72 (t, J = 9.4, 1H), 4.82 (dd, J = 10.0, 
4.0, 1H), 5.04 (t, J = 10.0, 1H), 5.22 (d, J = 4.1, 1H), 5.26 (t, J = 9.4, 1H), 5.30-5.38 (m, 













20.6, 20.7, 20.8, 20.8, 20.9, 20.9, 22.6, 25.1, 28.9, 29.0, 31.6, 36.7, 61.3, 62.2, 62.9, 67.9, 
68.5, 69.0, 69.3, 70.1, 70.4, 71.4, 71.6, 72.4, 73.7, 73.9, 74.8, 77.6, 95.6, 95.8, 169.5, 
169.5, 169.6, 169.8, 170.3, 170.5, 170.5, 170.6, 170.7, 171.1, 173.2; HRMS (ESI) cacld. 
for C46H68O26N [M + H]+ 1050.4029, found 1050.3988. 
 
β-Glucosyl octanOH amide 107 (Table 6). Amide 107 
as prepared following general procedure C using 
mmol). The reaction mixture was neu
6). 
mide 108 was prepared following 
) O








acetylated β-glucosyl octanamide 103 (0.320 g, 0.680 mmol) and NaOMe (6.80 mL, 1.35 
tralized with Dowex MAC-3 resin. Purification by 
column chromatography (CH2Cl2/MeOH, 6/1) afforded 0.177 g (85%) of β-glucosyl 
octanamide 107 as an amorphous solid: Rf = 0.17 (CH2Cl2/MeOH, 6/1); IR (ATR, Ge 
window, cm-1) 3430 (br), 2918 (w), 1628 (s), 1545 (s), 1077 (s); 1H NMR (400MHz, 
DMSO) δ 0.85 (t, J = 7.1, 3H), 1.23 (br s, 8H), 1.42-1.50 (m, 2H), 2.05-2.09 (m, 2H), 
2.99-3.12 (m, 3H), 3.15 (t, J = 9.0, 1H), 3.39 (br d, J = 11.4, 1H), 4.61 (br d, J = 11.4, 
1H), 4.45 (br s, 1H), 4.68 (t, J = 9.0, 1H), 4.87 (br s, 3H), 8.23 (d, J = 9.0, 1H); 13C NMR 
(100 MHz, DMSO) δ 14.0, 22.1, 24.9, 28.5, 28.7, 31.2, 35.4, 60.9, 70.0, 72.5, 77.6, 78.5, 
79.4, 172.5; HRMS (FAB) cacld. for C14H28O6N [M + H]+ 306.1917, found 306.1927. 
 






general procedure C using acetylated β-









chromatography (CH2Cl2/MeOH, 3/1) afforded 0.17 g (74%) of β-maltosyl octanamide 
108 as an amorphous solid: Rf = 0.38 (CH2Cl2/MeOH, 3/1); IR (Drop casting on CaF2, 
cm-1) 3331 (br), 2926 (m), 1664 (m), 1546 (m), 1377 (w); 1H NMR (400MHz, D2O) 
δ 0.71 (t, J = 7.9, 3H), 1.13-1.16 (m, 8H), 1.43-1.51 (m, 2H), 2.15-2.19 (m, 2H), 3.26 (t, J 
= 9.3, 1H), 3.27 (t, J = 9.3, 1H), 3.43 (dd, J = 10.0, 3.9, 1H), 3.49-3.76 (m, 9H), 4.81 (d, J 
= 9.3, 1H), 5.28 (d, J = 3.9, 1H); 13C NMR (100 MHz, D2O) δ 13.2, 21.8, 24.9, 27.9, 
28.0, 30.8, 35.7, 60.3, 60.4, 69.2, 71.5, 71.6, 72.5, 72.7, 75.9, 76.0, 76.9, 78.9, 99.4, 
178.7; HRMS (ESI) cacld. for C20H38O11N [M + H]+ 468.2445, found 468.2445. 
 




6). Amide 109 was prepared 
following general procedure C using 
3
mmol). The reaction mixture was neutralized with -3






acetylated β-lactosyl oactanamide 105 (0.230 g, 0. 00 mmol) and NaOMe (10.6 mL, 2.11 
 Dowex MAC  resin. Purification by 
forded 0.100 g (71%) of β-lactosyl 
octanamide 109 as an amorphous solid: Rf = 0.28 (CH2Cl2/MeOH, 3/1); IR (drop casting 
on CaF2, cm-1) 3269 (br), 2919 (m), 1655 (m), 1548 (m), 1373 (w); 1H NMR (400MHz, 
D2O) δ 0.72 (t, J = 6.8, 3H), 1.13-1.17 (m, 8H), 1.44-1.51 (m, 2H), 2.18 (t, J = 7.2, 2H), 
3.27-3.32 (m, 1H), 3.41 (dd, J = 9.2, 7.6, 1H), 3.51-3.69 (m, 8H), 3.78-3.81 (m, 2H), 4.32 
(d, J = 8.0, 1H), 4.84 (d, J = 9.2, 1H); 13C NMR (100 MHz, D2O) δ 13.2, 21.8, 24.9, 27.9, 
28.0, 30.8, 35.7, 59.7, 60.9, 68.4, 70.8, 71.3, 72.4, 75.0, 75.2, 76.3, 77.6, 78.9, 102.7, 




110 (Table 6). AmidHO HO
OH
e 110 
was prepared following 
m
mmol). The reaction mixture was neutralized with Dowex
column chromatography (CH2Cl2/MeOH, 2/1) afforded 0.
OHO
general procedure C using 
ol) and NaOMe (21 mL, 4.1 
 MAC-3 resin. Purification by 
19 g (74%) of β-maltotriosyl 
octanamide 110 as an amorphous solid: R
acetylated β-maltotriosyl octanamide 106 (0.43 g, 0.41 m
f = 0.17 (CH2Cl2/MeOH, 3/1); IR (drop casting 
on CaF2, cm-1) 3338 (br), 2927 (m), 1653 (m), 1544 (m), 1375 (w); 1H NMR (400MHz, 
D2O) δ 0.73 (t, J = 6.8, 3H), 1.15-1.18 (m, 8H), 1.45-1.51 (m, 2H), 2.17-2.21 (m,  2H), 
3.28 (t, J = 9.2, 1H), 3.29 (t, J = 9.2, 1H), 3.44-3.86 (m, 16H), 4.84 (d, J = 9.2, 1H), 5.27 
(d, J = 4.0, 1H), 5.29 (d, J = 3.6, 1H); 13C NMR (100 MHz, D2O) δ 13.2, 21.8, 24.9, 27.9, 
28.0, 30.8, 35.7, 60.3, 60.3, 60.3, 69.2, 71.0, 71.4, 71.5, 71.6, 72.6, 72.7, 73.2, 75.9, 76.2, 
76.5, 76.8, 78.9, 99.3, 99.6, 178.7; HRMS (FAB) cacld. for C26H47O16NNa [M + Na]+ 














Chapter 3: Preparation and Characterization of Carbohydrate-
Functionalized Gold Nanospheres for the Detection of Pathogens  
 
INTRODUCTION 
Since many biomolecules are tens of nanometers in size, it has been thought that 
accurately designed nanomaterials can be incorporated into biological systems. As a 
result, a variety of well-defined nanostructures possessing novel properties have emerged 
as versatile tools for biological and biomedical applications.98-102 Among them, colloidal 
gold nanospheres are especially promising in biological applications because of their easy 
of preparation and bioconjugation, non-toxicity and stability.  
Gold nanospheres (AuNSs) are easily prepared by the citrate reduction of auric 
acid with sodium citrate reported by Turkevich and co-workers in 1951103 and refined by 
Frens in 1973.104 The size of the nanospheres are controlled ranging from 16 nm to 147 
nm by changing the sodium citrate concentration.104 Typically, the formation of 
nanospheres is monitored by the generation of a deep red colored colloidal suspension. 
Citrate-capped AuNSs are very stable and are easily functionalized with various ligands 
containing thiol groups by the displacement of citrate caps. Another popular method for 
the synthesis of AuNSs is two phase synthesis reported by Brust and co-workers in 
1994.105 This method allows the direct synthesis of thermally and air stable AuNSs of 1-3 
nm. In synthesis, the gold salt (AuCl4-) is transferred from aqueous solution to toluene 
using tetraoctylammonium bromide as a phase-transfer agent and then reduced by sodium 
borohydride in the presence of dodecanethiol to produce thiol-stabilized AuNSs (Scheme 
 83
12). The formation of nanospheres is monitored also by the generation of a deep brown 











In addition to easy fabrication, gold is non-toxic in biological systems. Recent in 
vitro studies performed by Wyatt showed that gold nanospheres with a variety of surface 
modifiers are non-toxic to human cells.106 Furthermore, gold nanospheres have unique 
optical properties arising from surface plasmon resonance (SPR).  
SPR results from the collective oscillation of electrons in the conduction band of 
the metal nanoparticles upon incoming light. It depends on the shape, size, and dielectric 
constants of both the metal and the surrounding materials.107-109 For gold nanospheres, 
this resonance is observed in the visible spectral region at ca. 520 nm, which results in the 
brilliant red color of the nanosphere suspensions.103 The SPR of gold nanospheres is 
sensitive to the adsorption of molecules on the particle surface and to the coupling of 
other particles, leading to a shift in λmax.103,107-109 Upon the excitation of the SPR, the 
optical properties including absorption, scattering, and emission of gold nanospheres are 
dramatically enhanced.110 Based on the sensitivity of SPR and the SPR-enhanced 
properties, gold nanospheres hybridized with proteins or DNA have been utilized for the 
biological and biomedical applications including biosensor, diagnostics, drug delivery, 
and the photothermal therapy of cancer.103,110-112  
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The tremendous advantages of gold nanospheres have recently attracted great 
attention in the field of glycobiology. As a result, the first generation of new hybrid 
materials made of gold nanospheres and biologically relevant carbohydrates has been 
shown in 2001 by Penadés and co-workers.113 In fact, this approach extends tools for 
studying the structure and function of carbohydrates from two-dimensional (2D) 
microarrays to three-dimensional (3D) system in nanoscale. Although 2D microarrays 
allow high-throughput evaluation of carbohydrate functions to a variety of 
macromolecules, the study is mainly limited in vitro. By mimicking the situation 
encountered on cell surfaces, the multiple presentations of carbohydrates on the 
nanoscale-globular surface (3D) are promising for the study of carbohydrate-involved 
biological processes in vivo.  
 
Literature Survey for Carbohydrate-Functionalized Gold Nanospheres: Synthetic 
Effort and Their Applications 
Penadés group is the pioneer in the area of carbohydrate-functionalized AuNSs. 
They prepared various glycoconjugates anchored to thiol group for the functionalization 
of gold nanospheres (Scheme 13). The reaction of corresponding carbohydrates with 
thioacetyl alcohol 111 under the trichloroacetimidate method in the presence of a C-2 
participating group (such as acyl), followed by the deprotection provided dimeric β-O-
linked glucose 112, lactose 113, maltose 114, and tumor antigen Lewisx conjugates 115, 









































































Using the modification of the Brust method,105 preparation of carbohydrate-
functionalized AuNSs (116, 117, 118, and 119) was accomplished by adding a 
methanolic solution of the corresponding glycoconjugates to an aqueous solution 
containing tetrachloroauric acid, followed by subsequent reduction with sodium 
borohydride (Scheme 14).114 The resulting dark brown-gold nanospheres are highly water 
soluble, stable in solution for years, and showed a permanent magnetism which is an 
unusual property for gold nanospheres.115 The presence of carbohydrate moieties was 
confirmed by 1H-NMR and IR spectroscopy. The core size of gold nanospheres (< 2 nm) 





















The resulting carbohydrate-functionalized gold nanospheres have been utilized in a 
variety of applications. For example, LeX-functionalized AuNSs 119 were utilized for 
probing calcium ion mediated carbohydrate-carbohydrate interactions,113,116 which have 
been implicated in cell recognition.117 The possibility of carbohydrate-functionalized 
AuNSs as tools for anti-adhensive therapy was demonstrated in vivo.118 Mice injected 
with tumor cells pre-incubated with lactose-functionalized AuNSs 117 suppressed tumor 
progression about 70 %, compared with the group inoculated only with tumor cells.118  
Chen and co-workers prepared mannose-functionalized AuNSs 114 by the Brust 
method with mannose conjugates 113 anchored to a thiol group (Scheme 15).119 The α-
O-linked mannose conjugate 113 was synthesized by the reaction of acetylated mannosyl 
bromide 110 with pentenyl alcohol 111 under the Koenigs-Knorr condition, followed by 






























Au Mannose-AuNSs 114 (6 nm)
Koenigs-Knorr method
 
The size of gold nanospheres 114 (6±1 nm, mean diameter) was determined by 
TEM, and the UV-visible spectrum of particles 114 showed a clear SPR band at 520 nm. 
The presence of mannose conjugate 113 was confirmed by 1H NMR. Mannose-
functionalized AuNSs 114 were utilized to demonstrate the specificity of carbohydrate-
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receptor interaction. When mannose-functionalized AuNSs 114 were incubated with two 
E. coli strains ORN178 (expresses mannose receptor FimH) and ORN208 (deficient on 
the FimH gene), mannose-functionalized AuNSs 114 recognized only ORN178 strain and 
were visualized by TEM.119 Later on, they utilized carbohydrate-functionalized AuNSs as 
affinity probes for the efficient separation and enrichment of target proteins.120 When 
galactose-functionalized AuNSs prepared by a similar manner in Scheme 4 were 
incubated with a mixture of proteins, a galactophilic lectin Pseudomonas aeruginosa was 
captured by the galactose-functionalized AuNSs, separated by centrifugation, and 
detected by MALDI-TOF mass spectrometry. The strong affinity results from the 
multivalent interaction between the galactose residues on the gold surface and 
Pseudomonas aeruginosa lectins. 
Gervay-Hague and co-workers prepared monosaccharide-functionalized gold 
nanospheres (Scheme 16).121 The synthesis of glycosides 116 was performed by the 
reaction of corresponding carbohydrate 115 with nitromethane under basic condition to 
provide β-C-linked glycosides 116. Hydrogenation of glycosides 116 over 
palladium/charcoal, followed by coupling with bi-functional linker 118 afforded glycosyl 
conjugates 119. Under the Penadés conditions,114 glucose- and galactose-functionalized 








































Glucose-AuNSs 120 (2 nm)























The particle sizes were measured by TEM and atomic force microscopy (AFM). 
The presence of carbohydrate moieties and tethers were confirmed by IR and 1H NMR 
spectroscopy. These gold nanospheres (120 and 121) were utilized to investigate the 
multivalent interactions with recombinant glycoprotein 120 (gp 120), which initiates HIV 
infection, by a biotin-NeutrAvidin adhesion assay. The results indicated that the binding 
activity of carbohydrate-functionalized AuNSs (120 and 121) to recombinant gp 120 
were 300 times greater than corresponding dimers 119, demonstrating the importance of 
polyvalent display of carbohydrates on the gold nanospheres. 
Barchi and co-workers synthesized gold nanospheres 122 functionalized with 
Thomsen-Friedenreich disaccharide,122 which is a human tumor-associated carbohydrate 
antigen, by a modified procedure of that reported by Brust and co-workers.105 These 
particles 122 showed in vitro activity against tumor growth and inhibited lung metastasis 

















122 (1-2 nm)Thomsen-Friedenreich disaccharide AuNSs  
 
Kataoka and co-workers prepared carbohydrate-functionalized gold nanospheres 
through the immobilization of carbohydrate conjugates onto the gold nanospheres 
presenting poly(ethylene glycol) (PEG) derivatives (Scheme 17).123 Thiol-stabilized 
AuNSs 124 (mean diameter of 8.9 nm determined by TEM) were first prepared by the 
reduction of auric acid with sodium borohydride in the presence of PEG derivatives 123. 
The PEG terminal acetal groups were then converted to aldehydes 125 by acid treatment. 
The condensation of PEG terminal aldehyde groups 125 with a mixture of lactose and 
mannose derivatives (126 and 127) by reductive amination produced imines, which were 
reduced to generate gold nanospheres 128 containing both lactose and mannose (Scheme 
17). The authors also controlled the density of carbohydrates on the surface by changing 
the ratio of lactose and mannose derivatives (126 and 127). The presence of lactose 
moieties on gold nanospheres was confirmed by the assay with Recinus communis 
agglutinin (RCA120), a divalent lectin specifically recognizing β-galactose residue, by 














































































Russell and co-workers prepared lactose-functionalized AuNSs 134 (Scheme 
18).124 The β-O-linked lactose derivative 132 was synthesized by the reaction of 
peracetylated lactose 129 with bromoethanol 130 using the Koenigs-Knorr method. The 
bromide of lactose derivative 131 was then displaced by thioacetate, followed by 
deprotection of acetyl groups provided thiolated lactose derivative 132. Lactose-
functionalized AuNSs 134 (16 nm, mean diameter) were prepared by citrate reduction of 
auric acid, followed by the self-assembly of thiolated lactose derivative 132 on the pre-
formed, citrate-capped AuNSs 133 (Scheme 18).124 Similarly, they also prepared glucose, 

















































The lactose-functionalized AuNSs 134 were utilized to demonstrate calcium-
mediated carbohydrate-carbohydrate interactions by monitoring the SPR band. Visibly, 
the solution containing lactose-functionalized AuNSs 134 changed color from red to 
purple following the addition of calcium ions, suggesting calcium-induced 
aggregation.124 Recently, the authors reported a colorimetric assay to detect cholera toxin 
utilizing lactose-functionalized AuNSs 134 by mimicking the interactions between 
carbohydrates of GM1 ganglioside and the receptor presented on the cholera toxin.125 The 
AuNSs 134 selectively recognized cholera toxin and responded with a color change of 
the solution. The simple color change of the bioassay provided a selective detection and 
quantification of cholera toxin within 10 minutes.  
As discussed above, it is unambiguous that carbohydrate-functionalized gold 
nanospheres are fascinating tools for the study of their biological functions. Their unique 
properties, including the easy preparation, functionalization, biosafety, and stability, 
inspired us to develop cellular probes to detect pathogens. For these purposes, it is 
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important to control the size of gold nanospheres because of their size-dependent optical 
properties and their lifetime in bloodstream against physiological barriers126 such as the 
renal system, the reticular endothelial system (RES), and liver. Accordingly, the goal of 
research in this section was to prepare carbohydrate-functionalized gold nanospheres with 
tunable size and to characterize the bioactivity of carbohydrates on the surface of gold 
nanospheres.  
 
RESULTS AND DISCUSSION 
Preparation of Carbohydrate-Functionalized Gold Nanospheres 
In order to control the size of gold nanospheres, two different methods were 
utilized: (1) in-situ reduction of auric acid with sodium borohydride in the presence of 
glycoconjugates to provide small particles, and (2) a stepwise method where 
glycoconjugates were self-assembled on the surface of pre-formed, citrate-capped gold 
nanospheres to provide particles with larger diameters. For the surface functionalization 
of gold nanospheres, β-glucosyl thioctanamide 78 and β-lactosyl thioctanamide 81 
(Scheme 19) were selected because of the structural simplicity of the carbohydrate 
moiety. The methodology that would be perfected using these two systems would be a 
model for more complex oligosaccharide. In addition, the presence of the disulfide 
functionality on the tether would ensure a strong attachment to gold surface. 
 
 Via Sodium Borohydride Reduction in the Presence of Carbohydrate Conjugates 
The preparation of carbohydrate-functionalized gold nanospheres with diameters 
smaller than 2 nm was accomplished using an adaptation of Penadés’s procedure 
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(Scheme 19).114 A methanolic solution of the corresponding glycoconjugate (78 or 81) 
was added into an aqueous solution of tetrachloroauric acid. The resulting mixture was 
reduced with sodium borohydride to generate a dark suspension. The dark suspension 
was stirred at room temperature for 3 h, and then the solvent was removed. Purification 




























Glucose-AuNSs 135 Lactose-AuNSs 136  
These functionalized nanospheres were characterized by UV-visible, FT-IR, X-ray 
photoelectron spectroscopy (XPS), and TEM. The size information of each nanospheres 
was obtained by TEM. Figure 22a and 22b shows TEM images with inset size 
distribution of glucose-functionalized AuNSs 135 and lactose-functionalized AuNSs 136, 
respectively. Both AuNSs (135 and 136) showed small core diameters ranging from 0.5 
nm to 4 nm with a mean core size of 1.8 nm for glucose-AuNSs 135, and 1.9 nm for 
lactose-AuNSs 136. It was known that UV-visible absorption spectra of gold nanospheres 
present a size-dependent SPR band at around 520 nm, and the SPR band is little or absent 
for gold nanospheres with core size less than 2 nm, as well as for bulk gold.127,128 In the 
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absorption spectra (Figure 22c), AuNSs 135 and 136 showed no SPR band ca. 520 nm, 
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Figure 22. TEM images with inset size distribution histograms and UV-visible 
absorption spectra of carbohydrate-functionalized AuNSs. (a) glucose-AuNSs 135, dcore = 
1.8 ± 0.6 nm. (b) lactose-AuNSs 136, dcore = 1.9 ± 0.7 nm. (c) no SPR band was observed 
at ca. 520 nm.  
  
The presence of glycoconjugates (78 or 81) on the surface of gold nanospheres was 
confirmed by XPS and FT-IR spectroscopies. FT-IR spectra of both AuNSs 135 and 136 
showed an amide functional group at around 1655 cm-1 (amide I band, C=O stretching) 
and at around 1530 cm-1 (amide II band, a combination of C-N stretching and C-N-H 
bending). A broad band at around 3360 cm-1 for O-H, N-H stretching, and C-H stretching 
at around 2920 cm-1 were also observed. 
The XPS spectra of AuNSs 135 and 136 exhibited both gold core (Au 4f) and 
glycoconjugate-based peaks (S 2p, C 1s, and O 1s). The absence of nitrogen peaks is due 
possibly to the insensitivity of the technique to detect a small amount of nitrogen.129 
Figure 23 shows the Au 4f and S 2p regions of the XPS spectra of each AuNSs (135 and 
136).  The broad doublet peak observed in each region indicated that a single gold and a 
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single sulfur species were present. The binding energies measured for Au 4f7/2 and Au 
4f5/2 of each nanospheres are at around 83.4 eV and 87.2 eV, respectively, suggesting that 
the gold atoms in the nanospheres are largely in the bulk state.105 The binding energies of 
S 2p3/2 for each AuNSs (135 and 136) were observed at 161.3 eV and 161.8 eV, 
respectively, suggesting that glycoconjugates (78 and 81) bound to the surface of gold 
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Figure 23. Au 4f and S 2p regions of XPS spectra of carbohydrate-functionalized 
AuNSs. (a) and (b) for glucose-AuNSs 135. (c) and (d) for lactose-AuNSs 136. The 
numbers in each spectrum correspond to the binding energies. 
 
The preparation of carbohydrate-functionalized gold nanospheres using Penadés’s 
procedure was successful. However, under these conditions a significant amount of gold 
nanospheres 135 and 136 were aggregated during the purification steps. In addition, 
occasionally this procedure gave a wide size distribution. That is presumably due to the 
heterogeneous reaction conditions where gold nanospheres (insoluble in methanol) are 
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immediately formed by adding sodium borohydride into a mixture of auric acid in water 
and glycoconjugates in methanol. Therefore, a more reliable method was required.  
To achieve this goal, Penadés’s procedure was modified slightly by using a single 
solvent (water) instead of using a mixture of methanol and water. Into an aqueous 
solution containing a mixture of auric acid and glycoconjugate (78 or 81), an aqueous 
solution of sodium borohydride was added (Scheme 19). As expected, the color of the 
solution was changed from a light yellow to a dark brown, indicating the formation of 
gold nanospheres. However, no dark suspension was generated. TEM images and UV-
visible spectra of glucose-AuNSs 137 and lactose-AuNSs 138 showed homogeneous 
particles sizes with mean diameters of 1.7 ± 0.6 nm and 1.5 ± 0.4 nm for glucose-AuNSs 
137 and lactose-AuNSs 138, respectively.  
 
Via Citrate Reduction and Self-Assembly of Carbohydrate Conjugates 
The preparation of gold nanospheres with larger diameters was achieved by 
modification of the procedure reported by Frens.104 An aqueous solution of sodium citrate 
was added into a boiling solution of tetrachloroauric acid in water. In few seconds, the 
color of the boiling solution was changed from a light yellow to a corresponding color 
(see the Table 7), indicating the formation of gold nanospheres. By altering the amount of 
citrate added, it was possible to systematically alter the size of the nanospheres produced. 
The results for the preparation of citrate-capped gold nanospheres are summarized in 


































1 0.5 73.2 ± 18.6d Browne 540 nmf - 
2 1.0 28.3 ± 5.7d Purple 524 nm 1.54 
3 1.5 18.1 ± 2.2 Dark red 520 nm 6.63 
4 2.0 15.8 ± 1.6 Dark red 520 nm 10.1 
5 3.0 15.3 ± 1.3 Dark red 520 nm 11.1 
6 4.0 aggregated _ _ _
a The reaction was performed at reflux for 20 min with 100 mL of HAuCl4 solution (1.47 mM in H2O). See 
the experimental section for details. b 0.34 M of citrate solution was used. c The size of each particles was 
determined by TEM. d Relatively broad size distribution observed in TEM. e Tyndall effect of the scattered 
light was observed. f Broad SPR band was observed. See the experimental section for UV-visible spectra. g 
The concentration of particle solution was determined according to the literature.131 





Figure 24. Representative TEM images of citrate-capped gold nanospheres. 
 
By this method, citrate-capped AuNSs with mean diameter ranging from 15 nm to 
73 nm were prepared. The size of citrate-capped AuNSs depended on the amount of 
citrate solution. As the amount of citrate solution was increased, the size of particles 
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decreased. When 4.0 mL of citrate solution was introduced (Table 7, entry 6), most 
particles aggregated and settled out of solution. Interestingly, a variety of morphologies 
were observed in the particles (Table 7, entry 1 and Figure 24) formed with the smallest 
amount of citrate solution. 
Citrate-capped AuNSs provided an intense SPR band at ca. 520 nm except for the 
largest particles (Table 7, entry 1). The intensity of the absorbances decreased along with 
decreasing size (from entry 2 to entry 5). For the largest particles (Table 7, entry 1), the 
intensity and the position of the SPR band were decreased and largely red-shifted, 
respectively. Moreover, the shape of the SPR band was broadened, indicating broad size 
distribution which is a good agreement with the TEM image (Figure 24). 
The concentrations of the gold nanospheres were determined to be within a range 
of ca. 10 nM, based on the size and absorbance.131 The concentration of the largest 
particles could not be determined due to the broad size distribution and various shapes. 
This method overcomes the main disadvantage of direct synthesis of gold 
nanospheres, where the size of nanospheres formulated via the reduction of auric acid 
with sodium borohydride in the presence of the ligands are dependent on both the 
concentration of ligand and  reducing agent, which means that it is difficult to 
reproducibly control the size of particles. By this method, however, the size of particles 
are controlled only by the concentration of citrate as a reducing and stabilizing agent, and 
the resulting particles can be functionalized with various ligands by the displacement of 
citrate-caps without altering the size of particles.  
It was our intention to prepare gold nanospheres > 2 nm by citrate reduction, but 
the smallest particles that could be prepared by this method was ca. 15 nm (Table 7). In 
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order to prepare gold nanospheres sized between 2 and 15 nm, the reduction method had 
to be altered. Therefore, gold salts were reduced with sodium borohydride in the presence 
of sodium citrate according to the literature132 to produce citrate-capped AuNSs 139 with 
a mean diameter of 4.5±1.4 nm (Figure 25a). As anticipated, the resulting colloidal 
suspension showed the intense SPR band at the wavelength of 518 nm (Figure 3b).  
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Figure 25. TEM image (a) and UV-visible spectrum (b) of citrate-capped AuNSs 139 
(4.5±1.4 nm). 
 
Displacement of Citrates with Carbohydrate Conjugates 
Having prepared a variety of citrate-capped gold nanospheres, the study of a 
displacement reaction of citrate-caps on the surface of gold nanospheres with 
glycoconjugates was undertaken. As an initial study, a solution of glucosyl 
thioctianamide 78 in water was mixed with the solution of citrate-capped AuNSs (Table 


































Upon mixing two solutions, the solution color suddenly turned blue, and gold 
nanospheres precipitated. The resulting black suspension was stirred at room temperature 
for 3 days. During this time, the black suspension disappeared and the solution gradually 
recovered a red color (Figure 26). The glucose-AuNSs 140 were then purified by a 
centrifugal filtration, followed by a size exclusive column chromatography (SEC). 
Galactose-AuNSs 141, mannose-AuNSs 142, and lactose-AuNSs 143 were prepared by 
an analogous process.  
Figure 26. Monitoring the displacement reaction of citrate-capped AuNSs (Table 7, entry 
4, 16 nm) with glucosyl thioctanamide 78 as a function of time. 
 
 
As mixed     90 min       90 mina         22 h           30 h           50 h          72 h 
a The reaction vial was removed from the stirrer and allowed to sit for 1 min. All the particles were settled 
out of solution. 
 
The absorption spectra (Figure 27) of glucose-AuNSs 140 and lactose-AuNSs 143 
showed that the displacement of citrate-caps with glycoconjugates resulted in a small 
 101
shift of λmax (from 520 nm to 524 nm), indicating a change in the dielectric property of 

















λmax = 524 nm 
Figure 27. UV-visible absorption spectra of 16 nm citrate-capped AuNSs, glucose-
AuNSs 140, and lactose AuNSs 143. 
 
The preparation of glucose-AuNSs 144 and lactose-AuNSs 145 with 4.5 nm 
diameters were accomplished by the displacement reaction described above with the 
citrate-capped AuNSs 139. 
 
Bioassay of Carbohydrate-Functionalized Gold Nanospheres using Lectins 
Following the successful preparation of carbohydrate-functionalized gold 
nanospheres by the displacement reaction of citrate-capped gold nanospheres with 
thiolated glycoconjugates, attention turned toward investigating the bioavailability of 
carbohydrate-functionalized gold nanospheres. While we had demonstrated that the 
surface of gold nanospheres could be functionalized with glycoconjugates, there was no 
evidence available on how these materials were oriented on the surface. Base on our 
previous studies on gold films reported in Appendix, it was anticipated that the 
conjugates were oriented “away from the surface” as was observed in self-assembled 
 102
monolayers (SAMs). If this were the case, then it was expected that lectin binding to the 
nanospheres would occur, leading to aggregation. On the other hand, if the 
glycoconjugates were to “lay on the surface”, it was anticipated that aggregation would 
not occur (Scheme 21). 










Lectins are carbohydrate-binding proteins that are widely distributed in nature, 
including microorganisms, plants and animals. Lectins presented on the cell surface play 
roles as receptors to mediate cell-cell interactions by the recognition of carbohydrates on 
apposing cells.133,134 A lectin, concanavalin A (Con A) binds selectively to the 
monosaccharides mannose and glucose and to polysaccharides with terminal glucose or 
mannose residues.135,136 Another lectin, peanut agglutinin (PNA) binds selectively to the 
monosaccharide galactose and to oligosaccharides with terminal galactose residues.137,138 
Both of lectins are homotetramers at physiological pH, and each monomer possesses one 
saccharide binding site.139-141 Thus, it is anticipated that they would bind multiple 
carbohydrates and result in aggregation, followed by precipitation if there are 































































































































When Con A was added into a solution of glucose-AuNSs 144 (4.5 nm-
diametered), aggregation occurred and completely settled out of solution within 2 h 
(Figure 28a). TEM images (Figure 28b, 28c, and 28d) show Con A-induced aggregation 
of glucose-AuNSs 144. Before addition of Con A, the particles were dispersed on the grid 
(Figure 28b). Upon addition of Con A, aggregation occurred and the particles were 
brought together to form networks (Figure 28c and 28d). Similarly, PNA-induced 







(b) (c) (d) 
(f) (g) (h) 
 
Figure 28. Photographs and TEM images of lectin-induced aggregation. (a1) photograph 
of glucose-AuNSs 144 and (a2) 2 h after addition of Con A (1.0 μM). (b) TEM image of 
glucose-AuNSs 144. (c) 30 min after addition of Con A (1.0 μM) and (d) magnification 
of (c). (e1) photograph of lactose-AuNSs 145 and (e2) 2 h after addition of PNA (4.0 
μM). (f) TEM image of lactose-AuNSs 145. (g) 30 min after addition of PNA (4.0 μM) 
and (h) magnification of (g). 
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Aggregation depended on the concentration of Con A added. Figure 29a shows 
UV-visible absorption spectra for the aggregation of glucose-AuNSs 144 as a function of 
Con A concentration. As the concentration of Con A increased, the SPR band shifted 
toward longer wavelengths and the turbidity increased due to the scattering induced by 
aggregates.142  
Figure 29. Changes in the UV-visible spectra of glucose-AuNSs 144 on addition of 
different concentration of (a) Con A and (b) PNA. From bottom to top, 0, 0.1, 0.2, 0.3, 
0.4, and 0.5 μM of lectins. Spectra were obtained 40 min after addition of lectins. 
 
The task remaining was to confirm whether the aggregation was induced by the 
specific recognition of Con A to glucose residues on the surface of gold nanospheres, 
rather than electronic interactions. Therefore, control experiments were performed with 
PNA possessing galactose specificity. When different concentrations of PNA were added 
into a suspension of the glucose-AuNSs 144, no change in the UV-visible absorption 
spectra were observed (Figure 29b), indicating that there is no aggregation in the 
presence of PNA. An analogues set of experiments using lactose-AuNSs 145 with Con A 
gave no aggregation. 
 
 



























CONCLUSIONS AND OUTLOOK 
The preparation and surface functionalization of gold nanospheres with 
carbohydrates have been achieved by two methods: (1) in-situ reduction of gold salt in 
the presence of glycoconjugates to provide ca. 2 nm particles and (2) a stepwise method 
where glycoconjugates were self-assembled on the surface of pre-formed, citrate-capped 
gold nanospheres to provide nanospheres with diameters of 15-73 nm. Bioactivity of the 
carbohydrates on the surface of gold nanospheres has been demonstrated using 
agglutination assays. These results indicate that gold nanospheres display multiple 
presentations of carbohydrates, and the carbohydrates on the gold surface preserve their 
function. 
The development of cellular probes to detect pathogens utilizing glycosylated gold 
nanospheres is underway with collaboration of the Stein group (Department of Cell 
Biology and Molecular Genetics, UMCP). The initial results show their potential. 
Lactose-AuNSs 138 (mean diameter, 1.5 nm) in vitro targeted Neisseria gonorrhoeae, 
which is a human pathogen causing gonorrhea, and the pathogen was visualized under a 
conventional optical microscopy owing to the enhanced scattering of AuNSs 138 bound 
on the pathogen.  
In addition, bis-functionalized gold nanoparticles serve as the basis of TRIAD, a 
novel vaccine system. Immunized mice with a gold nanosphere-based vaccine (TRIAD) 
composed of an oligosaccharide derived from N. gonorrhoeae and a synthetic peptide 
(PADRE) showed no observable adverse effects and generated significant levels of IgG 




General. All chemicals were purchased from commercial suppliers and used without 
further purification unless noted otherwise. MilliQ water (Millipore, 18 MΩ) was used 
throughout. 
Instrumentation. UV-visible absorption spectra were recorded using an Ocean Optics 
USB 2000 Spectrometer. Transmission electron microscopy (TEM) measurements 
were performed using a ZEISS EM10 CA. Samples for TEM analysis were prepared by 
drop casting 5 μL of the sample onto a formvar coated copper grid. Images were recorded 
on film and scanned from the negatives. Particle sizes and distributions were analyzed 
using Image J.143 Infrared spectra were recorded on a Nicolet 5DXC FT-IR 
spectrophotometer. Band positions are given in reciprocal centimeters (cm-1) and relative 
intensities are listed as br (broad), s (strong), m (medium) or w (weak). X-ray 
photoelectron spectroscopy (XPS) measurements were performed on a Kratos AXIS 
165 spectrometer. The samples were prepared by the direct deposition of gold 
nanospheres onto a carbon tape.  
 
Preparation of Carbohydrate-Functionalized Gold Nanospheres 
Via Sodium Borohydride Reduction in the Presence of Carbohydrate Conjugates 
General procedure: A solution of glycoconjugate (12 mM, 3 equiv) in MeOH was 
added into a solution of HAuCl4·3H2O (25 mM, 1 equiv) in H2O. Under vigorous stirring 
at room temperature, a freshly prepared aqueous solution of NaBH4 (1.0 M, 22 equiv) 
was added to form a dark suspension. The resulting suspension was stirred at room 
temperature for 3 h. The solvent was evaporated in vacuo below 40 ºC. The residue was 
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dissolved in H2O and purified by centrifugal filtration (Centriplus YM-30, MWCO = 
30kD). This process was repeated three times until the nanoparticles were free of starting 
glycoconjugate (checking by TLC). The aqueous residue in the Centriplus filter was 
collected and precipitated by addition of MeOH. The precipitated gold nanospheres were 
centrifuged and resuspended (by vortexing) in MeOH. This process was also repeated 
three times, decanted, and dried in vacuo to afford gold nanospheres as a dark-brown 
solid. 
Glucose-AuNSs 135. AuNSs 135 were prepared following the general procedure using 
β-glucosyl thioctanamide 78 (44 mg, 0.12 mmol), HAuCl4·3H2O (16 mg, 0.040 mmol) 
and NaBH4 (33 mg, 0.88 mmol). After purification, 15 mg of glucose-AuNSs 135 (1.8 
nm, mean diameter) was obtained as a dark-brown solid: IR (KBr, cm-1) 3410 (br), 2919 
(w), 1650 (m, amide I band), 1539 (m, amide II band), 1409 (w), 1076 (s).  
Lactose-AuNSs 136. AuNSs 136 were prepared following the general procedure using β- 
lactosyl thioctanamide 81 (64 mg, 0.12 mmol), HAuCl4·3H2O (16 mg, 0.040 mmol) and 
NaBH4 (33 mg, 0.88 mmol). After purification, 6 mg of lactose-AuNSs 136 (1.9 nm, 
mean diameter) was obtained as a dark-brown solid: IR (KBr, cm-1) 3374 (br), 2920 (w), 
1654 (m, amide I band), 1540 (m, amide II band), 1414 (w), 1073 (s).  
 
Glucose-AuNSs 137 and lactose-AuNSs 138 were prepared following the general 
procedure except for the concentration of tetrachloroauric acid (30 mM used instead of 
25 mM) and purification procedures.  
Glucose-AuNSs 137. To a solution of β-glucosyl thioctanamide 78 (16.2 mg, 44.1 μmol) 
in H2O was added a solution of HAuCl4 (5.00 mg, 14.7 μmol) in H2O. Under vigorous 
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stirring at room temperature, a freshly prepared aqueous solution of NaBH4 (12.2 mg, 
0.323 mmol) was added, and the resulting solution was stirred at room temperature for 2 
h. The solution was neutralized by adding an aqueous solution of HCl (0.2 M) and then 
purified using size exclusive column chromatography (GE Healthcare, PD-10, Sephadex-
G25 medium). The suspension of glucose-AuNSs 137 was stored at 4 oC. TEM analysis 
(Mean ± std dev): 1.7 ± 0.6 nm. 
Lactose-AuNSs 138 were prepared following the procedure described above using β- 
lactosyl thioctanamide 81 (23.4 mg, 44.1 μmol), HAuCl4 (5.00 mg, 14.7 μmol) and 
NaBH4 (12.2 mg, 0.323 mmol). TEM analysis (Mean ± std dev): 1.5 ± 0.4 nm. 
 
UV-visible spectra  
Glucose-AuNSs 137 in black  


















 Wavelength (nm) 
Figure 30. UV-visible absorption spectra of AuNSs 137 and 138. 
 
A General Procedure for the Preparation of Citrate-Capped Gold Nanospheres with 
a Mean Diameter Ranging from 15 nm to 73 nm is as follows: an aqueous solution of 
sodium citrate dihydrate (given mL, 0.340 M) was added into a boiling solution of 
HAuCl4 (100 mL, 1.47 mM in H2O). In few seconds, the color of the boiling solution 
changed from a light yellow to a corresponding color (typically deep red, see the 
experimental data below), indicating the formation of gold nanospheres. The reaction 
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mixture was refluxed for 20 min and then cooled at room temperature. The particle 
suspension was stored at 4 oC. The experimental data is shown below. 


















1 0.5 73.2 ± 18.6 Brown 540 nm - 
2 1.0 28.3 ± 5.7 Purple 524 nm 1.54 
3 1.5 18.1 ± 2.2 Dark red 520 nm 6.63 
4 2.0 15.8 ± 1.6 Dark red 520 nm 10.1 
5 3.0 15.3 ± 1.3 Dark red 520 nm 11.1 
6 4.0 aggregated - - - 

























Figure 32. UV-visible spectra of citrate-capped AuNSs. The sample was prepared by 
diluting 1 mL of each particle solution with 2 mL of water. 
Wavelength (nm) 
 
Citrate-capped gold nanospheres 139 with a mean diameter of 4.5 nm. A solution of 
HAuCl4 (1.00 mL, 29.4 mM in H2O, Alfa Aesar) was added into 90.0 mL of H2O at room 
temperature. After being stirred for 1 min, a solution of sodium citrate (2.00 mL, 38.8 
mM in H2O) was added, followed by a fresh solution of NaBH4 (1.00 mL, 0.0750 % in 
38.8 mM of sodium citrate). The red-colored solution was stirred for 10 min and stored at 
4 oC. 
 
A General Procedure for the Displacement of Citrate-Caps on the Gold 
Nanospheres (Table 7, entry 4) with Glycoconjugates is as follows: To an aqueous 
solution of glycoconjugates (10.0 mL, 1.58 mM in H2O) was added a solution of citrate-
capped gold nanospheres (5.00 mL, Table 7, entry 4). The resulting mixture was stirred at 
room temperature until a deep red color of the solution was observed. Typically, the 
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displacement reaction took 2 - 3 days to completely replace citrates. The particle solution 
was then purification by centrifugal filtration (Centriplus YM-30, MWCO = 30kD, 
repeated two times with pure water) and a size exclusive column chromatography (GE 
Healthcare, PD-10, Sephadex-G25 medium). Finally, carbohydrate-functionalized gold 
nanospheres were stored at 4 oC. 
 
Glucose-AuNSs 140 (16 nm as a mean diameter) were prepared with citrate-capped gold 
nanospheres (5.0 mL, Table 7, entry 4) and glucosyl thioctanamide 78 (10 mL, 1.58 
mM). 
Galactose-AuNSs 141 (16 nm, mean diameter) were prepared with citrate-capped gold 
nanospheres (5.0 mL, Table 7, entry 4) and galactosyl thioctanamide 79 (10 mL, 1.58 
mM). 
Mannose-AuNSs 142 (16 nm, mean diameter) were prepared with citrate-capped gold 
nanospheres (5.0 mL, Table 7, entry 4) and mannosyl thioctanamide 80 (10 mL, 1.58 
mM). 
Lactose-AuNSs 143 (16 nm, mean diameter) were prepared with citrate-capped gold 
nanospheres (5.0 mL, Table 7, entry 4) and lactosyl thioctanamide 81 (10 mL, 1.58 mM). 

































(a)       (b)      (c)       (d)       (e) 
Figure 34. Photographs of (a) citrate-capped AuNSs (Table 7, entry 4), (b) glucose-
AuNSs 140, (c) galactose-AuNSs 141, (d) mannose-AuNSs 142, (e) lactose-AuNSs 143, 
and (f) UV-visible spectra of individual particle suspension. 
 
A General Procedure for the Displacement of Citrate-Caps on the Gold 
Nanospheres III-39 (4.5 nm as mean diameter) with Glycoconjugates is as follows: 
To a solution of glycoconjugates [3.0 mL, 5.4 mM in HEPES buffer (20 mM, pH = 7.4)] 
was added a suspension of citrate-capped gold nanospheres 139 (10 mL). The resulting 
mixture was stirred at room temperature for 2 days. The particle suspension was then 
purified by centrifugal filtration (Centriplus YM-30, MWCO = 30kD, repeated two times 
with pure water) and a size exclusive column chromatography (GE Healthcare, PD-10, 
Sephadex-G25 medium). Finally, carbohydrate-functionalized gold nanospheres were 
diluted with pure water with a total volume of 10 mL and stored at 4 oC for the lectin 
binding study. 
Glucose-AuNSs 144 (4.5 nm, mean diameter) were prepared using citrate-capped gold 
nanospheres (10 mL) and glucosyl thioctanamide 78 (10 mL, 5.4 mM): IR (drop-casting 
on CaF2, cm-1) 3332 (br), 2922 (s), 1661 (m, amide I band), 1540 (m, amide II band), 
1248 (m). 
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Lactose-AuNSs 145 (4.5 nm, mean diameter) were prepared using citrate-capped gold 
nanospheres (10 mL) and lactosyl thioctanamide 81 (10 mL, 5.4 mM): IR (drop-casting 




















λmax = 524 nm 
Figure 35. UV-visible absorption spectra of citrate-capped AuNSs, glucose-AuNPs 144, 










Concanavalin A (Con A, Type V, lyophilized power), peanut agglutinin (PNA, 
lyophilized power), HEPES, and all other reagents were obtained from Sigma. For the 
preparation of lectin stock solution, the lectin was dissolved in HEPES-buffered 
saline ([HEPES 10 mM, NaCl 150 mM, CaCl  1 mM, MnCl  1 mM, and MgCl  1 mM 
adjusted to pH 7.4]), incubated at room temperature overnight, and then syringe-
filtered (0.22 μm). The concentration of the stock solution was determined from the 
absorbance at 280 nm (A  = 1.37 × [mg/mL Con A],  A  = 0.96 × [mg/mL 
PNA] ). The solution was then diluted to given concentrations (based on Con A 
tetramer at 104 kDa, PNA tetramer at 110 kDa). The suspension of gold nanospheres 
(glucose-AuNSs 144 and lactose-AuNSs 145) was exchanged from water to HEPES-






centrifugal filtration (Centriplus YM-30, MWCO = 30kD with a total 
volume of 10 mL. For the specific binding assay: the suspension of carbohydrate-
functionalized gold nanospheres (0.5 mL) was added to the lectin solution (0.5 mL at 
0, 2, 4, 6, 8, and 10 μM, respectively). This assures that the pH and ionic strength are 
the same in all experiments and only the lectin concentration changes. The samples 
were incubated at room temperature for 40 min, and UV-visible absoption spectra of 
each sample solution were recorded. For the TEM experiment: each suspension of gold 
nanospheres (0.5 mL, 144 or 145) was mixed with a corresponding lectin solution (0.5 
mL, 1.0 μM). After incubation at room temperature for 20 min, 5 μL took out of each 
mixture, loaded on TEM grid, and dried for measurement.
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Figure 37. Changes in the UV-visible spectra of lactose-AuNSs 145 on addition of 
different concentration of (a) Con A and (b) PNA. From bottom to top, 0, 0.1, 0.2, 0.3, 
0.4, and 0.5 μM of lectins. Spectra were obtained 40 min after addition of lectins. 



























Chapter 4: Preparation and Characterization of Carbohydrate-
Functionalized Surfactant Vesicles for the Targeted Delivery of Drugs 
This chapter is related to the article published in Soft Matter 2008, 4, 1916-1921. 
INTRODUCTION 
In the clinical use, it is ideal that a drug has a high therapeutic index, which is 
the ratio of the drug’s efficacy over the its toxicity (side effects). However, many 
drugs, particularly chemotherapeutic drugs, have low therapeutic indices due to their 
side effects. One of the means being explored to achieve the improvement of 
therapeutic indices of drugs is targeted delivery, where drugs are delivered to selected 
cells, effectively reducing their toxic effects to normal cells. For this purpose, 
phospholipid-based vesicles, i.e. liposomes, are full of promise due to their huge 
inside cavity in which toxic drugs can be entrapped and delivered to the selected cells. 
Liposomes were discovered by Bangham and co-workers roughly 40 years 
ago146 and have been evolved to increase the circulation time by coating a protective 
layer such as polyethylene glycol (PEG) over the liposome surface.37,147 Targeting of 
liposomes in vivo has been accomplished by modifying the bilayer surface with 
targeting agents such as antibodies, folates, transferrins, carbohydrates, or arginine-
glycine-aspartic acid (RGD) analogs, thereby directing the drug toward a specific 
tissue type.36-38,147,148-150 Depending on the permeability and stability of the liposome 
in vivo, the drug solute may be released slowly and continually or it may be released 
rapidly in response to a specific stimulus, which allows ‘‘controlled-release’’ of a 
drug.151 Liposomal formulations approved for clinical use include Doxil, DepoCyt 
and DaunoXome for cancer chemotherapeutic drugs, DepoDur for morphine and 
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Ambisome for antifungal agent.37,152
In spite of their excellent performance, a major drawback of liposomal 
formulations is the inherent instability, expense, and difficulty of preparation 
associated with phospholipid-based vesicles. Liposomes formed by sonication or 
extrusion are essentially kinetically-trapped, nonequilibrium structures, that tend to 
fuse or rupture to form lamellar phases.  In the fusion process, the contents of the 
phospholipid vesicles are released. Typically, this fusion process and premature 
release of the payload can be avoided by changing bilayer composition.153-155  
A simple attractive alternative to phospholipid vesicles was offered by Kaler 
and co-workers in 1989.156 In this system (Figure 38), surfactant vesicles are 
spontaneously produced by simply mixing a cationic surfactant (CTAT: 
cetyltrimethylammonium tosylate) and an anionic surfactant (SDBS: sodium 
dodecylbenzenesulfonate) with water in the right proportion.157-159 These vesicles are 
approximately 120 nm in mean diameter with bilayer thickness of 2.5 nm.160
 
Figure 38. Phase diagram of CTAT/SDBS/H2O system at 25 oC. Vesicles are present 
in the two lobes, denoted by V+ for CTAT-rich vesicles and V- for SDBS-rich 
vesicles. The bottom axis is weight ratio of two surfactants and the side axes indicate 
a total concentration (wt %) of the two surfactants in H2O. Adapted from ref. 161. 
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In order to prepare 1 wt % of SDBS-rich vesicles (Scheme 23), for example, 
each s
cost, 
zation of vesicles produced by the CTAT/SDBS system 
was r
urfactant (30 mg of CTAT and 70 mg of SDBS) is weighed and mixed with 9.9 
mL of H2O, followed by gentle stirring at room temperatuer for 30 min. Finally, the 
resulting mixture allows to equilibrate at room temperature for at least 48 h to 
generate thermodynamically stable surfactant vesicles.  
Scheme 23 
  
Surfactant vesicles have several advantages over liposomes including lower 
ease of preparation and stability. Vesicle formation under these conditions is 
spontaneous and fairly rapid  and yields vesicles that are thermodynamically stable.  
Furthermore, the required materials for vesicle formation are readily available 
surfactants that are cheaper than purified or synthetic phospholipids. It is also 
possible to prepare vesicles that present different surface charge by changing the ratio 
of CTAT/SDBS (Figure 38). 
The surface functionali
eported by Walker and Zasadzinski.162 They prepared biotin-functionalized 
surfactant vesicles by mixing CTAT, SDBS, and phospholipid-tethered biotin. The 
addition of the phospholipid-tethered biotin at low concentration (0.2 mol % of total 









30 mg of CTAT
70 mg of SDBS
+
RT, 48 h
9.9 mL of H2O
10
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cross linking receptor, biotin-functionalized vesicles were aggregated.  
English and co-workers demonstrated the high efficiency of surfactant vesicles 
for th
icles produced by the CTAT/SDBS system was also 
demo
ers reported the transformation of  CTAT-rich vesicles 
into a
e capture and long-term storage of charged organic solutes, compared to those of 
phospholipid vesicles.161,163 The high carrying capacity of the surfactant vesicles is 
due to strong electrostatic interactions between the charged vesicle bilayer and the 
organic solute. The ability of long-term storage is due to the superior stability of 
surfactant vesicles. For example, CTAT-rich vesicles presenting cationic bilayers 
captured the anionic solute carboxyfluorescein with high efficiency (21 %) and 
retained the solute for long periods of time (half-life, t1/2 = 84 days). However, 
phospholipid-based vesicles showed only 1.6 % of  capturing efficiency and 2 days 
(half-life) of retention ability.  
The robust nature of ves
nstrated by Kaler and co-workers.164 They utilized CTAT-rich vesicles as a 
template to prepare silica hollow spheres. The silica coated vesicles were generated 
by addition of tetramethoxysilane into the vesicular templates, and then the core 
vesicles were dissolved in methanol to create hollow structures. During the deposition 
of silica precusor on the surface of surfactant vesicles, the vesicular structure was 
retained without disruption.  
Raghavan and co-work
n elastic gel by adding hydrophobically modified chitosan (polysaccharide).160 
In a three-dimensional network (an elastic gel), vesicles and chitosan were connected 
to each other by insertion of hydrophobic chains in chitosan into vesicle bilayers. 
Interestingly, the surfactant vesicles remained intact within the networks. 
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ehicles for the targeted delivery of drugs utilizing carbohydrate-receptor 
interactions. The vesicles formed from CTAT/SDBS surfactants are very attractive for 
the drug delivery because of their hollow structure, size (ca. 120 nm in diameter),147 
stability, and capturing ability. As shown previously in studies using hydrophobically 
modified chitosan to form a cross-linked vesicle gel,160 it is possible to functionalize 
their surface with carbohydrates by simple hydrophobic insertion of long 
hydrocarbon-modified carbohydrates. Anionic surfactant vesicles formed from SDBS 
and CTAT with a 3 : 1 molar excess of SDBS would be particularly useful for the  
selective cellular targeting since non-specific electrostatic interactions of the anionic 
vesicle with negatively charged cell surface can be avoided.165  
The goal of research in this section was to prepare carboh
tant vesicles and investigate the bioavailability of carbohydrates on the vesicle 











RESULTS AND DISCUSSION 
drocarbon-modified glycoconjugates ranging from 
mono
For these studies, the hy

















































Figure 39. Structures of N-linked glycoconjugates for the surface functionalization of 
surfactant vesicles: C8-glucose 107, C8-maltose 108, C8-lactose 109, and C8-




tion, the SDBS-rich vesicles consisting of 1 wt % total surfactant with a 7:3 
w/w of SDBS to CTAT were prepared in the presence of C8-glycoconjugates (1 mM 
in H2O) (Figure 40). To evaluate the amount of glycoconjugate that associated with 
the vesicle, size exclusion chromatography (SEC) was used to separate the vesicles 
from excess conjugate. Once separated, the presence of vesicles and the amount of 
carbohydrate in the vesicle-containing fractions were determined by dynamic light 
scattering (DLS) and UV-visible spectroscopy,166 respectively. The results are 
summarized in Table 8 and Figure 41. 
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SDBS-rich vesicles incorporated with glycoconjugate 


























Figure 40. Schematic illustration of the procedure for (a) the preparation of SDBS-
rich vesicles, (b) separation of vesicles from the excess glycoconjugates by size 
exclusion chromatography (SEC), (c) confirmation of vesicle sizes by dynamic light 
scattering, and (d) determination of carbohydrate contents by UV-visible 
spectroscopy following phenol-sulfuric acid assay. 
 
Figure 41 shows the results for the glucose and lactose conjugates in SDBS-rich 
vesicles. In all cases 18-25% of the conjugate eluted with the vesicle fractions. The 
incorporation values for all conjugates in SDBS-rich vesicles are shown in Table 8. 
At the incorporation levels summarized in Table 8, the ratio of carbohydrate 
conjugate to surfactant is approximately 1 : 100. DLS measurements (Table 1) showed 
that the vesicle sizes were not affected by inclusion of the glycoconjugate at these levels 
in SDBS-rich samples and remained intact before and after SEC, suggesting the 
stability of SDBS-rich vesicles. 
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Table 8. Glycoconjugate vesicle incorporation and DLS results. 
Vesicle Radius (nm)b
Glycoconjugate Incorporation (%)a Before SEC After SEC 
Bare vesicles _ 70 71 
C8-glucose  18 69 69 
C8-lactose  23 69 72 
C8-maltose  25 67 74 
C8-maltotriose  19 68 72 
 
a Incorporation percentage is the fraction of a 1 mM solution of glycoconjugate that elutes with vesicles 
during SEC. b Hydrodynamic radii were determined by DLS before and after SEC. See the experimental 













































































Figure 41. Results from SEC of vesicles with various glycoconjugates: (A) SDBS-rich 
vesicles prepared with C8-lactose; (B) SDBS-rich vesicles prepared with C8-maltose.  
SEC fractions were evaluated with DLS to identify the vesicle-containing fractions (solid 
line).  Fractions containing carbohydrates were identified with colorimetric detection 
(dashed line).166 Samples containing only glycoconjugate (no vesicles) were evaluated 
with SEC to determine the elution properties of the free compound (dotted line).  The 
apparent incorporation rates (ρ) correspond to the differences in peak areas of the 
conjugates with and without vesicles present (i.e. dotted line minus dashed line).  See the 
experimental section for details of this analysis. 
 
The task remaining was to confirm whether the carbohydrates introduced into the 
vesicle are located at the exterior of surfactant vesicles or embedded in the interior of 
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vesicles. Although the carbohydrates are presented on the surface of vesicles, it is also 
questionable whether they can serve as targeting entities.  
Lectins have high binding specificity for their carbohydrate ligands and are widely 
distributed in nature, including microorganisms, plants and animals. Lectins presented on 
the cell surface play roles as receptors to mediate cell-cell interactions by the recognition 
of carbohydrates on apposing cells.133,134 A lectin, concanavalin A (Con A) binds 
selectively to the monosaccharides mannose and glucose and to polysaccharides with 
terminal glucose or mannose residues.135,136 Another lectin, peanut agglutinin (PNA) 
binds selectively to the monosaccharide galactose and to oligosaccharides with terminal 
galactose residues.137,138 Both of them are a homotetramer at physiological pH, and each 
monomer possesses one saccharide binding site.139-141 Thus, it is anticipated that they 
would bind multiple carbohydrates and result in aggregation, followed by precipitation if 








Accordingly, attention turned to the binding assay using lectins to probe for the 
presence of surface carbohydrate residues. Monitoring lectin-induced turbidity provided a 
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convenient method to determine the bioavailability of synthetic mannose or glucose-
functionalized glycoconjugates.167-169  
Figure 42a summarizes the results from the Con A aggregation experiments. 
Bare vesicles and vesicles containing lactosyl conjugate 109 showed no increase in 
turbidity when titrated with Con A.  Conversely, vesicles carrying the glucosyl 
conjugate 107 had a distinct increase in turbidity with increasing additions of Con A 
above 2.0 μM.  The increase in turbidity was readily visible by eye and is due to 
aggregation of vesicles that occurs when a Con A tetramer binds one or more glucose 
residues on different vesicles (Scheme 24). Figure 42b shows an analogous set of 
experiments using the lectin peanut agglutinin (PNA). As with Con A, the solution 
turbidity for the three vesicle samples was monitored with increasing PNA 
concentration.  In the case of PNA, an increase in turbidity was observed only in the 
presence of lactose-functionalized vesicles. Binding of PNA to the terminal galactose 
of the lactosyl coconjugate induces agglutination in the lactose-bearing vesicles.  In 
both sets of experiments, control samples containing only the C8-glucosyl conjugate 
107 or C8-lactosyl conjugate 109 gave no change in turbidity with addition of lectins 
(data not shown). The results outlined in Figure 42 show that amphiphilic 
glycoconjugates can be used to functionalize surfactant vesicles for recognition by 
cell surface receptors and represent a promising first step toward targeted delivery 













































Figure 42. Results from lectin-induced agglutination studies with carbohydrate- 
functionalized surfactant vesicles.  Turbidity was monitored at 450 nm as a function 
of lectin concentration for samples containing glucose-functionalized vesicles (●), 
lactose-functionalized vesicles (■) and bare vesicles (▲). Curves shown are the 
average of three assays.  (a)  Titration results using Con A.  (b)  Titration results using 
PNA. Turbidity was measured 60 min after addition of lectins. 
 
In Figure 42, turbidity increases slightly more rapidly with PNA binding to 
lactose-functionalized vesicles than with Con A binding to glucose-functionalized 
vesicles. This difference in agglutination is rationalized by assuming increased 
accessibility at the bilayer interface of the terminal galactose in the disaccharide 
lactose relative to the monosaccharide glucose.  Others have demonstrated the binding 
of Con A to glycolipids embedded in phospholipid vesicle membranes and have 
shown that the binding of Con A to the mannose residues on the liposome surface 
depends on the  length of a water soluble spacer group between the alkyl chains and 
the carbohydrate head group.170 To explore the effect of oligosaccharide length on 
lectin-induced agglutination, we utilized vesicles functionalized with three different 
glycoconjugates whose terminal residue is glucose: C8-glucose 107, C8-maltose 108 
and C8-maltotriose 110 (Figure 39) and measured their aggregation as a function of 
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Con A concentration.  Figure 43a summarizes the results from these experiments. The 
vesicles functionalized with maltose conjugate 108, a disaccharide, shows increased 
turbidity relative to the vesicles functionalized with glucose conjugate 107, the 
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Figure 43. Effect of carbohydrate length on Con A-induced agglutination. (a) Final 
trubidity as a function of Con A concentration. Turbidity was measured 60 min after 
addition of Con A (b) Turbidity as a function of time with [Con A] = 6.0 μM.  
 
Surprisingly, the vesicles functionalized with maltotriose conjugate, a 
trisaccharide, did not induce aggregation as effectively as either the mono- or 
disaccharide. These results suggest that carbohydrate length is not the only governing 
factor in binding affinity. A plausible explanation for the diminished binding between 
Con A and maltotriose relative to the other conjugates is that the conformation of the 
trisaccharide may diminish the ability of Con A to access the terminal glucose.  To 
further verify the observed trend, the kinetics of binding were measured (Figure 43b).  
The initial slope of the maltose-functionalized vesicles in Figure 43b showed a 
significant increase in the turbidity compared to those of glucose- and maltotriose-
functionalized vesicles. These results from maltose and lactose suggest that a 
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disaccharide improves the accessibility of the terminal sugar at the bilayer interface. 
This is likely due to the increased separation between the ligand and the interface.  
However, this trend did not hold with the trisaccharide maltotriose and may indicate 
that the trisaccharide has sufficient flexibility to adopt a conformation which lessens 
the accessibility of the terminal sugar.  
 
 A detailed study will be required to fully elucidate the important factors and 
effects that ultimately determine binding affinity of carbohydrate-functionalized vesicles.  
 
CONCLUSIONS AND OUTLOOK 
We have demonstrated that the surface of SDBS-rich surfactant vesicles can be 
functionalized with carbohydrates linked to a short alkyl chain. The carbohydrates bound 
on the surface of surfactant vesicles preserved their function for the binding of receptors. 
These results represent an important first step in evaluating the viability of surfactant-
based vesicles for use as drug delivery vehicles. In addition, carbohydrate-functionalized 
surfactant vesicles (SDBS-rich) hold promise as diagnostic agents for in vitro 
investigation of cell surface receptors and as tools for glycobiology.  
However, a number of important questions remain unanswered regarding the 
suitability of carbohydrate-functionalized surfactant vesicles for drug delivery. For 
instance, the knowledge of toxicology for surfactant-based vesicles in vivo is limited 
since only a single study has been reported.171 Kuo and co-workers showed that the 
toxicity of surfactant vesicles formed from a mixture of anionic surfactant (SDS: sodium 
dodecylsulfate) and cationic surfactant (HTMAB: hexadecyltrimethylammonium 
bromide) depends on the concentration of vesicles. At the concentration of surfactant 
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vesicles lower than 9 μM, the murin macrophage-like cell line, RAW 264.7, appear to be 
nontoxic. The cytotoxicity study of vesicles formed from CTAT/SDBS system is 
currently underway with collaboration of the Fisher group (Department of 
Bioengineering, UMCP). The initial results showed that the majority of chondrocyte cells 
are survived with SDBS-rich vesicles at the concentration of vesicles lower than 1.0 
μg/mL. However, CTAT-rich vesicles are highly toxic to the cells at the same 
concentration, suggesting that SDBS-rich vesicles are more suitable as drug delivery 
vehicles. In addition to the further evaluation of their cytotoxicity, the stability of 




General. All reagents and solvents were purchased from commercial suppliers and used 
without further purification unless noted otherwise. The detailed experimental procedures 
for the synthesis and characterization of glycoconjugates are provided in the 
Experimental Section of Chapter 2. 
 
Vesicle Preparation. The surfactants cetyltrimethylammonium tosylate (CTAT) and 
sodium dodecylbenzenesulfonate (SDBS) were obtained from Aldrich Chemicals. CTAT 
was purified by recrystallization (ethanol/acetone). Millipore water (18 MΩ) was used as 
a solvent for sample preparation and purification in all cases. Vesicles were prepared by 
mixing the two surfactants with 1 mM of glycoconjugate in water (1 wt % of total 
surfactant), followed by gentle stirring for 30 min. The samples were then allowed to 
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equilibrate at room temperature for at least 48 h. A mole ratio of 3 : 1 SDBS to CTAT 
was used throughout. Dynamic light scattering (DLS) was used to confirm vesicle 
formation, and size exclusion chromatography (SEC) was used to purify vesicles. A 
column (length 5.5 cm; diameter 1.5 cm) packed with Sephadex G-100 (Sigma) was 
used. 
 
Dynamic Light Scattering (DLS). The mean size and size-dispersion of vesicles in 
solution was analyzed using a Photocor-FC light scattering instrument equipped with a 5 
mW laser light source at 633 nm. The scattering angle was 90o and all measurements 
were performed at 25 ºC.  A logarithmic correlator was used to obtain the autocorrelation 
function, which was analyzed by the method of cumulants to yield a hydrodynamic 
radius.  
 
Colorimetric Detection of Glycoconjugates. For glycoconjugate incorporation, vesicle 
samples were prepared using aqueous solutions containing 1.0 mM glycoconjugates. SEC 
was used to separate vesicle-incorporated glycoconjugate from free glycoconjugate in 
solution. The glycoconjugate content was then determined spectroscopically166 using the 
following procedure: the vesicle solution (1.0 mL) was eluted through the SEC column 
(fractions of 1.0 mL) and the vesicle containing fractions were identified by DLS.  A 0.5 
mL portion of each fraction was transferred into a test tube, 0.25 mL of aqueous phenol 
solution (0.53 M in water) was added, followed by 1.25 mL of concentrated sulfuric acid 
(in order to obtain reproducible results, the stream of sulfuric acid was introduced into the 
liquid surface rather than against the side of the test tube). After 10 min, the solution was 
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vortexed and then allowed to rest at room temperature for 1 h.  At this point, any 
fractions containing carbohydrates showed a light-yellow coloring.  Next, 0.5 mL of 
ethanol was added, mixed well, and after 10 min the absorbance was measured (Ocean 
Optics USB 2000 Spectrometer).  The absorbance values were plotted as a function of 
eluted volume as shown in Figure 4.  DLS was conducted on each fraction prior to the 
colorimetric assay and the vesicle containing fractions were identified by the peak in 
DLS intensity near 3.0 mL of eluted volume in Figure 4.  The corresponding absorbance 
intensity observed in the vesicle DLS band was due to the presence of glycoconjugate 
traveling in the vesicle band and therefore incorporated in the vesicle.  In determining the 
amount of incorporated glycoconjugate, it was found that the most reliable method was to 
measure the amount of free glycoconjugate that eluted and compare this value with the 
amount of glycoconjugate that eluted in the absence of vesicles.  This approach 
corresponds to comparing the peak areas of the dashed and dotted lines between 6.0 and 
13.0 mL in the panels of Figure 4.  This method was used to avoid artifacts that occur 
during the colorimetric analysis of vesicle-containing fractions due to the presence of 








1ρ  (1) 
where OD is optical density of absorbance at a given wavelength (491 nm for glucose 
conjugate, 492 nm for lactose and maltose conjugate, and 493 nm for maltotriose 
conjugate).  The OD values for fractions containing free glycoconjugate separated 
from the vesicle sample (dashed lines in Figure 4)  are denoted by ν  and i denotes 
values obtained from a solution of free glycoconjugates (1 mM, 1 mL) in the SEC 
 133
column (dotted line in Figure 4). 
Agglutination Assay. Concanavalin A (Con A, Type V, lyophilized power), peanut 
agglutinin (PNA, lyophilized power), HEPES, and all other reagents were obtained 
from Sigma. For the preparation of lectin stock solution, the lectin was dissolved in 
HEPES-buffered saline ([HEPES 10 mM, NaCl 150 mM, CaCl  1 mM, and MnCl  1 
mM adjusted to pH 7.4 for Con A], [HEPES 10 mM, NaCl 150 mM, CaCl  1 mM, 
MnCl  1 mM, and MgCl  1 mM adjusted to pH 7.4 for PNA]), incubated at room 
temperature overnight, and then syringe-filtered (0.22 μm). The concentration of the 
stock solution was determined from the absorbance at 280 nm (A  = 1.37 × [mg/mL 
Con A],  A  = 0.96 × [mg/mL PNA] ). The solution was then diluted to given 
concentrations (based on Con A tetramer at 104 kDa, PNA tetramer at 110 kDa). All 








mM glycoconjugates were purified by SEC (1.0 
mL of vesicle solution was eluted through the column and then collected with final 
volume of 2.0 mL). For the specific binding assay: vesicle solution (150 μL) was added 
to the lectin solution (150 μL at 0, 2, 4, 6, 8, 10, and 12 μM, respectively).  This assures 
that the pH and ionic strength are the same in all experiments and only the lectin 
concentration changes.  To determine the degree of agglutination, the samples were 
incubated at room temperature for 60 min and turbidity was recorded at 450 nm. For the 
carbohydrate length dependent assay: turbidity measurements were performed by the 
same manner described above except that the vesicle solution was diluted twice with 
water after SEC purification. To monitor agglutination kinetics: the samples were mixed 
for 5 s and the absorption at 450 nm was monitored with 1 s intervals at 25 oC. 
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Self-assembled monolayers (SAMs) of glucose derivatives on gold have been 
prepared from α- and β-glucopyranosylamide derivatives. The glucosyl conjugates were 
synthesized stereoselectively via the in situ generation of glucosyl isoxazolines followed 
by treatment with thiopyridyl esters. The resulting film structures were characterized by 
atomic force microscopy, reflection Fourier transform infrared spectroscopy, and X-ray 
photoelectron spectroscopy. The experimental data indicated that α- or β-linked 
glucopyranosylamide derivatives with free hydroxyl groups attach to gold via the thiol 
linker. Both derivatives form monolayer films with high packing densities - comparable 
to those typically observed for alkanethiol monolayers on gold. Acetate analogues of 




Self-assembled monolayers (SAMs) derived from biomolecules have significant 
potential in bioanalytical analysis if their assembly can be controlled to yield 
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reproducible films with high biological activities. SAMs of n-alkanethiols on gold are the 
archetypal system for studying physical and chemical properties of organic surfaces 
because these systems yield monolayers that can be highly crystalline and form well- 
defined structures.1 The surface characteristics of monolayers of complex thiol-
derivatized bioconjugates (DNA, proteins, carbohydrates) on gold and other noble metal 
surfaces, however, in comparison to simple alkanethiol derivatives, are poorly 
understood.2 It should not be assumed that thiol attachment of biomolecules will result in 
end-tethering of these species to the surface whereby they are properly oriented and fully 
accessible for binding to their conjugate ligands (i.e. receptors, enzymes, etc.) at the 
sensor interface (Figure 1). For example, it is well-established that the assembly of thiol-
derivatized DNA SAMs on gold is strongly influenced by the interaction of nucleotides 
with the gold surface and that the adsorption of single-stranded DNA on gold is strong 
enough to prevent hybridization with complementary DNA. In this case, the surface must 
be treated with a second thiol molecule to liberate adsorbed strands and to passivate the 
surface against nonspecific adsorption of DNA targets.3 For the development of devices 
that depend on the binding of biomolecules to surfaces, it is crucial that these films can 
be formed reproducibly and that their orientation in the film can be characterized 
unambiguously. Accordingly, we have undertaken a study to characterize the SAMs 
resulting from the attachment of carbohydrate bioconjugates to gold surfaces. The goal of 
this study was (1) to determine the orientation of the bioconjugates to the surface (Figure 
1), (2) to determine the density of SAM coverage, and (3) to measure whether the surface 
coverage is sensitive to the stereochemistry of the biomolecule attached.  
Carbohydrates are known to be involved in a variety of cell-cell mediated processes 
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including recognition, regulation of cell growth, infectivity (of bacteria), and the immune 
response.4 We are developing biosensors based on the rapid and specific recognition of 
cell surface oligosaccharides, and toward this goal, it is critical that the oligosaccharide 












































Figure 1. Possible conformations of thiol-modified glucopyranosyls adsorbed on gold. 
 
Although carbohydrate-based SAMs have been prepared by others,5 the surface 
characteristics of the SAMs (ie., orientation and surface coverage) of these groups have 
not been determined in most instances.5a In this study, we investigate a series of related 
sugar derivatives bound to gold utilizing a full complement of surface analytical 
techniques. Accordingly, our groups have studied the formation of glucopyranosyl-based 
SAMs by the attachment of thiol-modified glucosylamide conjugates to gold surfaces as 
the prototypical oligosaccharide SAM. In this paper we report the stereoselective 
synthesis of a series of glycosylamide conjugates, attachment of these conjugates to gold 
surfaces, and characterization of the resulting assembled molecular films by Fourier-
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transform infrared FTIR and X-ray photoelectron (XPS) spectroscopies, and by atomic 
force microscopy (AFM) measurements under differing deposition conditions. The time 
course experiments reported in this paper are particularly significant because they clearly 
demonstrate that films of different surface coverage and morphology can be obtained by 
altering either the structure of the glucosyl conjugate or the deposition conditions. In 
addition, as noted above, the resulting glycoconjugates have the potential to adsorb to the 
surface in a number of conformations (Figure 1), many of which may be unsuitable for 
diagnostic applications. However, the evidence from these studies demonstrates that these 
conjugates can be reproducibly assembled on gold surfaces at relatively high coverages 
and attach in an upright fashion via the thiol linker, thus presenting the carbohydrate to 
the solvent media. 
 
RESULT AND DISCUSSION 
Synthesis of Glucopyranosyl Conjugates. Glucopyranosylamide conjugates were 
prepared using the methodology developed by Damkaci and DeShong for the 
stereoselective synthesis of N-linked glycopeptide derivatives.6 The key step in this 
process is the coupling of a glucopyranosyl azide to an acid derivative to provide an N-
linked glucopyranosylamide derivative (Scheme 1). Two methods for synthesis of 
glucopyranosylamide conjugates were developed. In the first method, β-glucopyranosyl 
azide 1 was allowed to react with phosphine, followed by coupling with acid chloride 2 to 
provide either α-glucopyranosylamide 3 or β-glucopyranosylamide 6, respectively, 
depending on the conditions utilized in the coupling reaction. As shown previously, the α 
-stereochemistry of the amide linkage resulted from an equilibration of the 
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phosphorimine intermediate.6 Displacement of the bromide with thioacetate, followed by 
removal of the acetate protecting groups with sodium methoxide in methanol and air 
oxidation afforded α-glucopyranosylamide disulfide 5 (α-glu-S)2 or β-
glucopyranosylamide disulfide 8 (β-glu-S)2, respectively. Note that these conditions were 
selective for ester removal and did not result in hydrolysis of the amide functionality. 
Glucopyranosylamide conjugates of lipoic acid (10, 11, 13, 14) were synthesized by 
coupling azide 1 with the thiopyridyl ester 9 or thioctic acid 12 to afford either the α- or 


















3 : R1  = Ac ; R2 = Br















































10 : R = Ac

















6 : R1  = Ac ; R2 = Br













 Scheme 1. Synthesis of glucopyranosylamide conjugates.  Keys: (a) PPh3, 1,2-
dichloroethane, 95 °C, 16 h. (b) coupling partner, 24 h. (c) KSAc, DMF, RT, 20 h. (d) 
NaOMe, MeOH, RT. (e) PMe3, DIEA, 1,2-dichloroethane, RT, 30 m. (f) coupling 
partner, RT, 24 h. 
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This strategy for preparing oligosaccharide conjugates has several inherent 
advantages over the alternative approaches, the majority of which depend on attachment 
to a poly(ethylene glycol) (PEG) analogue to tether the saccharide moiety to the surface.8 
First, as noted in Scheme 1, it is possible to prepare either the α- or β-linkage at the 
anomeric center by choosing the appropriate combination of phosphine and reaction 
conditions, and as shown below, these stereoisomeric bioconjugates give SAMs with 
different surface characteristics. Second, it is possible to synthesize glycosylamide 
conjugates from the intact oligosaccharide derivatives, thus avoiding the need to develop 
a multistep synthesis of a complex oligosaccharide if it is available from natural sources 
(vide infra). Although only the monosaccharide conjugates are reported in this paper, we 
have reported the application of this methodology to the synthesis of oligosaccharide 
derivatives previously.6,7 More important, the resulting glucopyranosylamide conjugates 
have proven to be particularly robust to a wide variety of chemical and biological 
reaction conditions. For example, prolonged exposure of glucopyranosylamide 
conjugates to either strongly acidic or basic conditions did not result in significant loss of 
material due to hydrolysis of the amide linkage. This high chemical stability means that a 
wide variety of hydroxyl protecting groups can be employed for selective 
protection/deprotection of carbohydrates without inducing cleavage of the 
glucopyranosylamide linkage. 
Polycrystalline gold films (200 Au; 20 nm Cr) on single-crystal Si (100) wafers 
were used as substrates for the FTIR and XPS experiments. The gold films were cleaned 
using a “piranha solution” consisting of 70 % H2SO4 and 30 % H2O2 (30 % H2O2 in H2O) 
and rinsed thoroughly with deionized water (18.3 MΩ) immediately prior to adsorption 
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of glycosyl derivative. Piranha solution must be used with care: it is extremely oxidizing, 
reacts violently with organics, and should be stored in loosely covered containers to avoid 
pressure buildup. Gold-coated mica (Molecular Imaging) was used as a substrate for 
AFM experiments and used as-received. Deposition conditions for all 
glucopyranosylamide films were 1 mM (2 mL) glucopyranosylamide derivative in 
ethanolic solutions for 20 hours. Before analysis, each sample was extensively rinsed 
with ethanol to remove loosely bound material and blown dry under flowing nitrogen.  
 
Scanning probe microscopy of glycosylamide gold films.  The atomic force 
microscopy (AFM) determined morphologies of a representative set of the glucose SAMs 
on gold (compounds 5, 10 and 11) are presented in Figures 2 and 3 (2 hour and 20 hour 
incubation times, respectively).  For compounds 5 and 11, after 2 hours of deposition, 
monolayers were observed (as determined by nanografting experiments) with 
approximately 10 % and 25 % of a bilayer present, respectively (Figure 2) based on the 
areal density of the protruding features on the monolayers. 
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Figure 2. Comparison of sugar SAMs derived from disulfides after a 2 h immobilization 
period. AFM topographic images (1 μm × 1 μm) for [A] compound 11; [B] compound 5; 
[C] compound 10 and (300 nm × 300 nm) for [D] compound 11; [E] compound 5; [F] 
compound 10.  The cursor traces inset in A and B illustrate that a small amount of a 
bilayer is formed with features on the order of ~1.5 nm above the monolayer. 
 
We attribute these features to a biliayer structure as the features protrude from the 
surface by ~1.5 nm, consistent with the molecular length of the molecules of ~1.3 - 1.4 
nm. The bilayers are presumably held in place by hydrogen bonding between the glucose 
headgroups and under increased load and prolonged scanning may be swept away while 
imaging in ethanol. From nanografting of dodecanethiol and hexadecanethiol into the 
films derived from disulfides 5 and 11, respectively, the monolayer thicknesses were 
estimated to be ≈1 nm for each. For the acetylated disulfide 10, however, monolayer 
formation was never observed under the identical deposition conditions. Acetylated 
disulfide 10 was found to form only multilayered films with thickness on the order of 4 - 
5 nm. Moreover, rather than the molecularly smooth films which were observed for the 
disulfides 5 and 11, acetylated disulfide 10 formed nanoscale clusters on the order of ≈5 
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nm, suggesting that the acetate disulfide readily aggregates either before or during 
deposition. 
For deposition of each of these compounds after 20 h (Figure 3), the glucose 
monothiol and disulfide films show clean, smooth films on the Au surface with little to 
no evidence of a bilayer, while the acetate disulfide film is unchanged in its observed 
morphology and film thickness. The reduction in the formation of the bilayer over time 
may be due to an increase in packing density of the films. Our hypothesis is that as 
defects in the bilayer (2 h incubation) are filled, the bilayer disappears. This hypothesis is 
supported by the AFM images of the surface after 2 h vs 20 h incubation.Nomolecularly 
resolved ordered structures were observed in the case of any of the above molecules. 
AFM images of the β-glucopyranosylamide disulfide 14 (data not shown) also show 
smooth monolayers analogous to its α-anomeric congener. 
 
Figure 3. Comparison of sugar SAMs derived from disulfides after a 20 h immobilization 
period. AFM topographic images (1 μm × 1 μm) for [A] compound 11; [B] compound 5; 
[C] compound 10 and (300 nm × 300 nm) for [D] compound 11; [E] compound 5; [F] 
compound 10. 
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Reflectance FTIR of Glucosylamide Gold Films. FTIR spectra obtained from α-
glucopyranosylamide disulfide 5, β-glucopyranosylamide disulfide 8, and acetylated 
disulfide 10 adsorbed on gold are shown in Figure 4. All of the spectra contain features at 
≈1650 and ≈1560 cm-1, which we attribute to the amide I and amide II bands from the 
amide group, respectively. Several modes are present between 1200 and 1000 cm-1. We 
attribute these features to C-O stretches arising from the glucose component. Spectra 
obtained from the acetylated disulfide 10 contain a strong carbonyl feature arising from 
the ester functionalities at ≈1765 cm-1 as anticipated. 
 
Figure 4. Reflectance FTIR spectra obtained from SAMs prepared from compound 5 (α-
glu-S)2, compound 8 (β-glu-S)2, and acetylated disulfide 10 (α-glu-Ac-S)2 adsorbed on 
gold, 20 hour immobilization period. 
 
The absorbances measured for the amide I feature are relatively weak and are similar 
for all of the samples studied. The primary component of this feature is the carbonyl 
vibration. The small absorbance measured for this feature suggests that the amide 
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carbonyl may be aligned coplanar with the gold substrate.9 It has been proposed that 
immobilized molecules containing this functionality can hydrogen bond with adjacent 
molecules. The positions of the amide I and amide II features have been used to ascertain 
the degree of hydrogen bonding between adjacent molecules. For the amide II feature, a 
shift from ≈1520 to ≈1560 cm-1 has been interpreted as indicating a higher degree of 
hydrogen bonding.10 That the amide II feature is similarly shifted to ≈1560 cm-1 in these 
glucosylated films shift suggests that these films may be similarly stabilized through the 
hydrogen bonding. Additional hydrogen bonding interactions between the adjacent sugar 
moieties may further stabilize films. Similar spectra were obtained from thiol-modified 
disaccharides. 
 
XPS of Glucosylated Gold Films. XPS was used to ascertain the composition, mode 
of binding to the surface, and surface density of glucopyranosylamides monolayers self-
assembled on gold. SAMs of α-glucopyranosylamide disulfide 5 (a-glu-S)2, β-
glucopyranosylamide disulfide 8 (β-glu-S)2, and n-dodecanethiol (C12-SH) were 
characterized using XPS. The C12-SH SAM was selected as a reference sample for 
comparing data acquired from the thiol-derivatized glucosylamide SAMs because C12-SH 
contains approximately the same number of C atoms (12) as that in the (α-glu-S)2 and (β-
glu-S)2 molecules (11). Wide binding energy (BE) XPS spectra of the 
glucopyranosylamide SAMs samples contained only features assignable to gold (Au), 
nitrogen (N), carbon (C), oxygen (O), and sulfur (S). The C12-SH sample only contained 
features assignable to C and S. 
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Representative high-resolution spectra of the S 2p, C 1s, and N 1s regions acquired 
from the three SAMs are displayed in Figure 5. 
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Figure 5. XPS S 2p, C 1s, and N 1s spectra obtained from compound 5 (α-glu-S)2, 
compound 8 (β-glu-S)2, and dodecanethiol (C12-SH) adsorbed on gold, 20 h 
immobilization period. 
 
The C12-SH SAM exhibits a S 2p doublet spectrum with a BE of the primary peak at 
162.2 eV consistent with reported S 2p BE values for n-alkylthiolates on gold. The S 2p 
spectra acquired from (α-glu-S)2 and (β-glu-S)2 SAMs are nearly identical in BE and 
shape, suggesting that the glucopyranosylamide molecules are bound as thiolates to the 
gold surface. In addition, the uncorrected S 2p/Au 4f peak area ratios (see Table 1) 
obtained from the (α-glu-S)2 (0.0036) and (β-glu-S)2 (0.0042) SAMs are less than that 
obtained from the C12-SH SAM (0.0045), suggesting that the surface coverage of the α-
glucose monolayers is nearly 20% less than that the n-alkanethiol SAMs on gold, while 
the β-glucose SAMs, despite the sterically demanding glucose headgroup, have ratios 
similar to that of the alkanethiol standards. The efficient packing of the β-glucopyranosyl 
side chains is consistent with the observed hydrogen bonding in the (β-glu-S)2 
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monolayers, which enhances packing of molecules on the surface. 
Table 1.  Uncorrected XPS Peak Area Ratios for C12-SH, 5 (α-glu-S)2, and 8 (β-glu-S)2 
SAMs on Gold.a
 S 2p / Au 4f C 1s / Au 4f N 1s / Au 4f 
C12-SH 0.0045 0.050 – 
5 (α-glu-S)2 0.0036 0.041 0.067 
8 (β-glu-S)2 0.0042 0.048 0.072 
a Ratios represent the average of two samples. 
 
The C 1s spectra are also consistent with the formation of glucopyranosylamide 
SAMs on gold. The C 1s region of the C12-SH SAM exhibits a symmetric peak centered 
at 285.0 eV characteristic of carbon existing as CH2 groups. In contrast, the C 1s spectra 
of both glucopyranosylamide SAMs, while similar to each other as expected, exhibit a 
more complex spectral envelope compared to the C12-SH SAM. We assign the peak 
centered at ≈285.0 eV to the CH2 linker groups of the glucopyranosylamide molecules. 
The peak centered at ≈286.7 eV is most likely associated with carbons singly bonded to 
oxygen in the glucosyl moiety. There appear to be 1 - 2 other weaker, higher-BE 
components that contribute to the spectral envelope that we tentatively assign to the 
amide group carbon and the number 1 carbon of the glycosyl ring that is bound to both 
oxygen and nitrogen. In addition, the C 1s/Au 4f peak area ratios for the 
glucopyranosylamide SAMs are similar to that of the C12-SH SAM (see Table 1), 
consistent with the conclusion that the coverage of the glucopyranosylamide SAMs is 
close to that of n-alkanethiols on gold. 
The N 1s regions of both the 5 (α-glu-S)2 and 8 (β-glu-S)2 SAMs exhibit a symmetric 
peak centered at 400.0 eV, consistent with nitrogen existing as an amide functionality. 
Finally, we note that given the consistently higher S 2p/Au 4f, C 1s/Au 4f, and N 1s/Au 
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4f peak area ratios for the 8 (β-glu-S)2 SAMs compared to the 5 (α-glu-S)2 SAMs, it is 
tempting to conclude that the 8 (β-glu-S)2 molecules pack at slightly higher densities. 
 
CONCLUSIONS 
Glucopyranosylamide conjugates were prepared by coupling of glucopyranosyl azide 
derivatives, and the coupling reaction can be tailored to provide either the α- or β-anomer 
of the corresponding conjugate (Scheme 1). Gold surfaces were exposed to ethanol 
solutions containing glucopyranosylamide disulfide derivatives to provide SAMs and 
multilayered structures which were characterized by AFM, FTIR, and XPS analysis. 
AFM analysis showed that both α- or β-anomers of hydroxylated conjugates formed 
dense adsorbed layers with monolayer thickness. Acetylated conjugates, on the other 
hand, formed clusters on the surface. XPS analysis suggested that the SAMs derived from 
hydroxylated conjugates attach to gold in an upright fashion via the thiol linker (see 
Figure 1) and have packing density approaching that commonly observed for alkanethiol 
monolayers. FTIR spectra suggested that one possible mechanism for the high packing 
densities observed may be hydrogen bonding between amide groups on adjacent 
immobilized molecules. Now that saccharide-derived SAMs have been produced and 
fully characterized, we shall investigate the specific binding capacity of saccharide-
derived SAMs with enzymes (lectins) and cells as models for biological recognition 
events. Initial studies of selective binding of concanavalin A to nanopatterned features of 
compound 11 are quite promising (see Supporting Information). The complete results of 




General. Certain commercial equipment, instruments, or materials are identified in 
this article to adequately specify the experimental procedure. In no case does such 
identification imply recommendation or endorsement by the National Institute of 
Standards and Technology, nor does it imply that the materials or equipment identified 
are necessarily the best available for the purpose. 
Polycrystalline gold films (200 Au; 20 nm Cr) on single-crystal Si (100) wafers were 
used as substrates for the FTIR and XPS experiments. The gold films were cleaned using 
a “piranha solution” consisting of 70 % H2SO4 and 30 % H2O2 (30 % H2O2 in H2O) and 
rinsed thoroughly with deionized water (18.3 MΩ) immediately prior to adsorption of 
glycosyl derivative. Piranha solution must be used with care: it is extremely oxidizing, 
reacts violently with organics, and should be stored in loosely covered containers to avoid 
pressure buildup. Gold-coated mica (Molecular Imaging) was used as a substrate for 
AFM experiments and used as-received. Deposition conditions for all 
glucopyranosylamide films were 1 mM (2 mL) glucopyranosylamide derivative in 
ethanolic solutions for 20 hours. Before analysis, each sample was extensively rinsed 
with ethanol to remove loosely bound material and blown dry under flowing nitrogen. 
Scanning Probe Microscopy. AFM images were acquired using a commercial 
instrument with a deflection-type scanning head (Molecular Imaging, PicoSPM, Phoenix, 
AZ), controlled by an SPM1000 feedback electronics Revision 8 (RHK Technology Inc., 
Troy, MI).  The scanner was calibrated using the crystalline surfaces of both mica (0001) 
and Au (111) to establish lateral dimensions, with lattice constants of 0.56 nm and 0.288 
nm, respectively.  The z-scale was calibrated using monatomic Au (111) steps (0.235 nm) 
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and verified using the known thicknesses of n-alkanethiol SAMs.  Contact-mode images 
were acquired under ethanol using Si3N4 microlevers (VeecoProbes, Santa Barbara, CA) 
with a nominal force constant of  ≈0.5 N/m.    
To estimate film thicknesses, nanografting was employed to examine the comparative 
heights of the SAMs to grafted patterns of dodecanethiol and hexadecanethiol in the 
SAM layers.  Nanografting combines adsorbate displacement with the self-assembly of 
thiols on gold.11 Fabrication is accomplished while scanning by exerting pressure on an 
AFM tip, thus pushing through the matrix molecules to contact the underlying gold 
surface.  The pressure of the AFM tip is used to displace or scrape away selected areas of 
the matrix SAM, following the scanning track of the tip.  For nanografting, the imaging 
media contains a different thiol molecule than the matrix.  As the AFM tip scans at high 
force over nano-sized areas, matrix molecules are removed and replaced by new 
molecules from solution.  Nanografted structures can then be imaged using the same tip 
at low force.  The AFM controller was interfaced with a programmable vector scanning 
module (VSCAN, RHK Technology, Inc.) to enable automated scanning probe 
lithography.12 Sets of programmed motions were written and compiled into lithography 
scripts, to create designed surface arrangements of nanopatterns. 
FT-IR Measurements. FT-IR absorption spectra were measured in a Digilab FTS 
7000 series spectrometer with a wire grid infrared polarizer (p-polarized) and a Vee Max 
variable-angle specular reflectance accessory (reflectance angle 75˚).  Spectra (2000 cm-1 
- 900 cm-1) were collected using a cryogenic mercury cadmium telluride detector in a 
nitrogen-purged environment. 
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XPS Measurements. The X-ray photoelectron measurements were performed using a 
Kratos Axis 165 spectrometer at a vacuum of 4 × 10-10 Torr with monochromatic AlKα 
radiation.  The X-ray power used for the measurements was 144 W.  The samples were 
introduced into the vacuum chamber using a conductive carbon tape.  A wide scan survey 
and various slots of regions (Au 4f, S 2p, N 1s, O 1s and C 1s) were measured.  All 
measurements were performed in hybrid mode using both electrostatic and magnetic 
lenses, with a step size of 0.1 eV and sweep time of 60 s.  All individual region spectra 
were recorded in the FAT analyzer mode with pass energy of 80 eV, and an average of 10 
scans.  The energy resolution during acquisition of single region-scan was about 1.0 eV.  
Charge neutralizer was off during the measurements and binding energy calibration was 
done with respect to Au 4f at 84.0 eV. 
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